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Abstract 
 
Malaria and tuberculosis (TB) endemic regions overlap considerably, especially in 
sub-Saharan Africa. Although it is very likely that co-infections occur in these regions, 
not much is known about malaria-TB co-infections in humans, and how the interplay 
between these two infections might affect the prognosis of co-infected individuals. 
Furthermore, multiple Plasmodium infections will likely result in accumulation of 
malaria pigment (hemozoin) in host organs. Hemozoin was first thought of as an inert 
waste product resulting from hemoglobin digestion. However, several studies have 
associated the presence of hemozoin with host immunosuppression. Thus, the subject of 
this thesis was the study of Malaria-Tuberculosis co-infections with a particular focus 
on a possible role for hemozoin induced immunosuppression.  
For this, protocols for hemozoin production and characterization were first 
established. Then, in vitro studies to investigate how hemozoin ingestion affected 
cellular functions of human peripheral blood mononuclear cells (PBMC) were 
performed. For the first time hemozoin effects at the single cell level were investigated 
by flow-cytometry, using a novel method developed by us, which uses Side Scatter 
Depolarization for hemozoin detection.  
Following in vitro studies, we investigated hemozoin dynamics in host tissues of 
two murine models, post-malaria clearance. Hemozoin deposition in host organs was 
evaluated both by flow-cytometry, as well as by observation of histological preparations. 
Finally, the murine model was used to evaluate the susceptibility of Plasmodium 
infected mice to subsequent tuberculosis infection. Tuberculosis infection was evaluated 
during acute malaria, and during chronic Plasmodium infection.  
Results from in vitro studies suggested that hemozoin impaired cell functions and 
that these effects could be propagated to non-hemozoin containing cells. Hemozoin-
induced impairment decreased microbicidal activity, as shown by higher mycobacterial 
load in these cells. Our investigation of hemozoin kinetics in host organs revealed that 
hemozoin is dynamic within and between host organs, with very little signs of it being 
eliminated over time.  
Malaria-tuberculosis co-infection in vivo demonstrated that mice presenting with 
acute malaria, have a poor prognosis when co-infected with tuberculosis. Mice infected 
with tuberculosis during chronic malaria did not become as sick as mice during acute 
infection however, they still exhibited symptoms of malaria-induced anaemia. Thus, in 
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our model of co-infection hemozoin did not seem to contribute significantly to 
immunosuppression of the host nor to increased susceptibility to tuberculosis infection.   
Overall, we present a novel method for the detection of hemozoin that allowed 
functional investigation of hemozoin-containing and non-hemozoin containing 
leukocytes at the single cell level, in the same sample. This might be useful for further 
studies using leukocytes from malarious patients, who usually only have a few percent 
of these cells in circulation. We also provide evidence for poor prognosis of malaria-
tuberculosis co-infection. Furthermore, we demonstrated that following a malaria 
episode, hemozoin deposition in host organs did not seem to contribute to 
immunosuppression of the host nor to increased susceptibility to tuberculosis infection 
by M. bovis BCG. However, we observed that hemozoin-containing macrophages 
participated in granuloma formation in response to tuberculosis infection. This might 
prove relevant in the context of a tuberculosis infection by the virulent strain M. 
tuberculosis, in which tighter control by immune cells is necessary to prevent 
tuberculosis dissemination.  
 
Keywords: Hemozoin, Malaria, Tuberculosis, Immunosuppression, Co-infection.   
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Resumo 
 
As regiões endémicas da malária e tuberculose sobrepõem-se consideravelmente, 
especialmente na África sub-Saariana. Embora seja bastante provável que co-infecções 
entre malária e tuberculose ocorram nestas regiões, pouco se sabe sobre a sua incidência, 
ou como a sua interação poderá afectar o prognóstico de indivíduos co-infectados. 
Episódios consecutivos de malária poderão levar à acumulação do pigmento malárico 
(hemozoína) nos órgãos do hospedeiro. Inicialmente, a hemozoína era considerada um 
sub-produto inerte, resultante da digestão da hemoglobina pelo parasita. No entanto, 
vários estudos têm associado a presença da hemozoína com imunossupressão do 
hospedeiro. Assim, o tema desta tese foi o estudo da co-infecção malária-tuberculose, 
com especial foco no possível papel da hemozoína na indução de imunossupressão no 
hospedeiro.  
Neste projecto, começou por estabelecer-se protocolos para produção e 
caracterização de hemozoína. Consequentemente, foram realizados estudos in vitro para 
investigar o impacto da ingestão de hemozoína nas funções celulares de células 
mononucleadas do sangue periférico (PBMC) humanos. Pela primeira vez, os efeitos da 
hemozoína foram investigados por citometria de fluxo, utilizando um novo método 
desenvolvido por nós, que utiliza a detecção da despolarização da luz para a 
identificação de células que contêm hemozoína. 
Após esta caracterização in vitro, a dinâmica da hemozoína em tecidos do 
hospedeiro após a infecção por Plasmodium foi investigada, usando dois modelos de 
ratinho. A acumulação de hemozoína em órgãos do hospedeiro foi avaliada por 
citometria de fluxo, e pela observação de preparações histológicas, ao longo do tempo.   
Finalmente, o modelo de murino foi usado para avaliar a susceptibilidade de 
ratinhos com malária a uma subsequente infecção por tuberculose. A infecção por 
tuberculose foi avaliada durante as fases aguda e crónica de malária.  
Os resultados dos estudos in vitro sugerem que a hemozoína compromete funções 
celulares importantes e que estes efeitos podem ser propagados a células que não têm 
hemozoína. A inibição de funções celulares levou à redução da capacidade microbicida, 
como mostrado pelo aumento da carga bacteriana nestas células. Relativamente à 
avaliação da cinética da hemozoína nos tecidos do hospedeiro, este estudo revelou que a 
hemozoína tem uma distribuição dinâmica tanto dentro do mesmo órgão, como entre 
 IV 
 
diferentes órgãos do hospedeiro. Também se observou que, ao longo do tempo, a 
hemozoína não parece ser eliminada dos órgãos do hospedeiro. 
 Os ensaios in vivo de co-infecção malária-tuberculose demonstraram que ratinhos 
com malária desenvolvem uma doença fulminante, quando co-infectados com 
tuberculose. Este fenótipo agravado não foi observado em ratinhos infectados com 
tuberculose durante uma infecção crónica de malária, ainda que estes apresentassem 
sinais de anemia associada à malária. Tendo em conta os resultados obtidos com o 
nosso modelo, a hemozoína não parece contribuir de forma significativa para a 
imunossupressão do hospedeiro nem para um aumento de susceptibilidade à infecção 
por tuberculose. 
Em resumo, este trabalho apresenta um novo método para a detecção de 
hemozoína. Este método permitiu a investigação de funções celulares em leucócitos 
com e sem hemozoína na mesma amostra, ao nível celular. Esta metodologia poderá ser 
aplicada noutros estudos, nomeadamente na análise de leucócitos com hemozoína de 
doentes com malária, cujas percentagens são normalmente baixas. Os resultados 
apresentados nesta tese também sugerem que co-infecções de malária-tuberculose 
resultam numa deterioração rápida do hospedeiro. No entanto, como observado durante 
a infecção crónica de malária, a deposição de hemozoína nos órgãos do hospedeiro não 
parece contribuir para um aumento da imunossupressão do hospedeiro, não tendo sido 
observada uma maior susceptibilidade à infecção por tuberculose. Ainda assim, foi 
observado que macrófagos com elevado conteúdo em hemozoína contribuem 
significativamente para a formação de granulomas, em resposta à infecção por M. bovis 
BCG. Isto pode ser relevante no contexto de uma infecção de tuberculose pela estirpe 
virulenta M. tuberculosis, em que é necessário um controlo mais restrito por células do 
sistema imunitário para prevenir a disseminação da tuberculose. 
 
Palavras-chave: Hemozoína, Malária, Tuberculose, Imunossupressão, Co-
infecção. 
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General Introduction 
Malaria in ancient times 
Malaria’s history extends into antiquity and like many other parasitic infections has 
evolved hand in hand with humans. The first records of ‘periodic fevers’ can be found 
in Chinese manuscripts as early as 2700 BC. Later descriptions can also be found in 
manuscripts of Greek, Roman, Indian, Arabic and European physicians, up to the 19
th
 
century
[1]
. In the 5
th
 century BC Hippocrates made detailed accounts of the disease 
including the association with splenomegaly and classification of the fevers as tertian 
and quartan
[2]
. Furthermore, development of molecular techniques allowed the 
identification of ancient DNA from Plasmodium falciparum, one of the species causing 
malaria, in a 4000 year old Egyptian mummy
[3]
. Another study reported findings that 
support the hypothesis that a particular lethal form of malaria in the 5
th
 century A.D. 
contributed to the fall of the Roman Empire
[4]
.         
Discovery of the malaria parasite 
The name malaria comes from medieval Italian mal’aria meaning bad air since it 
was believed, until late in the 19
th
 century, to be caused by miasmas coming from 
swamps and marsh lands
[5]
. It was only after the work of Pasteur and Robert Koch and 
the establishment of the germ theory that the miasma theory fell out of grace and the 
search for the causative agent of malaria intensified
[6]
. In 1880 Charles Laveran, 
knowing that the spleens of malaria patients contained pigment (hemozoin), started to 
look for pigment in fresh unstained blood of patients. Laveran described different forms 
of erythrocytic organisms including crescents, spherical motionless bodies with pigment, 
spherical moving bodies with pigment and bodies that extruded flagella-like structures. 
He noted that these forms were present in all patients with malaria and that quinine 
removed these stages from the blood. He named this protozoan parasite Oscillaria 
malariae and presented his findings to the French Academy of Medical Sciences in 
1880
[7]
. However, it was only four years later that it was accepted that malaria was 
caused by a protozoan and not a bacterium. By 1890 three species of malaria were 
recognized, according to their specific periodicities and other characteristics: 
Haemamoeba vivax (benign tertian), Laverania malariae (malignant tertian) and 
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Haemamoeba malariae (quartan), now known as Plasmodium vivax, P. falciparum and 
P. malariae, respectively. Later in 1918, John Stephens discovered a forth human 
species that he named P. ovale
[6]
. More recently, P. knowlesi, previously known as one 
of the plasmodia infecting apes and monkeys
[8]
, was reported as a frequent natural 
human infection in the Malaysian Borneo
[9]
. Although, human-to-human transmission 
has yet to be documented conclusively, P. knowlesi is now recognized as a fifth 
plasmodia species infecting humans, with a transmission apparently restricted to 
Peninsular Malaysia
[10]
. 
 
                
                                
Figure I1. Mal’aria. It was early recognized that proximity to swamps and marsh lands was associated 
with the occurrence of febrile illness and hence the name Mal’aria meaning bad air was given to the 
disease today know as Malaria. 
 
Malaria transmission  
At the end of the 19
th
 century no malariologist could explain how the parasite 
spread from human to human. Before the discovery that mosquitoes were responsible 
for the transmission, the findings of William MacCallum were of great significance. 
MacCallum, in 1897 was the first to observe flagellated structures in the blood of crows 
infected with Haemoproteus columbae (a species closely related to malaria parasites). 
He also described how this flagellated structures fused with non-motile bodies to form a 
vermicule (now known as an ookinete) and suggested that he was observing sexual 
reproduction. He further suggested that sexual reproduction also occurred in human 
malaria parasites
[11]
. Meanwhile, Patrick Manson was increasingly convinced that 
mosquitoes could be involved in the transmission of malaria. However, he was under 
the misconception that mosquitoes would then contaminate drinking water and thus 
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indirectly infect humans. Since Manson himself was unable to go to malarious countries 
he convinced Ronald Ross, an army surgeon working in India, to pursue this 
investigation. So it was that in 1897, by combining Laveran’s idea of ‘following the 
pigment’ and Manson’s descriptions of the flagellum, that Ross showed that mosquitoes 
fed on the blood of malaria patients contained pigmented structures which ruptured and 
released rods that could then invade the mosquitoes’ salivary glands. Ross later 
demonstrated that mosquitoes fed on Plasmodium relictum-infected birds, took up male 
and female gametocytes which fused in the mosquito, developing into spores in the 
mosquito’s gut. From the spores, rod like structures could be produced that had the 
ability to invade the mosquito salivary glands and be injected into a new host when the 
infected mosquito fed
[12]
. Ross suggested that human malaria was probably transmitted 
in the same way but it was the work of Grassi, Bignami and Bastianelli that provided 
the definite proof. Grassi and his colleagues fed Anopheles claviger mosquitoes on 
infected patients and successfully transmitted the infection to uninfected individuals by 
the bite of these mosquitoes
[6]
.        
Malaria liver stage 
To complete the life cycle of the malaria parasite it remained necessary to 
discover what happened to the parasite in the first 10 days post-infection, during which 
it could not be observed in the blood. Although Grassi was the first to suggest that some 
sort of development must take place in cells other than the erythrocytes, it wasn’t until 
1937 that Sydney James and Parr Tate shed some light on the exoerythrocytic 
development of malaria. Their work demonstrated that, in chickens infected with 
Plasmodium gallinaceum there was a phase of parasite multiplication that occurred in 
reticuloendothelial cells, prior to the appearance of parasites in the blood
[13]
. Ten years 
later, in 1947, Henry Shortt and Cyril Garnham infected rhesus monkeys with P. 
cynomolgi and showed that a phase of development in the liver preceded the appearance 
of parasites in the blood. They further proved, using human volunteers, that P. vivax, P. 
falciparum and P. ovale also had an exoerythrocytic stage of development in the liver 
[14–16]
. 
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The life cycle of the malaria parasite in the mammalian host 
The life cycle of the Plasmodium parasite in the mammalian host starts with the 
bite of an infectious female mosquito, and the deposition of sporozoites in the dermis of 
the mammalian host. The sporozoites then follow an erratic forward movement through 
the dermis that culminates with their entry into the lumen of a capillary or lymph vessel 
(Figure I2). Recent data from a murine model estimates that sporozoites actually 
reaching the lymph vessels or capillaries are only 15 to 25%, respectively, whilst around 
60% of them remain  at the bite site
[17]
. Sporozoites that enter lymph vessels are carried 
to the proximal lymph node where they are degraded or partially develop, delivering 
early exoerythrocytic form (EEF) antigens
[18]
. Sporozoites that enter blood vessels, 
reach the liver where they will first glide along the sinusoids that are lined by 
endothelial and Kupffer cells. To cross the sinusoidal barrier, sporozoites are thought to 
wound Kupffer cells, and reach hepatocytes, although there are other possible 
mechanisms of sinusoidal barrier crossing
[19]
.  
Once across this barrier, sporozoites traverse several hepatocytes before invading 
a final one where they will further develop into the next infective stage
[20]
. Following 
this final hepatocyte invasion the sporozoite develops inside a  parasitophorous vacuole 
and undergoes a series of morphological changes that culminate in the generation of 
thousands of merozoites
[21]
. These merozoites are packaged together inside vesicular 
structures known as merosomes which are surrounded by the hepatocyte membrane. 
Merosomes bud off and detach from hepatocytes into the sinusoidal lumen
[22]
. Once in 
circulation, merosomes reach the lung microvasculature where they accumulate and 
eventually disintegrate, disseminating merozoites into the bloodstream
[23]
.  
The erythrocytic stage begins when merozoites released from the lung attach to 
specific receptors on the membrane of red-blood cells (RBC) and initiate asexual 
development. This stage is characterized by cyclic development of the parasite inside 
RBC from early ring stage, to early and late trophozoite stage and finally to schizont 
stage
[24]
. Depending on the parasite species schizonts may contain 6-32 merozoites
[25]
. 
The rupture of the schizont releases new merozoites into the bloodstream and these will 
then infect new erythrocytes and re-initiate the asexual cycle. During the repeated cycle 
of asexual development, some merozoites differentiate into male and female 
gametocytes. These can be taken up by female mosquitoes during a blood meal, thus 
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initiating the sexual blood stage of parasite development, and eventually be transmitted 
into a new host
[26]
. 
                                   
 
Figure I2. Plasmodium life cycle. In the mammalian host, infection starts through the bite of an infected 
Anopheles mosquito. Sporozoites are injected into the dermis and migrate rapidly from the region of the 
bite. Some sporozoites will enter lymph vessels and establish themselves in lymph nodes. Other 
sporozoites enter blood capillaries (1) and migrate to liver cells where they will establish the liver stage 
(2). This is the first stage of intracellular development where thousands of merozoites will be generated. 
Merozoites generated during the liver stage will then invade erythrocytes, and subsequently undergo 
cycles of asexual reproduction (3). During the blood stage some merozoites will differentiate into 
gametocytes (4) thus completing the life cycle when the sexual stages are ingested by a new Anopheles 
mosquito. 
 
Malaria: early 20
th
 century to today 
The discovery that mosquitoes played an essential role in the transmission of 
malaria provided malariologists with a new weapon against the disease. The first 
decades of the 20
th
 century saw concerted efforts to control malaria via reducing contact 
with infected mosquitoes. These efforts included drainage of swamps and free-laying 
water to eliminate mosquito breeding sites, and by promoting the protection of 
individuals from mosquito bites. Another strategy implemented was to make quinine 
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widely available to treat fever attacks in malaria-endemic areas, and later the use of 
quinine as a prophylactic measure
[27,28]
. These efforts contributed to the elimination of 
malaria from most northern countries in Western Europe. Further progress was achieved 
with the advent of dichloro-diphenyl-trichloroethane (DDT) and chloroquine. DDT’s 
success in reducing mosquito transmission and chloroquine’s efficacy against human 
malaria fuelled the belief that malaria could be eradicated globally. Thus, in 1955 the 
World Health Organization launched the Global Malaria Eradication Program (GMEP). 
As a result, by 1978, malaria was eliminated from 37 of the 143 countries in which it 
was endemic in 1950
[29]
. In other countries, although elimination was not achieved, the 
burden of disease and deaths due to malaria was greatly reduced. Despite the initial 
success of the GMEP, the program was closed by 1969, with the emergence of drug 
resistance, malaria resurgence in areas where its transmission had already been 
interrupted, reports of avoidance of vector contact with DDT, and the later ban on DDT 
use, fuelled by Rachel Carson’s ‘Silent Spring’[30].  As it became clear that there were 
countries where eradication was not feasible in the short term, and that control measures 
were more appropriate for the future eradication of malaria in those areas, a renewed 
interest in malaria research increased
[31]
.      
 
 
       
Figure I3: Malaria risk areas from mid 19
th
 century to present. In the 19
th
 century approximately 90% 
of the world population lived in malarious regions. Later in the same century and likely as a result of 
improved housing and changes in agricultural land use, large areas of North America and Northern and 
central Europe became malaria-free. Other events such as the discovery of the malaria parasite and its 
mode of transmission, discovery of DDT and chloroquine and the use of focal mosquito control measures 
resulted in the eradication of malaria in 37 out of the 143 countries in which it was endemic in 1950. The 
implementation of the Global Malaria Eradication Programme played a major role in this.  (Source: From 
malaria control to eradication: The WHO perspective.)
[29]
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Today, malaria is still transmitted in 106 countries, with 1.2 billion people living 
in high transmission areas that account for 225 million cases of clinical malaria and 
781,000 malaria-related deaths, mainly in children under age 5
[32]
.  Malaria transmission 
occurs primarily in tropical and subtropical regions in Sub-Saharan Africa, Asia, Middle 
East, Eastern Europe, Central and South America, Caribbean, the Indian subcontinent 
and Oceania
[33]
. However, the intensity and risk of malaria transmission is quite variable 
within tropical and subtropical areas, and even within the same endemic country. 
Highest transmission is found in warmer regions closer to the equator, whereas in cooler 
regions, transmission is likely to be less intense and more seasonal
[34,35]
. Within 
endemic regions, malaria transmission will depend on factors such as urbanization, 
altitude, proximity to sea, river or floodplain, local climate, land use, local vector 
species and vector breeding sites, waste management, human movement patterns, 
socioeconomic factors and local malaria intervention programs
[36]
. 
The current research agenda aims primarily to control and reduce morbidity and 
mortality. Others, such as the Malaria Eradication Research Agenda (malERA), aim at 
identifying strategies, which will ultimately lead to the complete eradication of the 
parasite. Past failures have helped to recognize that malaria eradication will only be 
possible with concerted efforts to develop not only new tools for malaria control, but 
also with a sustained commitment from local communities, civil society, policy leaders, 
and the scientific community, to implement the necessary strategies for control and 
elimination of malaria
[32]
.   
Tuberculosis – brief overview 
Evidence of tuberculosis (TB) disease has been found in 5000 year old Egyptian 
mummies
[37,38]
. Contrary to the earliest view of an animal origin for TB, there is now 
evidence to support the idea that the Mycobacterium tuberculosis complex originated as 
a human pathogen in Africa, and spread throughout the world via the Out-of-Africa 
migrations of modern humans
[39]
. During the seventeenth and eighteenth centuries, 
tuberculosis increased dramatically in Europe and North America
[40]
. This was likely 
fuelled by the industrial revolution and the extremely poor socio-economic conditions, 
such as overcrowding, malnutrition, lack of hygiene and sanitation and poor access to 
medical care
[41]
. In 1882 the etiologic agent of tuberculosis was first identified by 
Robert Koch
[42]
. Later, he would develop tuberculin and present it as a remedy against 
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tuberculosis. Although the use of tuberculin for the treatment of tuberculosis would 
prove a failure it would later lead to the development of the tuberculin skin test (also 
known as purified protein derivative (PPD) or Mantoux)
[43]
. Mortality rates began to 
decline by the mid-nineteenth century, perhaps due to improved living conditions, better 
nutrition and increased social conditions
[44]
. With the isolation of streptomycin in 1944, 
the first antibiotic effective against tuberculosis became available
[45]
. However, 
streptomycin only became available in Europe later and the first treatment report was 
only published in 1950
[46]
. Meanwhile, another compound, p-aminosalicylic acid (PAS), 
became available for the treatment of tuberculosis in conjunction with 
streptomycin
[47,48]
. However, it was the discovery of isoniazid’s superior activity against 
tuberculosis
[49,50]
 that soon brought an end to sanatoriums and collapse therapy, and 
started a new era for the control of tuberculosis. 
Today, tuberculosis still remains a global problem with an estimated 8.7 million 
new cases and 1.4 million deaths in 2011. Geographically, the burden of tuberculosis is 
highest in Asia and Africa, with 60% of cases in South-East Asia and Western Pacific 
regions whilst the African region accounts for 24% of the world’s cases. Almost 80% of 
tuberculosis cases among people with HIV occur in Africa
[51]. WHO’s (World Health 
Organization’s) current goal for tuberculosis care and control, endorsed by the Stop TB 
Strategy, is to reduce tuberculosis prevalence and deaths by 50% by 2015 and to 
eliminate tuberculosis as a public health problem by 2050
[51]
.  
Tuberculosis, the disease and immunity 
Tuberculosis disease 
Tuberculosis (TB) is spread by the inhalation of airborne droplet nuclei, which are 
small size particles of 1-5 µm in diameter containing M. tuberculosis bacilli. Their small 
size allows them to pass into the lower respiratory tract
[52]
. Ingestion of M. tuberculosis 
by alveolar macrophages in the lung leads to a series of events that either results in the 
successful containment of the infection, or progression to active disease (primary TB 
disease). The risk of developing active disease will depend on factors such as time since 
infection, age and host immunity
[53]
. One third of the world population is estimated to 
be latently infected with M. tuberculosis and of those only 5-10% will ever develop 
active disease
[54]
.  
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Typical symptoms developed during tuberculosis disease vary from development 
of fever, weight loss and night sweats, to persistent cough and development of 
radiological abnormalities such as thoracic lymphadenopathy and lung cavities or 
densities
[55]
. Development of primary tuberculosis weeks or months following first 
exposure occurs frequently in young children, the elderly or immunodeficient patients. 
This is often characterized by disseminated infection to other organs, such as liver, 
kidney, bone marrow and meninges. In other individuals, tuberculosis infection 
develops only years later after exposure from a previous latent asymptomatic infection. 
This is normally characterized by a predominant pulmonary infection of the upper 
lungs, which in some cases can progress to extra-pulmonary tuberculosis via lymphatic 
and/or hematogenous spread (reviewed by Brändli
[56]
).       
Innate immnuity 
The initial response to M. tuberculosis infection is thought to involve 
phagocytosis by alveolar macrophages, neutrophils and dendritic cells
[57–60]
. 
Macrophages and neutrophils are thought to act as the initial line of defense against TB 
by producing and secreting antimicrobial peptides, cytokines, and chemokines
[61]
. 
Phagocytosis of M. tuberculosis by macrophages involves various receptors, including 
the mannose receptor, scavenger receptors and complement receptors
[62]
. Within 
infected macrophages, lipid mediators, such as prostaglandin E2 (proapoptotic) or 
lipoxin (pronecrotic) will determine downstream events that will either lead to the 
induction of apoptosis or necrosis. Necrotic death of macrophages is associated with 
immune evasion and cell-to-cell spread of the bacilli whilst apoptotic death is associated 
with enhanced immunity and diminished pathogen viability
[63]
.   
The role of neutrophils in tuberculosis infection is still not clear, with reports 
suggesting that they can participate in granuloma formation
[64]
 and facilitate the 
activation of adaptive immune responses by delivering bacilli to dendritic cells in a 
form that enables dendritic cells to more effectively activate CD4 T-cells
[65]
. Other 
reports suggest that neutrophils play a detrimental role in the pathogenesis of 
tuberculosis, with increased neutrophil numbers associated with respiratory failure and 
mortality in active tuberculosis patients
[66]
. In the murine model, susceptible mouse 
strains feature higher numbers and accelerated recruitment of neutrophils into the lungs, 
as compared to more resistant mouse strains
[67]
. M. tuberculosis can inhibit apoptosis of 
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both macrophages and neutrophils which in turn can result in delayed activation of 
naïve CD4 T-cells in the lymph nodes 
[68]
.  
Intracellular mycobacteria within macrophages can be killed by different 
mechanisms, such as production of reactive oxygen and nitrogen species
[69–71]
. Another 
potential mechanism of mycobacterial killing is macrophage activation, which leads to 
phagosome maturation and fusion with the lysosome
[72,73]
. However, M. tuberculosis 
has developed mechanisms to counteract the bactericidal activity of macrophages.  
Studies have demonstrated that mycobacteria are capable of inhibiting phagosome-
lysosome fusion and can also produce ammonia which could further help mycobacteria 
cope with phagosome acidification
[74]
. Sulfatides, a glycolipid produced by 
mycobacteria can also inhibit phagosome-lysosome fusion
[75]
. It was also demonstrated 
that virulent strains of mycobacteria can escape the phagolysosome into cytoplasmic 
vacuoles that do not fuse further with secondary lysosomes
[76,77]
. Establishment of an 
asymptomatic latent state is viewed by some as a resistance mechanism in its own right, 
enabling mycobacteria to attain a state of dormancy and persist for quite some time in 
this state in host tissues
[78]
. 
During innate response, cytokines such as TNF-α can play a major role in the 
killing and control of mycobacterial growth. The essential role of TNF-α was 
demonstrated in humans receiving anti-TNF treatment for rheumatoid arthritis or 
Crohn’s disease. Individuals latently infected with tuberculosis and receiving anti-TNF 
therapy had higher rates of reactivation of active tuberculosis
[79,80]
. Experiments in mice 
in which TNF-α was lacking, either through antibody treatment or by genetically 
knocking out the TNF receptor, demonstrated that without TNF-α/TNF receptor M. 
tuberculosis infection is lethal, with both increased bacterial load and necrosis within 
granulomas
[81]
. It has been demonstrated, in a cynomolgus macaque latency model, that 
TNF-α neutralization leads to disseminated disease and reactivation in most animals 
with latent tuberculosis, ultimately leading to fulminant disease
[82]
.   
The granuloma 
Intracellular killing and control of mycobacteria by macrophages is aided by the 
action of T-cells. T-lymphocytes can be recruited to sites of mycobacterial infection by 
the action of TNF-α and further assist macrophages in the growth inhibition and killing 
of mycobacteria
[83]
. Macrophages and T-cells come together and form a specialized 
structure called the granuloma. Although granulomas can be formed in response to 
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several infectious and non-infectious agents, tuberculosis is the most frequent cause, 
with granulomas being seen as the hallmark of TB infection
[84]
. The granuloma is an 
organized structure of epithelioid cells. These originate from macrophages that 
underwent a specialized transformation into cells with tightly interdigitated cell-
membranes, linked to adjacent cells. Other macrophages in the granuloma fuse into 
multinucleated giant cells or differentiate into foam cells. Foam cells, derive their name 
from their high lipid content and are often found at the edge of the necrotic centre in 
mature granulomas. Mycobacteria are commonly found at the centre of the necrotic 
regions together with dead/dying macrophages. Other cells participating in the 
granuloma structure are neutrophils, dendritic cells (DC), B- and T-cells, natural killer 
(NK) cells, fibroblasts and cells that secrete extracellular matrix components. Epithelial 
cells are also normally found surrounding the outer region of the granuloma
[85]
.  
Classically, the granuloma is seen as a protective structure that helps to contain 
and kill mycobacteria until effector mechanisms of the adaptive immune response come 
in play. This idea is supported by evidence from old autopsy studies of individuals who 
died from unrelated causes, which revealed the presence of  healed granulomas that 
contained no trace of viable bacteria, even after inoculation into the extremely 
susceptible guinea pig
[86,87]
. Further evidence is provided by deficiencies in TNF-α 
which are associated with the presence of disorganized granulomas and increased 
susceptibility to tuberculosis infection
[88–91]
. However, recent evidence suggests that 
mycobacteria exploit granuloma formation for their own proliferation and dissemination 
in the host
[92]
. Using a larval-zebrafish model of M. marinum infection, it was 
demonstrated that granulomas could form in the context of innate immunity
[93]
. Further 
insight was obtained from dynamic imaging studies which demonstrated that new 
macrophages arriving at the granuloma show a continuous and dynamic movement 
throughout the entire structure, instead of the long-held view that they are static within 
granulomas. The rapid and continuous migration of the newly arrived macrophages 
provides them access to numerous dying infected cells within the granuloma. The 
moving macrophages can then phagocytose the contents of dying macrophages, thereby 
becoming infected themselves and thus increasing the number of infected cells
[85,94]
. 
Studies of this dynamic process of macrophage movement also demonstrated that 
primary granulomas can seed new granulomas via the egress of infected macrophages. 
Thus, these data implicate the granuloma as a primary mean of disseminating 
infection
[94]
. 
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Adaptive immune response 
The adaptive immune response to M. tuberculosis is initiated not in the lung 
granuloma but in the draining lymph node. However, the initiation of the adaptive 
immune response is characterized by a lag in its initiation, which has been attributed to 
a delay in the migration of infected DC from primary granulomas to lymph nodes
[95,96]
. 
Regulatory T-cells (Treg) may also play a role by inhibiting the induction of Th17 cells 
that would otherwise lead to the recruitment of Th1 effector T-cells to the sites of 
infection in the lung
[97]
. It was also demonstrated that M. tuberculosis-specific Treg cells 
present in pulmonary lymph nodes are capable of delaying the priming of effector CD4 
and CD8 T-cells and  their subsequent accumulation in the lung
[98]
. On the other hand, 
even after pathogen-specific effector T-cells arrive in the lung, it seems that 
mycobacterium-infected macrophages remain unresponsive to T-cell help and fail to 
increase their microbicidal activity
[99]
. Eventually, adaptive, Th1-mediated immunity 
controls M. tuberculosis lung infection and the mycobacteria are thought to assume a 
state of nonreplicating persistence
[100]
. During chronic infection, effector T-cell 
responses continuously control infection, hence the risk of disease reactivation if these 
T-cell responses are lost or suppressed. Recent studies suggest that these effector T-cells 
responses are maintained from a proliferative population of CD4 T-cells expressing PD-
1 (programmed cell death protein-1)
[101,102]
. PD-1 expressing T-cells are normally 
regarded as functionally exhausted
[103]
, however, in tuberculosis this seems not to be the 
case. PD-1
+
 cells seem to exhibit a high degree of proliferation and continuously give 
rise to antigen-specific effector T-cells necessary to maintain a protective response 
during chronic tuberculosis infection
[101,102]
.  
Malaria co-infections with other endemic infectious diseases 
The considerable geographic overlap between malaria, HIV/AIDS and 
tuberculosis is well known
[104]
. However, individuals living in these endemic areas are 
exposed to several other pathogens causing diseases such as, buruli ulcer, chagas, 
cholera, dengue, sleeping sickness, leishmaniasis, leprosy, lymphatic filariasis, 
schistosomiasis, and other helminthiasis
[105]
 (Table I1). Bacteremia is also common in 
malaria endemic areas and a frequent cause of febrile illness and acute pediatric 
admissions that may be mistaken as malaria
[106]
. This can lead to a delay in diagnosis 
and failure to treat severe bacterial infections. However, more often than not a 
Malaria and Tuberculosis co-infection: a role for Hemozoin immunosuppression? 
13 
 
significant proportion of the populations living in sub-Saharan Africa will be 
polyparasitized with helminths, schistosomes, and filarial worms
[107]
. Occurrence of 
bacteremia concomitantly with malaria is also common with either malaria predisposing 
to bacteremia
[108,109]
 or bacteremia causing more severe malaria
[110]
. Increasing evidence 
suggests that HIV/AIDS, tuberculosis, and malaria occur predominantly in populations 
who are polyparasitized
[111,112]
. Helminths, being the most common parasite found in 
HIV-, tuberculosis-, and malaria-infected populations
[113]
.   
 
Disease Pathogen Approximate 
global prevalence 
Major affected areas 
Ascariasis Ascaris lumbricoides 800 million Asia, Africa, Latin America 
Chagas  Trypanosoma cruzi 10 million Latin America 
Hookworm Necator americanus and 
Ancylostoma duodenale 
600 million Asia, Africa, Latin America 
Human African 
Trypanosomiasis 
 Trypanosoma brucei  <0.1 million Africa 
Leishmaniasis  Leishmania sp 12 million Asia, Africa, Latin America 
Leprosy  Mycobacterium leprae <0.5 million Asia, Africa, Latin America 
Lymphatic Filariasis 
 
Wuchereria bancrofti,  
Brugia malayi and Brugia timori 
115 million Asia, Africa, Latin America 
Onchocerciasis Onchocerca volvulus 26 million Asia, Africa, Latin America 
Schistosomiasis Schistosoma sp 200-600 million Asia, Africa, Latin America 
Trachoma Chlamydia trachomatis 41 million Asia, Africa, Latin America 
Trichuriasis  Trichuris trichiura 600 million Asia, Africa, Latin America 
 
Table I1. Prevalence of pathogens commonly found in malaria endemic areas. Individuals living in 
malaria endemic areas are exposed to a variety of other pathogens. The group of pathogens presented in 
the table is part of a group known as neglected tropical diseases (NTD), common in impoverished tropical 
regions and for which known preventive measures and/or medical treatments exist in more developed 
countries. Together NTD have an impact comparable to that of malaria or tuberculosis. Table adapted 
from Hotez
[114]
.  
 
Malaria and HIV 
With respect to malaria-HIV co-infection it has been shown that malaria infection 
can transiently enhance/reactivate viral replication
[115–118]
. Thus, it is likely that a 
positive correlation exists between areas of malaria prevalence and the risk of HIV 
infection. The first study to provide evidence for this correlation was conducted in East 
sub-Saharan Africa (including data from Kenya, Malawi and Tanzania) by Cuadros et 
al
[119]
. In contrast, another study performed by the same group, this time in western sub-
Saharan Africa (Burkina Faso, Ghana, Guinea, Mali, Liberia and Cameroon) found no 
evidence of an association between malaria incidence and HIV infection. The western 
region of sub-Saharan Africa has a lower prevalence of HIV than the eastern regions, 
which suggests that malaria might only contribute to the spread of HIV where the 
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incidence is already high, with malaria acting as a facilitator of HIV transmission rather 
than as a contributor to HIV dissemination throughout the general population
[120]
. 
HIV and malaria co-infection is associated with a higher risk of fetal anemia, cord 
blood malaria parasitaemia, and low birth weight and post neo-natal mortality
[121–123]
. 
The risk of increased malaria severity appears higher in HIV positive individuals, and is 
further associated with a low CD4
+
 T-cell count
[124,125]
. There is little information 
regarding the impact of malaria on HIV pathology. However, epidemiological data 
indicates a higher morbidity in malaria-HIV-positive patients and an increased risk of 
HIV vertical transmission
[126]
. Malaria infection has been shown to induce cytokine 
production, leading to the activation of CD4
+
 T-cells. This may prove detrimental for 
HIV positive individuals with higher CD4
+
 T-cell counts, as more T-cells will become 
available for viral replication
[116]
. On the other hand, repeated P. falciparum episodes 
have been shown to contribute to a faster decline in CD4
+
 T-cell counts, potentially 
leading to more rapid progression to AIDS
[127]
. There is also evidence that the malaria 
pigment (hemozoin), which is produced by the malaria parasite during infection, might 
play an important role in viral transfer of HIV from dendritic cells (DC) to CD4 T-cells. 
This is thought to involve the induction of a partial maturation phenotype on DC upon 
exposure to hemozoin, which renders DC less permissive to HIV infection, whilst 
enhancing viral transfer to CD4 T-cells
[128]
.  
Malaria and helminths  
The most common parasitic worm found in helminth-malaria co-infections is 
Ascaris lumbricoides, followed by hookworm and Schistosoma
[129]
. While several 
studies seem to indicate that Ascaris co-infection is associated with a reduced 
prevalence and/or reduced parasitaemia
[130–132]
, others indicate an increase in malaria 
prevalence 
[133,134]
. Ascaris-malaria co-infection has also been associated with improved 
protection against severe malaria in adults
[135,136]
. On the other hand, hookworm co-
infection seems to mostly be associated with an increase in malaria severity
[137–139]
. 
Disparity in results can be explained by variability in the study design, the age groups 
sampled and on the parameter reported (malaria prevalence, incidence or protection 
against severe disease).  
Helminthic infection is known to skew the immune reaction towards a Th2/Treg 
type response. This is particularly relevant when considering co-infections with malaria 
since it has the potential to modify the malaria-specific immune response. Observations 
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that helminthic infection was protective against more severe forms of malaria may be 
explained by the induction of high amounts of IgE. This in turn leads to the release of 
anti-inflammatory IL-10 and nitric oxide which contributes to a reduction in 
sequestration of parasitized red blood cells, thus decreasing the chances of cerebral 
malaria
[140]
. Another explanation is that helminth-infected individuals feature a higher 
induction of regulatory T-cells, that inhibit Th1 T-cells and their pro-inflammatory 
activity
[141,142]
. On the other hand, increased incidence of clinical malaria cases in 
helminth-infected individuals may be explained by a shift in antibody subclasses, from 
malaria-protective cytophilic subclasses (IgG1 and IgG3) to a more predominant 
subclass of non-cytophilic antibodies (IgG2, IgG4 and IgM)
[143]
. Another aspect to take 
into consideration is that studies on immunologic effects of helminthic infections tend 
to pool worms together into a single group, based on the assumption that they induce 
similar immune responses. However, it is clear from epidemiological studies that 
different worms can have different interactions with the host, with Ascaris lumbricoides 
contributing to a milder malaria outcome, and hookworm apparently contributing to 
higher malaria incidence
[129]
. 
Malaria and bacterial infections 
Together with helminths, bacteremia is also widespread in sub-tropical and 
tropical regions
[105]
. However, contrary to what is seen with helminth co-infection, 
where some appear advantageous to the host (ie, less incidence of severe malaria and 
protection against allergic and auto-immune diseases), bacteremia-malaria co-infections 
appear always to be detrimental, with only a few studies reporting no further association 
between co-infection and disease severity. 
Although evidence of an association between Salmonella infection and higher 
incidence of malaria cases had been noted as early as 1929
[144]
, with Japanese 
investigators reporting malaria-related complications of syphilis therapy due to 
Salmonella infection
[145]
, at this time a direct association between malaria and 
bacteremia had not been clearly established. Mabey et al were the first to conduct a 
retrospective study showing a direct association between septicemia and malaria 
incidence
[146]
. In their study, non-typhi Salmonella (NTS) was reported as the most 
common bacteremia isolated from blood (mostly in children under 4 years of age), 
followed by Salmonella typhi (commonly in older patients), coliforms, Streptococcus 
pneumonia and Haemophilus influenza. Malaria or evidence of recent malaria was more 
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commonly found in patients with NTS septicemia than other septicemias. More 
importantly, Mabey and colleagues found that, whilst the carriage of Salmonella in stool 
samples did not seem to change throughout the year, a higher incidence of Salmonella 
septicemia cases occurred during the rainy season, concomitantly with malaria. This 
suggested that malaria predisposed to NTS sepsis
[146]
. Others have published similar 
findings, associating malaria with persistent fever due to bacteremia/sepsis
[147–151]
. 
Association of bacteremia/sepsis with increased malaria severity was suggested by 
some of the smaller studies/case reports mentioned above, however this was more 
clearly demonstrated by a large study in Kenya, performed by Berckley et al. In his 
study, the most prevalent species found in blood cultures were Streptococcus 
pneumoniae, followed by Staphylococcus aureus, Salmonella non-typhi, Haemophilus 
influenzae and Pseudomonas aeruginosa. Children under six months of age were more 
affected than those between 6 and 30 months. Nonetheless, in both age groups 
bacteremia was correlated with higher mortality in children with a previous diagnosis of 
severe malaria
[110]
. The authors further proposed that young children presenting with 
severe disease consistent with malaria infection be treated with anti-malarial drugs as 
well as broad-spectrum antibiotics, to cover cases where disease is actually caused by 
bacterial infection. Further studies suggested that bacteremia caused by Gram-negative 
organisms is associated with low-density parasitaemia, higher incidence of severe 
malaria anaemia (SMA) and increased susceptibility to respiratory distress
[106,108,152,153]
.  
Whilst two studies reported reduced rates on invasive NTS and other bacteremia 
associated with reductions in malaria incidence
[109,154]
, an association between 
bacteremia and malaria severity, or higher incidence of bacteremia in malarial 
individuals is not always  observed
[155,156]
. Other confounding factors such as blood 
culture contaminants, nutritional status and prevalence of HIV and malaria transmission 
might contribute to different observations.  
The mechanisms by which malaria might predispose to bacteremic infections, 
mainly NTS, were reviewed by Graham et al
[157]
.  This include altered antibody 
responses and humoral immunity to Salmonella antigens; low serum complement which 
is associated to lower bactericidal activity; inhibition of Fc-receptor mediated 
phagocytosis; increased iron availability due to malaria induced hemolysis; and 
alteration of bactericidal functions induced by the ingestion of hemozoin, which will be 
described later in the introduction.  
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Malaria and Tuberculosis  
Molecular studies of ancient DNA suggest that malaria-tuberculosis co-infections 
were already common place in ancient Lower Egypt. It is likely that the increased 
agricultural development at the time, together with increased population density, 
contributed to the spread of both malaria and tuberculosis
[158]
. However, the information 
available today regarding incidence of malaria-tuberculosis co-infections, their possible 
interactions and potential outcomes are still very limited. It is possible, that this 
limitation comes from the generalized idea that the two diseases do not spatially 
overlap. Even though both malaria and tuberculosis are endemic in sub-Saharan Africa 
(Figure I4), malaria incidence is greater in rural areas whilst tuberculosis incidence is 
higher in crowded urban areas
[159,160]
. A recent review on tuberculosis-parasitic disease 
co-infections found 44 studies, of which 22 were case reports, five were 
epidemiological studies and 17 were immunological research/reviews. However, on 
malaria-tuberculosis co-infection specifically, only one case report, one epidemiological 
study and three immunological research/reviews were found
[161]
. The epidemiological 
report refers to a study in Tanzania where 3% of tuberculosis infected patients also had 
malaria
[162]
. A more recent report showed incidence of malaria co-infection in 37.5% of 
tuberculosis infected patients in Angola
[163]
. Only one study has associated malaria with 
increased mortality among tuberculosis infected individuals, by demonstrating that the 
outcome of severely ill tuberculosis patients could be improved by preventing/reducing 
malaria transmission
[164]
. 
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Figure I4. Overlap of Malaria-Tuberculosis endemic regions. Shown, are estimated incidences of 
malaria and tuberculosis for 2011, according to the WHO 2013 report. Shades of purple represent regions 
endemic for both malaria and tuberculosis. Dark-purple represent regions with high incidence of both 
malaria and tuberculosis; light-purple represent regions in which tuberculosis’ incidence is higher than 
malaria (<5.000).    
 
 
Even though malaria-tuberculosis interactions in humans are poorly characterized 
several studies have been performed using animal models. Early studies reported that 
M. tuberculosis infection could confer protection against Plasmodium infection in non-
human primates
[165,166]
. In the murine model, M. bovis BCG was also shown to confer 
protection against several murine Plasmodium species
[167–169]
.  This suggested that the 
immune response elicited by infection with mycobacteria could have desirable 
protective effects against malaria. Further investigation suggests that the protective 
effect of BCG vaccination is possibly due to a shift towards a Th-1 type response 
following parasite infection. Thus, susceptible A/J mice vaccinated with BCG become 
more resistant to infection with the lethal strain P. yoelii 17XL
[170]
. Conversely, a 
different study demonstrated that C57BL/6 mice infected with M. tuberculosis became 
more susceptible to an otherwise non-lethal infection with P. yoelii 17X. Co-infected 
mice had increased mortality compared to control mice infected with P. yoelii alone, 
higher mycobacterial loads than control mice infected with M. tuberculosis, and higher 
numbers of IFN-γ producing CD4 T-cells[171]. Work by the same group also 
demonstrated that mice normally susceptible to P. yoelii 17XL became resistant if they 
were pre-infected with M. tuberculosis; this protection was associated with a higher 
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magnitude of a Th-1 type response. Contrastingly, BALB/c mice gained no protection 
against malaria following M. tuberculosis pre-infection
[172]
. To add to these findings, a 
different study again showed that C57BL/6 mice normally resistant to P. chabaudi 
infection became susceptible if they were previously infected with M. bovis BCG. In 
parallel, A/J mice normally succumb to P. chabaudi infection but became resistant 
following M. bovis BCG infection
[173]
.  
The effect of malaria-tuberculosis co-infection on the progression of tuberculosis 
disease has also been investigated. One study reported that malaria exacerbates 
tuberculosis, with co-infected mice exhibiting higher bacterial loads, and higher levels 
of circulating inflammatory cytokines. In this study it was also suggested that malaria, 
and possibly hemozoin accumulation in granulomas, might promote tuberculosis 
reactivation in a model of latent tuberculosis
[174]
. A second study reported that, even 
though malaria-tuberculosis co-infected mice were more resistant to malaria, the 
concomitant tuberculosis disease was more severe. Co-infected mice had lower levels of 
malaria parasitaemia but increased mycobacterial loads and inflammation in the lungs. 
The inflammatory response in these mice was significantly altered with cytokines in 
tissue and sera increased to levels similar to those observed in sepsis
[175]
. The different 
tuberculosis/parasite versus host strain combination and consequent outcome of the 
above studies are summarized in Table I2. 
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Mycobacterium sp Plasmodium sp Mice 
strain 
Findings/Outcome Reference 
M. bovis BCG 
(Tokyo) 
P. yoelii 17XL 
 
A/J BCG protects mice from lethal 
infection with P. yoelii. Protection 
was associated with higher levels of 
Th1 cytokines.  
Matsumoto S. 
 (Yamada T.), 
2001[170] 
M. tuberculosis 
(CDC1551) 
P. yoelii 17X NL 
 
C57BL/6 22% co-infected mice died vs 10% 
in P. yoelii group. Lethality was 
associated with higher bacterial 
burdens and higher levels of IFN-γ 
in co-infected animals  
Scott C.  
(Manabe Y.), 
2004[171] 
M. tuberculosis 
(CDC1551) 
P. yoelii 17XL C57BL/6 
BalbC 
Exposure to M. tuberculosis 
conferred protection to C57BL/6 
but not BalbC mice through 
enhancement of Th-1 response  
Page K,  
(Manabe Y.), 
2005[172] 
M. bovis BCG, 
(Copenhagen) 
P. chabaudi AS C57BL/6 
A/J 
P. chabaudi infection in previously 
BCG infected animals became 
lethal in C57BL/6 mice whilst it 
conferred protection to A/J mice. 
Lethality was associated with an 
earlier and stronger Th-1 type 
response in C57BL/6 mice than A/J  
Leisewitz A., 
2008[173]  
M. bovis BCG 
(Pasteur) 
P. chabaudi AS C57BL/6 
 
Infection of C57BL/6 mice with P. 
chabaudi exacerbated acute BCG 
infection and promoted reactivation 
of latent mycobacterial infection 
Hawkes M. 
(Kain K.), 2010[174] 
M. tuberculosis 
(H37Rv) 
P. berghei NK65 C57BL/6 
 
Co-infection exacerbated chronic 
tuberculosis while protecting mice 
against Plasmodium infection. 
Exacerbation of tuberculosis was 
associated with uncontrolled 
production of inflammatory 
cytokines by innate cells.   
Mueller A-K 
(Schneider B.), 
2012[175] 
 
Table I2.  Malaria-Tuberculosis co-infection studies in the murine model. Co-infection studies in the 
murine model suggest that tuberculosis infection can modulate the immune response to a subsequent 
infection by the malaria parasite and influence the outcome of co-infection. 
 
 
Other work has focused on the potential effect of BCG infection on experimental 
vaccination against malaria or the effect of malaria on novel tuberculosis vaccines. An 
initial study investigated the interaction of BCG vaccination administered together with 
irradiated sporozoites. As BCG infection was shown to confer some protection to 
malaria, the idea was that it may have an adjuvant effect when given together with 
irradiated sporozoites (an experimental anti-malaria vaccine). The authors found that 
BCG infected mice survived the first challenge with live sporozoites, but not subsequent 
challenges, whilst those mice vaccinated with irradiated sporozoites alone, that survived 
the first challenge, all survived subsequent challenges. Vaccinating mice both with BCG 
and irradiated sporozoites appeared to have a synergistic effect on them, with increased 
protection against a first challenge, however they were unable to survive subsequent 
challenges. These results suggests that although BCG infection can induce a non-
specific protection against malaria, this protection in short lived and, more importantly, 
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it appears to interfere with the protective immunity induced by other live vaccines
[176]
. 
A second study evaluated if malaria co-infection would disrupt the protective anti-
tuberculosis immunity induced by BCG vaccination or other experimental tuberculosis 
vaccines. Results seem to indicate that protective immunity induced by either of the 
anti-tuberculosis vaccines tested was not affected by malaria co-infection. Mice infected 
with the Plasmodium parasite malaria after tuberculosis vaccination remained resistant 
to tuberculosis infection upon challenge at the same level as vaccinated mice that were 
not co-infected with malaria
[177]
.     
Taken together, studies in animal models suggest that malaria and tuberculosis 
infections can mutually influence each other and the outcome of co-infection will 
ultimately depend on the overall immune response elicited in the host. 
Malaria, the disease and immunity 
Malaria disease 
Of the five Plasmodium species known to infect humans, P. falciparum is the 
most deadly. Overall, infection by Plasmodium frequently results in a mild, 
uncomplicated febrile illness characterized by intermittent episodes of fever and peaks 
of parasitaemia. Other symptoms such as chills, nausea, headaches, diarrhea and 
muscular pain are also common and usually occur just before or at the time of schizont 
rupture. In endemic regions of Africa where P. falciparum is predominant some malaria 
infections, particularly in young children, progress to severe disease and may lead to 
death. Malaria severe disease can be divided in three overlapping syndromes: cerebral 
malaria, metabolic acidosis and severe anaemia
[178]
. Another form of severe disease is 
placental malaria a common complication of malaria infection during pregnancy that 
may result in fetal loss or babies of low birth weight
[179]
.  
Sequestration of infected RBC to endothelial cells causes cell injury, promotes 
disruption of blood flow and leads to the development of tissue hypoxia and lactic 
acidosis. These mechanisms can contribute to the development of cerebral malaria due 
to sequestration of parasites in the brain. Severe anaemia may develop not only due to 
the hemolysis of infected and uninfected RBC but also due to inhibition of 
erythropoiesis
[178]
. Whilst cerebral malaria is more common in 3- to 4- year old 
children, living in lower endemic regions, severe malaria anaemia occurs more 
frequently in children younger than 3 years of age, living in higher endemic regions
[179]
. 
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Malaria acidosis affects children of all age groups equally. Children with acidosis often 
present with respiratory stress and other clinical symptoms resembling sepsis such as 
hypovolaemic shock. Metabolic acidosis, especially when occurring concomitantly with 
impaired consciousness, is considered as strong predictor of death. The majority of 
malaria related deaths occur within 12 hours of admission before antimalarial 
medication can have its full effects. Therefore, implementation of supportive therapies 
together with fast acting antimalarial drugs is important to improve the outcome of 
severe malarial cases
[180]
.  
Exo-erythrocytic stage immunity 
As mentioned earlier malaria infection in the mammalian host starts with the bite 
of an infected mosquito. Some sporozoites deposited in the skin enter blood capillaries 
through gliding motility, whilst most remain in the skin or make their way to lymph 
vessels, in a recently described “skin stage”[17]. Most lymph parasites are captured and 
degraded by dendritic cells and, while it was demonstrated that a host response can be 
induced by these captured parasites
[181]
, it remains unclear if the host possesses an 
innate immune response able to detect sporozoites in the “skin stage”.  
Sporozoites that reach blood capillaries circulate to hepatocytes where they will 
eventually develop into merozoites. Wounding of hepatocytes during sporozoite 
traversal results in the release of cytosolic factors into the microenvironment, which 
seem to induce an innate pro-inflammatory response
[182]
. Studies by other groups also 
suggest that sporozoite infection in the liver induces innate inflammatory responses, as 
demonstrated by the presence of macrophages, neutrophils and eosinophils surrounding 
infected hepatocytes
[183–185]
. While it seems clear that the Plasmodium parasite is 
detected, and a weak inflammatory response induced during the liver stage, several 
questions remain unanswered. What are the parasite molecules recognized by the host? 
Which host pattern recognition receptors (PRRs) sense the parasite? How is the parasite 
detected by the host during its development inside the parasitophorous vacuole (PV)? 
What type of innate response is induced?
[186]
  
The Plasmodium parasite appears to have evolved host evasion mechanisms that 
could explain why, during the liver stage, only weak inflammatory responses are 
induced. One of these putative mechanisms is the release of circumsporozoite protein 
(CSP) – the most abundant protein on the surface of sporozoites – into the host-cell 
cytoplasm. The CSP protein was shown to be able to outcompete NF-κB for nuclear 
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translocation thereby inhibiting the transcription of NF-κB-dependent pro-inflammatory 
genes
[187]
. Another possible mechanism by which host immunity is evaded, is the 
induction of the anti-inflammatory enzyme heme oxygenase-1 (HO1), which appears to 
reduce the frequency of inflammatory cells and cytokines
[185]
. While developing inside 
the hepatocyte the parasite is able to inhibit host cell apoptosis
[184]
, and once it has fully 
matured into thousands of merozoites, is released into circulation inside merosomes: 
structures surrounded by the hepatocyte membrane and thereby protected from the host 
immune system
[188]
.    
Erythrocytic stage immunity 
It is during the erythrocytic stage of Plasmodium infection that clinical symptoms 
of the disease manifest, and it is also during this stage that severe malaria disease may 
develop. Human and animal studies (mainly using the murine model) suggest that the 
optimal anti-malarial immune response is characterized by an early, intense, pro-
inflammatory response, mediated by cytokines and effector mechanisms that lead to the 
destruction and clearance of parasite-infected cells. Once parasite replication is under 
control, the inflammatory response must be rapidly suppressed by anti-inflammatory 
mediators to avoid adverse pathological effects to the host
[189]
.  
Studies suggest that IFN-γ is a key cytokine for the control of initial parasite 
levels, and for the induction of protective immunity against blood stage malaria, both in 
the murine model
[190,191]
, and in humans
[192,193]
. The earliest source of IFN-γ are NK 
cells. These cells are activated by IL-12, and to some extent IL-18, cytokines produced 
by activated DC and macrophages
[194]
.  Optimal activation of NK cells appears to 
require further contact between NK cells and infected erythrocytes
[195]
. Production of 
large amounts of IFN-γ may further activate macrophages and promote non-opsonic 
phagocytosis of infected erythrocytes, as well as intra-erythrocytic killing of the 
parasites
[196,197]
. Within this highly inflammatory environment, the adaptive acquired 
immune response is initiated, with mature DC and activated monocytes/macrophages 
presenting parasite antigens to naïve T-cells, resulting in Th1 polarization of CD4 T-
cells
[198]
. Activation of Th1 responses promotes the activity of γδ T-cells, which help 
inhibit the growth of intra-erythrocytic parasites
[199]
, and further induces B-cell and 
humoral responses necessary for the complete clearance of plasmodium parasites
[200]
. 
Although an early robust pro-inflammatory response is seen as beneficial for the 
host, as it allows the control of the infection until the adaptive immune response kicks 
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in, it may also promote increased disease severity. In the murine model, overproduction 
of IFN-γ and TNF-α/LT-α[201] was associated with increased pathology in a process that 
seemed to involve IL-12
[202]
.  The host mechanisms involved in the control of cytokine 
levels, such that parasite clearance is facilitated without promoting pathology, are 
unclear at present. However, key cytokines that might be involved in the 
immunoregulation of innate immunity appear to be IL-10 and/or TGF-β, both of which 
can be produced by innate (macrophages) and adaptive (T-cells) responses
[200]
.      
Evidence suggests that during the blood stage the parasite is able to modulate the 
immune system to its own advantage. The expression of variable surface antigens 
(VSA) is thought to promote sequestration of parasitized erythrocytes (pRBC), 
preventing their removal by the spleen
[203–205]
. Also, rosetting (adherence of pRBC to 
uninfected RBC) seems to protect pRBC from the immune system
[206]
. Macrophage 
function seems to be impaired by interactions with pRBC and/or parasite products 
(mainly hemozoin)
[207,208]
. Urban et al
[209]
 demonstrated that DC incubated with pRBC 
were unable to fully mature and present antigens to T-cells. This was later linked to 
binding of pRBC to CD36 on DC
[210]
. Furthermore, the same study showed that DC 
incubated with pRBC developed a polarized anti-inflammatory phenotype, and 
produced IL-10
[210]
. Evidence for modulation of DC function by plasmodium parasites 
during acute infection was also observed in Kenyan children, in whom a significant 
proportion of DC had low expression of HLA-DR: an important molecule for DC-T-cell 
interactions
[211]
.  However, this does not necessarily reflect a detrimental action of the 
parasite on the host, but rather, might reflect a beneficial homeostatic process, in which 
harmful inflammatory responses are down-regulated and immunopathology is 
prevented
[212]
. 
Malaria infection and host immunosuppression 
The idea that malaria infection could cause immunosuppression of the host 
immune system was fuelled by vaccine studies carried out in highly malaria-endemic 
regions. One of these first studies was carried in 1962 by Mcgreggor and Barr
[213]
 in a 
group of Gambian children, which had been kept malaria free by chemoprophylaxis 
treatment. In this study, children that received no chemoprophylaxis had lower antibody 
responses to tetanus toxoid vaccination than children kept malaria free. At the same 
time however, these authors showed that despite frequent malaria infections, Gambian 
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children had high antibody titers against diptheria toxin
[214]
. Later studies also observed 
diminished responses to Salmonella typhi O antigen, tetanus toxoid and meningococcal 
vaccine in children with acute malaria
[215–217]
. Febrile illness due to malaria or other 
acute illness was also associated with lower antibody titers in response to vaccination 
with Haemophilus influenzae type b conjugate vaccine
[218]
.  
Further evidence for malaria induced immunosuppression was the association of 
malaria endemicity with a higher occurrence of Burkitt’s lymphoma[219]. This was later 
associated with malaria induced reduction of T-cells during infection, that in turn 
promoted abnormal proliferation of Epstein-Barr virus (EBV) infected B-cells. High 
numbers of EBV infected B-cells are correlated with a higher risk of developing 
Burkiit’s lymphoma[220]. Initially, several mechanisms were proposed to explain 
malaria-induced immunosuppression including: depletion of antigen-reactive cells, 
disruption of lymphatic tissue architecture, polyclonal activation, macrophage 
dysfunction, antigenic competition and activation of non-specific suppressor cells
[221]
. 
Today, it is still a matter of great debate as to whether regulatory mechanisms such as 
inhibition of antigen presentation, switching from a polarized pro-inflammatory to an 
anti-inflammatory response and massive apoptosis of splenic T- and B-cells following 
malaria infection, are truly immunosuppressive and harmful to the host, or are important 
regulatory mechanisms to prevent harmful pathology
[212]
.    
Hemozoin role in the modulation of the immune system  
What is hemozoin? 
The presence of hemozoin (Hz) was first described at autopsy, by Giovanni 
Lancisi, in brains and spleens of patients that had died of malaria, in 1717; and in the 
blood, liver and spleen of an insane woman, by Meckel in 1847. Later, Virchow would 
associate the presence of this pigment with the causative agent of malaria (reviewed 
in
[222]
). The recognition that Hz was associated with malaria and its presence, not only 
in patients suffering from malaria, but also in the invertebrate host, played a pivotal role 
in the identification of the Plasmodium parasite, as well as its mode of 
transmission
[6,7,12]
. Hz was initially described as a melanin pigment – hence, it also 
being known as malaria pigment – but was later found to be derived from heme[223]. Hz 
is a paramagnetic crystal with an average size of 0,5-1 μm[224]. The crystal is composed 
of cyclic dimers of ferriprotoporphyrin IX (heme), via the coordination of the 
propionate group of each heme monomer to the Fe(III) centre of its partner. The dimers 
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are then linked via hydrogen bonds between the propionic groups
[225,226]
. Hz is produced 
during the blood stage of the Plasmodium parasite as a result of haemoglobin 
catabolism. As the parasites mature inside erythrocytes, up to 80% of the haemoglobin 
is digested
[224]
. Haemoglobin degradation occurs inside the digestive vacuole of the 
parasite and results in the release of amino acids and heme. It has been proposed that 
haemoglobin degradation is necessary, both to provide amino acids as a food source, 
and also as a requirement to maintain osmotic balance whilst the parasite matures and 
increases in size
[227]
. The released heme is toxic not only to the parasite, but also the 
host and, apparently, Hz formation is the end product of a detoxification mechanism 
employed by the parasite to pack a potentially damaging molecule into a highly 
insoluble and seemingly innocuous crystal
[226]
. The process of Hz biocrystallisation is 
still unexplained. Initially it was thought to be mediated by histidine-rich proteins 
(HRPs), which are secreted by some Plasmodium species and can bind very efficiently 
to heme molecules. However, this seems unlikely since Hz production in P. falciparum 
clones, in which HRPII has been silenced, is identical to wild-type parasites
[228]
. It is 
now thought that neutral lipid nanospheres, also located in the digestive vacuole, 
promote Hz formation at the surface interface between the acidic environment of the 
food vacuole and the lipid nanosphere
[229]
. This hypothesis is further supported by the 
fact that other Hz producing species, such as Schistosoma mansoni and Rhodnius 
prolixus, also biosynthesize Hz in lipid droplets
[230]
. Recent evidence points to a 
possible role for heme detoxification protein (HDP). This recently described protein is 
thought to be involved in the formation of the heme dimer and to contribute to the 
seeding of crystal growth
[231]
. 
Hz and the immune system 
The first evidence that Hz might be involved in the pathology of malaria was 
provided by W.H. Brown in 1912, when he observed that rabbits injected with a 
hematin precipitate solution (possibly resembling synthetic Hz) exhibited symptoms 
typical of malaria, such as fever and shaking chills
[232]
. However, for a long time Hz 
was only regarded as an inert waste product resulting from the detoxification of the 
heme liberated during hemoglobin digestion
[233,234]
. 
Although impairment of macrophage function during malaria infection had been 
demonstrated by Loose et al in 1972
[235]
, it was Schwarzer et al that in 1992 associated 
the ingestion of Hz by macrophages with their functional impairment
[208]
. Defects in 
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function resulting from ingestion of Hz by monocytes/macrophages include: reduced 
phagocytic capacity; inhibition of phorbol myristate acetate (PMA)-induced oxidative 
burst due to the inhibition of protein kinase C (PKC) activity and NADPH oxidase 
(NOX) assembly at the cell membrane, both of which are important for the generation 
of oxidative burst; reduced ability to kill bacteria, fungi or tumor cells; and inability to 
induce expression of ICAM-1, integrin-CD11c and MHC-class II in response to IFN-
γ[208,236–239].  
Further studies demonstrated that high levels of lipidperoxides are generated 
during Hz ingestion. Hydroxynonenal (HNE) and other derivatives of lipid peroxidation 
were shown to directly interact with key cellular enzymes, thus leading to the inhibition 
of several cellular functions
[240–242]
. Lipid peroxide derivatives were further associated 
with the inhibition of monocyte maturation to dendritic cells
[243,244]
, inhibition of 
erythroid progenitors development
[245,246]
, and increased destruction of non-parasitized 
erythrocytes resulting in the promotion of malaria anaemia
[247,248]
. The importance of 
lipid peroxidation catalyzed by Hz was further demonstrated by Carney et al, whereby 
β-hematin (synthetic Hz) was unable to inhibit PMA-induced oxidative response in 
RAW macrophages. Previous reaction of β-hematin with RBC membranes (erythrocyte 
ghosts) before incubation with macrophages restored the inhibitory effects normally 
observed with native Hz
[249]
.   
Work by Urban et al explored the inhibitory effects of Hz on dendritic cells. P. 
falciparum infected erythrocytes were shown to inhibit the up-regulation of MHC-II, 
ICAM-1 and the important co-stimulatory molecules CD83 and CD86 following LPS 
stimulation
[209]
.  This inhibitory effect was apparently mediated by binding of infected 
RBC to CD36 on dendritic cells
[210]
. At the same time, experiments by Millington et al 
provided evidence that splenic DC isolated from P. chabaudi infected animals had an 
activated phenotype when isolated shortly after infection (4 days), but when isolated 
from infected animals later during infection (12 and 20 days) featured decreased 
expression of DC maturation markers and were unresponsive to LPS in vitro. It was 
further demonstrated that the parasite component responsible for DC inhibition was Hz 
ingestion by DC during malaria
[250]
. In a separate study, synthetic Hz was found to 
induce partial maturation of DC, with upregulation of CD80, CD83 and CXCR4 but not 
HLA-DR or CCR7. This, coupled with a lower production of IL-12, suggests that, 
although DC migrate to lymphoid organs, their subsequent activation of T-cell 
responses might be impaired
[251]
. Hz inhibition of HLA-DR upregulation might explain 
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clinical findings in Kenyan children suffering from mild to severe malaria, in whom a 
significant proportion of DC were found to express lower levels of HLA-DR than 
healthy children
[211]
.  
Several in vivo studies correlate natural acquisition of Hz by human monocytes 
with altered chemokine profiles – mainly MIP-1α, MIP-1β and RANTES – with disease 
severity
[252,253]
. These studies demonstrated that increased levels of Hz deposition were 
associated with increased severity of malaria anaemia and lower levels of RANTES. 
Incubation of peripheral blood mononuclear cells (PBMC) from healthy volunteers with 
Hz in a Cytokine Expression Array identified human stem cell growth factor (SCGF) – 
an important hematopoietic growth factor – as one of the most dysregulated genes. 
Indeed, in children with higher deposition of Hz, SCGF levels were lower, and this was 
associated with reduced erythropoietic responses in children with malaria anaemia
[254]
. 
In other studies, elevated levels of Hz are positively associated with severity of malaria 
anaemia and decreased levels of IL-12
[255,256]
. These studies demonstrated that IL-12 is 
regulated by IL-10, and more importantly, that Hz was able to induce production of 
both pro-inflammatory (TNF-α) and anti-inflammatory cytokines (IL-10).  
Despite all of the aforementioned studies supporting the idea that Hz plays an 
important role in malaria-induced immunosuppression, data implicating Hz as a pro-
inflammatory mediator also exists. Ingestion of Hz by monocytes was shown to induce 
the production of high levels of inflammatory cytokines, such as TNF-α and IL1-
β[257,258]. In a different study, Hz was shown to induce IL1-β and TNF-α together with 
the anti-apoptotic cytokines MCP-1 and IL-8. Expression of HSP27, another inhibitor of 
apoptosis was also induced, thus suggesting that ingestion of Hz might promote 
induction of inflammatory cytokines and prolong survival of impaired monocytes
[259]
. 
Jaramillo et al, demonstrated that Hz injection in a murine model led to increased 
recruitment of leukocytes and increased levels of IL-1β, IL-1α, IL-6, MIP-1α, MIP-1β, 
MIP-2 and MCP-1 mRNA
[260]
.  Hz phagocytosis by macrophages in vitro enhanced 
iNOS production in response to IFN-γ stimulation[261]. In a different study, Hz 
phagocytosis by macrophages was associated with increased mRNA levels of MIP-1α, 
MIP-1β, MIP-2 and MCP-1 chemokines, but not IL-1β, IL-1α or IL-6. Induction of 
chemokine mRNA was dependant on ERK1/2 MAPK pathway activation and nuclear 
translocation of NF-κB[262].     
A series of studies demonstrated that Hz promotes the expression and activity of 
matrix metalloproteinase-9 (MMP9)
[263]
. MMPs belong to a family of proteolytic 
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enzymes able to degrade basement membranes, cleave pro-forms of inflammatory 
molecules, and disrupt inter-endothelial tight junctions
[264]
. There is growing evidence 
for a possible involvement of MMPs in severe malaria
[265,266]
. In vitro, it was shown that 
Hz or trophozoite fed monocytes had increased levels of MMP-9 and enhanced matrix 
invasion ability. Activity of MMP-9 seemed to be mediated by Hz-induced TNF-α[267]. 
Further studies demonstrated that Hz-induced MIP-1α and IL-1β were also mediators of 
MMP-9 expression and activity
[268,269]
. The Hz-enhanced effects on MMP9 could be 
mimicked by 15-HETE, suggesting a role for the lipid moiety of Hz. Moreover the Hz 
induction of MMP9 and related cytokines (TNF-α, IL-1β and MIP-α) were dependant 
on the nuclear translocation of NF-κB, and on the p38 MAPK pathway[270,271]. 
Monocyte incubation with Hz also seems to promote degranulation, resulting in the 
release of lysozyme. As was shown for Hz-enhancement of MMP-9 activity, lysozyme 
release is apparently dependent on the NF-κB and p38 MAPK pathways, which lead to 
induction of TNF-α, IL-1β and MIP-α[272–274]. Recently, it was found that host 
fibrinogen is frequently bound to Hz and might be responsible for increased levels of 
TNF-α and MCP-1. Hz-bound fibrinogen induced a rapid oxidative burst, peaking at 7 
minutes post-Hz addition, and lasting for 20 minutes, declining thereafter
[275]
.  
Hz recognition was shown to require TLR-9
[276]
 however, this is controversial as 
another study demonstrated that Hz-induced NF-κB nuclear translocation was TLR 
independent
[277]
. In parallel to TLR studies, several groups have investigated the role of 
the inflammasome in the response elicited by Hz. To this end it was demonstrated that 
Hz-induced IL-1β and neutrophil recruitment were dependent upon the NLRP3 
inflammasome
[278,279]
. Griffith et al also demonstrated that Hz-induced recruitment of 
neuthrophils into the peritoneal cavity of mice occurred in a NLRP3 inflammasome-
dependant manner. However, in this study in vitro phagocytosis of Hz did not result in 
induction of IL-1β by THP-1 cells, a commonly used cell line for the study of 
inflammasome activation and IL-1β production[280]. 
Overall, studies demonstrate that Hz is responsible for modulating several aspects 
of the innate and adaptive immune response. Nonetheless, some studies argue against a 
role for Hz as an immune modulator.  One study demonstrated that Hz purified from P. 
falciparum culture had no in vitro stimulatory activity when fed to DC, and that protein-
DNA complexes were the component responsible for activating DC
[281]
. Pichyangkul 
also demonstrated that the stimulatory activity of Hz was abolished following treatment 
with proteases, further supporting the idea that proteins on Hz surface are responsible 
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for the effects and not the crystal itself
[257]
. Another study demonstrated that Hz itself is 
inert but enhances immune responses by presenting malaria DNA to TLR-9 on DC
[282]
. 
Yet another series of studies suggest that in vivo Hz is naturally released inside intact 
food vacuoles, stimulates oxidative burst and drives neutrophils to a state of functional 
exhaustion; Hz itself is not ingested by phagocytes
[283–285]
. Some contradictory findings 
were also observed, for example, Hz was shown to induce production of ROS in RAW 
murine macrophages
[286]
, but in a different study no ROS production was observed 
following Hz stimulation
[249]
. Similarly, synergistic production of NO by Hz and IFN-
γ/LPS co-stimulation was observed by some groups[261,277], in contrast to another study 
in which Hz pre-incubation, prior to stimulation with IFN-γ/LPS, prevented NO 
induction
[287]
. Although some of these discrepancies between studies might be explained 
by the different cell types used, or differences in protocols (ie pre-incubation of Hz or 
Hz used as a stimulus), it also raises the question of what is the “true Hz”. It is likely, 
that Hz released from schizont rupture is covered in multiple proteins and lipids. Thus, 
some studies use Hz extracted from culture, with different degrees of purification to 
remove DNA and proteins, whilst others favor the use of synthetic Hz, which, whilst 
virtually free of proteins/lipids/DNA, may vary in crystal size and quality
[224,288]
.    
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Aims 
Individuals living in malaria-endemic regions acquire anti-malaria immunity 
against severe life-threatening disease early in childhood, and eventually also develop 
immunity to uncomplicated febrile malaria by early adulthood. However, this immunity 
is not sterile and individuals often carry blood-stage parasites without symptoms
[289]
. As 
reviewed earlier, effective control of malaria parasites involves innate immune 
responses, as well as activation of a polarized Th1 adaptive response that must be 
tightly regulated to avoid immune pathology. However, repeated malarial episodes will 
lead to increased Hz deposition in host organs with potential detrimental effects. If Hz 
impairs cellular functions, such as phagocytosis and oxidative burst, the ability to kill 
intracellular bacteria might be impaired. On the other hand, Hz phagocytosis by DC also 
seems to impair antigen presentation and activation of T-cells, therefore it might impair 
the immune system’s ability to properly control an infection such as the one produced 
by M. tuberculosis. Still, not much is known about malaria-tuberculosis co-infections 
and how their interaction might impact upon the disease outcome in co-infected 
individuals. 
Thus, this project aimed to: 
1) Produce and characterize Hz from different sources. 
2) Use flow cytometry to identify Hz containing cells 
3) Analyze the cellular function of human PBMC from healthy donors after the 
ingestion of Hz. 
4) Using a murine model, investigate the kinetics of Hz deposition in host organs.  
5) Using a murine model, investigate the in vivo susceptibility to tuberculosis 
infection during both acute malaria episodes, and during chronic malaria. 
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CHAPTER I 
Hemozoin production and characterization. 
Introduction 
The exact processes involved in hemozoin (Hz) biosynthesis remain unknown, 
although it is thought that lipid droplets, and some as yet to be identified proteins, may 
have an important role in the initial nucleation of Hz crystal growth
[224]
. Studies of Hz 
are performed either with Hz extracted from Plasmodium falciparum cultures (natural-
hemozoin) or β-hematin produced from hemin (synthetic-hemozoin). Although nHz and 
sHz are structurally identical
[225,290]
, the lack of standardised protocols for the 
production of either type of Hz may account for the discrepant results found in the 
literature
[224,288,291]
. Extraction of Hz from P. falciparum cultures normally involves 
some kind of cell lysis
[208,237,239]
 or the natural release of the crystals into the culture 
medium
[283,284]
. Either of these processes may result in Hz contacting any one of several 
biomolecules such as proteins, DNA or lipids, all of which can easily attach to Hz due 
to its amphilic nature
[224]
. Further purification procedures can be employed to remove 
these attaching molecules. On the other hand, synthetic hemozoin (sHz) can be 
produced via several different protocols which may lead to the production of a 
crystalline material that differs in size and shape to natural Hz.   
This chapter describes the standardization of in house protocols for the production 
of Hz. The different Hz preparations were then quantified, and characterized with 
respect to the presence of common biomolecules, such as DNA and proteins and 
unreacted heme contamination. They were further characterized by scanning electron 
microscopy (SEM) and X-ray diffraction.  
Results 
Production and quantification of Hz. 
Hz was produced either by synthesizing β-hematin (sHz) from hemin as described 
by Slater
[292]
 or by isolating Hz from P. falciparum cultures
[276,293]
.  Hz crystals are dark 
brown in colour and when in suspension have a blackish colour as shown in Figure 1. 
To the naked eye all these preparations appear very similar. Hz was quantified in terms 
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of heme-equivalents using the QuantiChrom
TM
 Heme Assay Kit, which correlates 
absorbance at 400 nm with the concentration of total heme in solution. The ranges 
obtained were 0.2 mM-1 mM for sHz; 0.013-0.29 mM for crude native Hz (cHz) and 1 
mM for native Hz (nHz). Here, cHz and nHz refer to P. falciparum culture extracts that 
did not undergo further purification, or to those that were extensively purified to remove 
protein and DNA, respectively (also see table 1). The differences in yields can be 
explained by the different volumes used to start the crystallization reaction; by the 
culture volumes used, and by the extent of purification.  
All the different Hz preparations presented a crystalline appearance under light 
microscopy and depolarized light as observed by microscopy at 1000× magnification 
(Figure 2). The observed crystals were generally homogeneous in size, with the 
exception of nHz, which tended to form larger aggregates (Figure 2C) whereas sHz 
crystals appeared more dispersed and needle-like (Figure 2A).   
                        
 
 
Hemozoin Type Description 
Synthetic hemozoin (sHz) Hz synthesized from β-hematin 
Crude native hemozoin (cHz) 
Hz isolated from P. falciparum cultures 
without extensive purification 
Native hemozoin (nHz) 
Hz isolated from P. falciparum cultures 
and extensively purified to remove 
possible protein and DNA 
contamination. 
 
Table 1. Types of Hz. The table summarizes the types of Hz produced and their designations. 
 
 
 
                                
 
Figure 1. Suspensions of different hemozoin preparations, in water. A – sHz; B – cHz and C – nHz, 
suspensions in water were quantified  in terms of heme equivalents. 
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Figure 2. Observation of hemozoin preparations by microscopy. Hemozoin preparations were 
observed under light (upper pannel) and polarizing-light (lower pannel) microscopy, at 1000× 
magnification, using a Leica DM2500 optical microscope. A – sHz; B – cHz and C – nHz. 
 
Assessment of Hz: purity and attached biomolecules 
The different Hz preparations were assessed for the presence of possible 
biocontaminants such as DNA, protein and heme. Whereas DNA and protein are 
frequent contaminants of nHz, heme contamination – resulting from unreacted hemin – 
is more frequent in sHz.  
Heme contamination in Hz samples was assessed by thin layer chromatography 
(TLC). cHz and nHz were found to be free from contaminating heme (Figure 3B and 
3C). sHz was contaminated with a residual amount of free heme which represented less 
than 1% of total heme content (Figure 3A).  
To investigate whether DNA was present, Hz samples were analyzed on an 
agarose gel and stained for DNA. sHz and nHz samples had no detectable DNA 
contamination as illustrated in Figure 4 (lanes 1-3). Not surprisingly, the cHz sample 
was found to be contaminated with DNA (lanes 4 and 5). Interestingly, even after pre-
treating the cHz sample with saponin, the contaminating DNA did not migrate beyond 
the loading site. This may be due to interactions between DNA and other contaminants 
in the unpurified sample, such as lipids and/or proteins which were resistant to the 
saponin treatment and remained attached to the cHz crystals.  
Hz samples were also assessed for the presence of protein contamination. As 
indicated by polyacrylamide gel electrophoresis under denaturing conditions (SDS-
PAGE), sHz and nHz were free of protein (lane 1 and 2, Figure 5, respectively). cHz on 
the other hand, contained proteins, as revealed by Coomassie blue staining (lane 3, 
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Figure 5). The dark band in lane 1 is due to the dark brown color of Hz itself and is not 
a protein-derived band, as this would be revealed by the Coomassie blue staining. 
 
 
        
              
 
Figure 3: Remaining heme contamination in hemozoin samples as assessed by thin layer 
chromatography. Samples were eluted on silica gel plates along with 10 μl of 0,2 mM (Lane 1); 0,04 
mM (Lane 2) and 0,02 mM (Lane 4) hemin chloride solutions in methanol. Lane 3: 10 μl of 0,2 mM of 
each hemozoin sample (A – sHz; B – cHz and C – nHz).  
 
 
 
                                      
 
Figure 4: DNA contamination assessment of hemozoin samples by agarose gel electrophoresis. L: 1 
kb Plus DNA Ladder; 1 – sHz; 2*&3 – nHz and 4*&5 – cHz. Samples denoted with * were pretreated 
with saponin.                               
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Figure 5: Assessment of protein contamination in hemozoin samples. Hemozoin samples were run on 
a polyacrylamide gel under denaturing conditions (SDS-PAGE) to assess protein contamination. L – 
Precision Plus Protein™ Dual Color Standards; 1 – sHz; 2 – nHz and 3 – cHz. Gel was stained with 
Coomassie blue stain to reveal the presence of proteins. 
 
Scanning Electron Microscopy of Hz samples 
The morphology and size of Hz crystals was determined by scanning electron 
microscopy. As shown in Figure 6, crystals of sHz and nHz were similar in size, 
ranging from 0.9 to 1.9 μm and 0.7 to 1.5 μm, respectively. The morphology of the nHz 
crystals featured the characteristic brick-like shape (Figure 6B) whereas sHz presented a 
more tapered needle-like morphology which can be attributed to a faster growth of the 
crystal faces (Figure 6A)
[294]
.  
A sample of sHz from a different source (our collaborator, Professor Cevayir 
Coban, Osaka University, Japan) was included in the analysis for comparison (Figure 
6C). Although Coban´s sHz produced larger crystals than our preparations (3.8 to 6.3 
μm), they were morphologically similar to our sHz, presenting with the same needle-
like shape.         
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Figure 6: Scanning electron microscopy of Hz. A – sHz; B – nHz and C – Coban sHz at 15000× and 
5000 magnification, respectively. Images of air-dried hemozoin samples were obtained with a JEOL, 
JSM-2500 LV scanning electron microscope. Size bars 1 µm (A and B) and 5 µm (C). 
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X-ray diffraction of Hz samples 
sHz and nHz samples were analyzed with a Philips Analytical PW 3050/60 X’ 
Pert PRO X-ray diffractometer. As shown in Figure 7 their X-ray diffraction peak 
patterns were identical. These patterns match  those obtained by others 
[225,277,295]
.  
 
 
            
 
    
 
Figure 7: X-ray diffraction of Hz samples. sHz (blue line) and nHZ (green line) air-dried samples were 
analyzed on silicon sample holders with a Phillips Analytical PW 3050/60 X’ Per PRO X-ray 
diffractometer using a Cu Kα radiation source (λ= 1,54060 Å). 
 
 
Concluding Remarks 
In summary we were able to produce both sHz and nHz and further showed that 
both Hz obtained were morphologically and physicochemically identical to each other 
and to preparations obtained by others. cHz differed from sHz and nHz since it 
contained DNA and protein. Moreover, isolation of Hz from P. falciparum cultures is 
costly and time consuming, even more so if further purification to obtain nHz is 
performed. Therefore the use of sHz was favoured in subsequent studies.     
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Materials and Methods 
 
Reagents 
Reagents were obtained from Sigma–Aldrich (St. Louis, MO, USA), unless stated 
otherwise. 
 
Plasmodium falciparum culture  
Plasmodium falciparum 3D7 strain was obtained from Malaria Research and 
Reference Reagent Resource Center (MR4; Manassas, VA, USA) and grown in 
continuous culture as follows: 10× Albumax stock solution was prepared with 25 g 
AlbuMAX II
®
 (Invitrogen™ Life Technologies; Carlsbad, USA), 0.1 g hypoxanthine, 1 
g glucose, 1.67 g NaHCO3, 2.98 g Hepes (VWR; Radnor, PA, USA), 500 µl 
gentamincin (Gibco™ Life Technologies; Grand Island, NY, USA) and 5.2 g RPMI 
1640 (w L-glutamine, w/o NaHCO3, Gibco™). Each stock was then diluted in 500 ml 
of RPMI 1640 (no L-glutamine, with NaHCO3, Gibco™) and further supplemented 
with 500 µl gentamycin (50 mg/ml stock), 5 ml of 200 mM L-glutamine and 12 ml 1 M 
Hepes (Gibco™). Cultures were incubated at 37ºC, 5% CO2 and maintained at a 
parasitaemia < 1% in a hematocrit of 5% according to the recommendations of MR4
[296]
. 
Red blood cells for cultures were obtained from discarded buffy coats from healthy 
blood donors, kindly donated by Instituto Portguguês do Sangue and leucocytes 
removed by three RPMI 1640 (without L-glutamine, with NaHCO3) 
washes/centrifugations at 600xg (without brake) for 5 min. 
 
Extraction of crude Hz  
P. falciparum Hz was extracted without further purification (cHz), as described by 
Keller et al
[293]
, with some modifications. Briefly, P. falciparum cultures (3D7 strain) 
were grown at 5% hematocrit until a parasitaemia of 2-5% was reached. Then, cultures   
were centrifuged at 800xg for 10 min and the RBC pellet resuspended in 40 ml of 1x 
PBS (prepared from 10x PBS; Gibco™) containing 1% saponin, for 10 min. Cell lysates 
were centrifuged at 16000xg for 15 min, and the resulting pellet was washed seven 
times in 1x PBS to obtain the crude Hz extract. After the final wash the pellet was 
resuspended in 1 ml of ultrapure water, quantified and stored at 4°C.  
 
 
Malaria and Tuberculosis co-infection: a role for Hemozoin immunosuppression? 
41 
 
Purification of crude Hz 
Native hemozoin (nHz) was purified after saponin harvesting of parasites from 1 
L of P. falciparum (3D7 strain) cultures, grown in 1% hematocrit to parasitaemias of at 
least 10% to enrich in trophozoites, as previously described by Coban et al
[297]
. Culture 
pellets were extensively washed with 1x PBS, sonicated for 5 min and extensively 
washed with 2% sodium dodecyl sulfate (SDS). This was followed by an overnight 
incubation with 2 mg/ml proteinase K (Promega; Madison, WI, USA). The following 
day pellets were again washed with 2% SDS, and further incubated for 3 h in 6 M urea. 
Finally, pellets were washed with 2% SDS and ultrapure water. Purified nHz was 
resuspended in 1 ml ultrapure water, quantified and stored at 4°C. 
 
Production of synthetic Hz  
Synthetic hemozoin (sHz) was obtained by the method described by Slater et 
al
[292]
, with some modifications. Briefly, 475 mg of hemin chloride were dissolved in 
100 ml of 0.1 N sodium hydroxide and heme was precipitated by slowly adding 35 ml 
of glacial acetic acid (Merck; Whitehouse Station, NJ). Crystallization was promoted by 
overnight incubation of the mixture at 80°C. Non-crystalline heme was then removed by 
washing three times with 1 vol of 100 mM sodium bicarbonate pH 9.1 during 3 h, 
followed by a 15 min centrifugation at top speed. The pellet was further washed three 
more times in 1 ml of ultrapure water and finally resuspended in ultrapure water, 
quantified and stored at 4°C. 
 
Hz concentration measurement 
The amount of Hz was quantified as heme-equivalents using QuantiChrom
TM
 
Heme Assay Kit DIHM-250 (BioAssay Systems; Hayward CA, USA), by colorimetric 
determination of total heme at 400 nm. Shortly, after solubilization in an aqueous 
solution of 20 mM sodium hydroxide for 1 h, samples were added to the Reagent 
solution for 5 min, after which the absorbance (A) at 400 nm was read. The 
concentration in μM (heme equivalents) was then determined using the following 
expression:  
Total heme concentration = 5.62


AblankrAcalibrato
AblankAsample
x Dilution factor, which 
correlates absorbance at 400 nm with the concentration of heme present in solution. 
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Light/Depolarizing microscopy 
Hz preparations were observed with light and depolarizing microscopy, using the 
brightfield microscope Leica DM2500 (Leica Microsystems, Wetzlar. Germany). 
 
Heme contamination assay  
Hz preparations were assessed for remaining heme contamination using thin layer 
chromatography (TLC). Quantified Hz samples were first diluted in absolute methanol 
(Merck) to the highest concentration of hemin chloride to be eluted (0.2 mM). Then, 10 
μl of diluted Hz samples were eluted for 30 to 40 min on silica gel glass plates (Merck) 
along with hemin solutions of known concentrations (0.2, 0.04 and 0.02 mM), inside a 
methanol-saturated tank. Images of the plates were acquired with Alpha Imager® HP 
System (ProteinSimple; Santa Clara, CA, USA). Image analysis was then performed 
using ImageJ software 1.47v (National Institute of Mental Health, Bethesda MD, USA) 
to calculate the integrated density of each standard/sample. The standard samples were 
used to create a standard curve comparing integrated density with hemin concentration 
and used to calculate the percentage of remaining heme contamination in Hz samples.    
 
DNA contamination 
Hz samples were assessed for DNA contamination by agarose gel electrophoresis. 
Ten microliters of each sample, pretreated or not with 10 μl of 1% saponin for 10 min, 
were loaded with 3.5 μl of Gel Loading Buffer on a 0.8% agarose gel with 10000x 
GelRed
®
 Nucleic acid gel stain (Biotium; Hayward CA, USA) diluted 1:20000, and ran 
in 1x TAE Buffer for 30 min at 100 mA. 
 
Protein contamination 
Hz samples were assessed for protein contamination by polyacrylamide gel 
electrophoresis under denaturing conditions. Twenty microliters of each sample were 
boiled for 5 min at 100°C with 20 μl of 2x Loading buffer and then loaded onto a SDS-
polyacrylamide gel (5% Acrylamide resolving gel/4% Acrylamide stacking gel) and ran 
in 1x Running buffer, for 40 min at 180 V. The gel was stained in 1% Coomassie 
Brilliant Blue staining solution (Bio-Rad; Hercules, CA, USA) for 20 min, destained 
overnight in Destain solution (constituted by 30% ethanol and 10% acetic acid in 
distilled water). An image of the gel was acquired with Alpha Imager
®
 HP System. Gels 
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were dried on a filter paper with the DrygelSr Slab Gel Dryer SE1160 (Hoefer
®
 
Scientific Instruments, Holliston MA, USA), for at least 40 min at 70°C.  
 
Scanning Electron Microscopy (SEM) 
Ten microliters of each Hz sample were allowed to air dry overnight on top of a 
carbon tape placed on a metallic sample holder. Air dried samples were then metalized 
for 30 min using JEOL, JFC-1200 with a gold target. Scanning electron microscopy was 
performed with JEOL, JSM-2500 LV scanning electron microscope (JEOL, Tokyo, 
Japan), at Faculdade de Ciências da Universidade de Lisboa. 
 
X-ray diffraction 
Hz samples were subjected to X-ray diffraction (XRD) analysis. Crystals were 
resuspended in 10 μl of absolute ethanol (Merck) and allowed to air dry on silicon 
sample holders. XRD patterns were then acquired at Faculdade de Ciências da 
Universidade de Lisboa, with the automatic X-ray diffractometer Philips Analytical PW 
3050/60 X’ Pert PRO (Ө /2Ө) (PANalytical, Almelo, The Netherlands), with an 
X’Celerator detector and automatic data acquisition with X’Pert Data Collector, version 
2.0b. Cu Kα radiation (λ= 1.54060 Å) was used, operating with 30 mA and 40 kV. The 
diffractograms were recorded in the 2Ө range between 5° and 30° with a step size of 
0.0170° (2Ө) and scan step time of 100 seconds. 
Discussion  
Synthetic Hz (sHz) can be obtained from hemin by reaction with acid producing 
β-hematin, the chemical equivalent of hemozoin. Alternative methods for production of 
sHz use a rather long anhydrous base reaction
[224]
. Hemozoin can also be obtained from 
P. falciparum cultures (natural hemozoin) however, this can be a time consuming and 
expensive process
[297]
. Moreover, the different protocols implemented and the source of 
hemozoin (synthetic or culture) can generate preparations that are quiet different in 
terms of crystal morphology, size and in the case of natural hemozoin, the type of 
biomolecules present on the crystal surfaces after isolation
[277,295]
. Thus, it is important 
to characterize hemozoin preparations before performing further studies.   
Results presented in this chapter demonstrated that hemozoin preparations 
resulting from three distinct protocols were indistinguishable to the naked eye. 
Microscopic observation using polarizing light gave little information as to the ultra-
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structure of hemozoin crystals, although it served to confirm the birefringent nature of 
the hemozoin preparations. To further evaluate the ultra-structure of hemozoin it was 
necessary to perform SEM and X-ray diffraction. This allowed the confirmation of 
crystal size and morphology of the different hemozoin preparations and their structural 
arrangement. Hemozoin preparations were identical, morphologically and structurally to 
those obtained by others
[298,299]
. Thus, careful standardization of protocols can yield 
both sHz and natural hemozoin that are equivalent in terms of crystal size, morphology 
and structural properties. However, as noted by the presence of protein and DNA in 
hemozoin that was not extensively purified (cHz), extra steps may be required to 
produce hemozoin that is equivalent in terms of the molecules adsorbed to its surface. 
Heme contamination was also evaluated by TLC to demonstrate that remaining heme 
(either from unreacted hemin or from RBC lysis) was not present in our preparations. 
This is important since remaining heme could exert toxic cellular effects and confound 
the interpretation of results.  
It is important to highlight that whilst many studies reported different findings on 
the modulatory properties of hemozoin
[277]
, very few of these studies performed 
extensive hemozoin characterization, using SEM and X-ray diffraction
[293,295]
. Many 
earlier studies did not perform any characterization at all
[261,268,300]
. On the other hand, 
some studies report that hemozoin itself is inert and that effects normally associated to 
hemozoin are exclusively due to the presence of other biomolecules on its surface, such 
as DNA
[282]
. Fibrinogen has also been shown to bind to crude hemozoin and to induce 
strong initial stimulation of ROS, TNF-α and MCP-1 in vitro[275]. Additionally, it was 
reported that whilst hemozoin itself appears inactive, it can exert immune effects when 
in the presence of RBC ghosts. This was interpreted as resulting from interactions 
between hemozoin and RBC lipids
[249]
. Thus, some studies suggest that hemozoin 
serves as a vehicle of diverse biomolecules that then exert their immune effects
[282]
. 
Others suggest that hemozoin is released within digestive vacuoles, and that it is the 
ingestion of these vacuoles and not hemozoin itself that contribute to immune 
effects
[283,284]
.  
These observations raise the question as to what is the ‘true hemozoin’ in vivo. 
How is natural hemozoin released into circulation upon schizont rupture in the 
mammalian host? Another important question is what happens to ingested hemozoin 
once phagocytes reach the end of their natural life span. Natural hemozoin is likely 
released into circulation upon schizont rupture either as a free crystal or inside the food 
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vacuole. In any case, it is likely that hemozoin comes in contact with host-derived 
and/or parasite-derived biomolecules. Then, due to the highly amphiphilic nature of 
hemozoin these biomolecules easily adsorb to hemozoin crystals. Hemozoin is very 
resistant to degradation and withstands treatments with acids, alcohols, dimethyl 
sulfoxide (DMSO) and hydrogen peroxide (H2O2)
[301]
. Thus, acidification or H2O2 
production in the phagocytic compartment is unlikely to contribute to significant 
hemozoin degradation, and as phagocytes reach the end of their natural life span it is 
likely that hemozoin is re-ingested by new phagocytic cells. In such a scenario, it is 
reasonable to assume that the nature and/or amount of biomolecules attaching to 
hemozoin changes over time. Eventually, in the long term hemozoin might become free 
of contaminants, such as proteins and lipids, as these are degraded inside 
phagolysosomes. In our studies, the use of synthetic hemozoin over hemozoin isolated 
from cultures was favored because it probably reflects better the hemozoin present in 
host organs in the long term. Moreover, synthetic hemozoin used in our studies (either 
synthesized by us or supplied by Professor C. Coban) was thoroughly characterized 
before being used in functional studies. As discussed, hemozoin characterization is 
important as many protocols are available for its production and as emphasized by 
Jaramillo et al
[277]
, some may even yield hemozoin with poor crystalline nature.     
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CHAPTER II 
1. Detection of Hz-containing cells using flow-
cytometry 
Introduction 
Hz has been the focus of a substantial amount of research in recent years. 
However, identification of Hz-containing leucocytes and/or parasitized erythrocytes 
normally involves microscopy, with all its inherent limitations, which are mostly related 
to the difficulties in counting relatively low cell numbers
[302,303]
. Alternatively, Hz can 
be detected by flow-cytometry using depolarized side-scatter
[304,305]
. Hz is a birefringent 
crystal, and is able to rotate the plane of polarized light, a property known as 
depolarization. Thus, a conventional flow cytometer can detect depolarization via the 
combination of an orthogonally placed polarization filter (90º rotated) located in front of 
a second side-scatter detector. Haematology analysers, such as the Cell-Dyn® (Abbott, 
Santa Clara, CA, USA) already incorporate depolarized SSC detection to distinguish 
eosinophils from granulocytes. When blood samples from malaria patients were 
processed in these analysers, the lobularity-granularity plots showed characteristic 
abnormalities, such as the appearance of monocytes in the eosinophil area and a widely 
scattered eosinophil population
[306]
. This was most likely caused by the presence of Hz 
in monocytes and neutrophils, respectively
[307]
.  The use of this system for further 
studies is, however, limited by the fact that software analysis, the analyser’s analytical 
algorithms, and the raw data are inaccessible to the operator. 
The Cyflow® Blue laser (Partec, Münster, Germany) instrument was adapted to 
detect depolarized SSC as described in the Methods section of this thesis. With this 
simple modification it was possible to detect Hz in different cell types including human 
whole-blood, peripheral blood mononuclear cells (PBMC), murine peripheral blood 
(described in this chapter) and single-cell suspensions of murine tissues (see also 
Chapter 3). This allows for the first time to look at possible Hz effects at the single-cell 
level, whereas previous studies rely on the assumption that all cells being studied 
contain Hz or that Hz effects are propagated to all cells.  
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Results  
Detection of Hz in human whole-blood 
Whole blood from healthy human volunteers was incubated with anti-CD14 and 
anti-CD16 antibodies to identify monocyte and granulocyte populations, respectively. 
Hz containing cells were then identified based on their depolarized side scatter (SSC-2) 
vs. side scatter (SSC-1). The upper panel of Figure 8 shows the gating strategy used for 
analysing blood from a healthy donor without Hz; the lower panel shows the analysis of 
the same donor’s blood after six hours incubation with sHz. As expected, the sample 
without Hz had negligible depolarizing events whereas in the sample incubated with 
sHz, depolarizing events were detected both in the monocyte and granulocyte 
populations (Figure 8, upper rows). Importantly, Hz-containing monocytes (red dots) 
showed much higher side-scatter than normal monocytes (blue dots), which overlapped 
with the granulocyte population (Figure 8, bottom rows). Thus, the use of a classical 
monocyte gate, based on forward scatter (FSC)/SSC-1 should be avoided at the risk of 
excluding Hz-containing monocytes. Instead, monocytes and granulocytes were 
identified exclusively based on the expression of CD14 and CD16 (Figure 8).   
A time course incubation of whole blood from healthy volunteers with sHz further 
showed that the percentage of Hz-containing monocytes and granulocytes depended 
upon the initial Hz dose and time of incubation. Furthermore, the monocyte population 
was the main population to phagocytose Hz (Figure 9). 
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Figure 8. Detection of Hz in human whole blood. Top  two rows show the gating strategy used for the 
detection of Hz in human whole blood. Monocytes and granulocytes were identified based on the 
expression of CD14 and CD16, respectively, and then analysed in terms of their side scatter (SSC-1) and 
depolarized side scatter (SSC-2). The first row is representative of blood from a healthy donor without 
Hz; the second row is the same sample incubated for 6 hours with sHz (60 μM heme equivalents). Bottom 
two rows: Colour back-gating for samples shown in row one and two. Blue: non-depolarizing monocytes; 
red: depolarizing monocytes; green: non-depolarizing granulocytes and orange: depolarizing granulocytes. 
FSC: forward scatter; SSC-1: Side scatter and SSC-2: depolarized side scatter.  
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Figure 9. Hz phagocytosis in-vitro is dose and time dependant. Whole Blood from a healthy human 
volunteer was incubated with increasing sHz concentrations: no sHz (control), 10, 60 and 120 μM heme 
equivalents. The percentage of Hz-containing granulocytes and monocytes was determined at time zero, 
and after four and seven hours of incubation. Identification of leukocytes and depolarization was 
performed as described in the text and as shown in Figure 8. The results shown are the mean values of 
triplicates (± one SD) of one representative experiment. 
 
Effect of different types of Hz in human PBMC 
Hz detection was further investigated in human peripheral blood mononuclear 
cells (PBMC). Most in vitro studies use concentrations of Hz based on the assumption 
that an average adult infected with P. falciparum, with a 1% parasitaemia (relatively 
mild malaria), will release as much as 200 µmol of Hz at the end of each intra-
erythrocytic cycle. This is based on reported estimates of haemoglobin degradation and 
conversion to Hz in P. falciparum infected cells, and on reference haematological 
values
[262,308]
. Although, these concentrations of Hz aim to be physiologically relevant, 
most experiments use amounts that when used in vitro, result in all phagocytes 
containing Hz, which is unlikely to represent the in vivo reality.  
Using a similar strategy as that used for whole blood, Hz was detected in human 
PBMC isolated from buffy coats discarded from blood samples of healthy adults donors 
of both sexes, kindly provided by IPS (Instituto Português do Sangue). PBMC were 
stained with anti-CD14 and anti-CD16 antibodies and the monocyte population was 
defined as the population of cells expressing CD14
+
.
 
 The percentage of Hz-containing 
monocytes following incubation with different Hz doses was then determined for a 
period of 24 hours. Using this strategy we determined that incubating human PBMC 
with 10-20 µM Hz resulted in a mixed population of non-Hz containing and Hz-
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containing cells (Figure 10). The percentage of Hz-positive cells ranged from 29-55.8% 
for sHz and 17.3-31.4% for cHz. 
Monocytes are often defined as expressing high levels of CD14 and low levels of 
CD16. However, in peripheral blood, differential expression of CD16 can subdivide the 
monocyte population into classical monocytes that are CD14
+
CD16
-
 and inflammatory 
monocytes that also express CD16 (CD14
+
CD16
+
). This population is known as 
inflammatory monocytes because it more closely resembles mature tissue 
macrophages
[309,310]
. Interestingly, when the geometric mean fluorescence intensity 
(gMFI) of CD16 in the monocyte population was investigated, it was observed that 
cHz-containing monocytes had significantly higher levels of CD16 gMFI (Figure 11). 
This supports the idea that Hz preparations may have different stimulatory activity 
depending on the presence/absence of adsorbed biomolecules on the Hz crystal faces.        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.  Hz detection in human peripheral blood mononuclear cells (PBMC).  PBMC were 
isolated from buffy coats and incubated with sHz at 10 and 20 μM heme equivalents or with cHz at 10 
μM heme equivalents. PBMC incubated with latex beads or left unexposed to Hz were used as controls. 
The percentage of Hz-containing monocytes was determined at time zero, and after six and 24 hours of 
incubation, by flow cytometry. The mean values of triplicates (± one SD) for one representative 
experiment are shown. Controls and beads had no depolarizing populations.  
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Figure 11. gMFI of CD16 on monocytes fed in-vitro with different types of Hz. PBMC were isolated 
from buffy coats and were incubated either with sHz at 10 and 20 μM heme equivalents or with crude Hz 
(cHz) at 10 μM heme equivalents. PBMCs incubated with latex beads or left unexposed to Hz were used 
as controls. Cells were incubated for 6 hours and then labelled with anti-CD14 and anti-CD16 antibodies. 
Geometric mean fluorescence intensity (gMFI) of CD16 was calculated for non-Hz containing monocytes 
(gray bars) and Hz-containing monocytes (black bars). Differences between sHZ and cHz were 
significant (p < 0.0001). Triplicate values (± one SD) for one representative experiment are shown. 
Controls and beads had no depolarizing populations. 
 
Presence of Hz in leucocytes is correlated with disease severity in two models of 
experimental malaria.  
Following successful detection of Hz using in vitro assays, where cells from 
healthy donors were incubated with sHz, fresh blood from two distinct mouse models of 
experimental malaria was investigated to see if Hz-containing cells could be detected 
and if a correlation with disease severity could be established. Mice infected with P. 
berghei ANKA (PbA) were sacrificed on day 5 when symptoms compatible with 
experimental cerebral malaria started to develop. Mice infected with P. berghei NK65 
(PbNK65) were sacrificed on day 18 when they reached high parasitaemia and started 
showing signs of morbidity. Monocyte (inflammatory and resident) and granulocyte 
populations were identified based on their SSC-1 and on CD11b and Gr1 expression. 
CD11b is mainly expressed on monocytes and macrophages and at lower levels on 
granulocytes and NK cells whilst Gr1 is mainly expressed in mature granulocytes. Thus, 
using Petkova’s gating strategy, granulocytes were defined as CD11b+SSChighGr1++, 
inflammatory monocytes as CD11b
+
SSC
low
Gr1
+
 and resident monocytes as 
CD11b
+
SSC
low
Gr1
-[311]
. Overall, results showed that the percentage of Hz-containing 
leukocytes increased when parasitaemia was higher (Figure 12). Interestingly, when 
mice infected with the two parasite strains were compared at a time-point at which their 
parasitaemias were similar, i.e. day 5 for PbA (5.7%) and day 12 for PbNK65 (7.7%), 
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PbA infected mice had significantly (p<0.02) higher percentages of Hz-containing 
inflammatory monocytes than PbNK65 infected mice (22.1% and 9.1%, respectively). 
Furthermore, at day 18 of infection, when PbNK65 mice were sick, the percentage of 
Hz-containing inflammatory monocytes was similar to that observed in PbA infected 
mice at day 5 of infection (14.2%). The levels of parasitaemia were, however, 
significantly higher in PbNK65-infected mice (28.5%) than in PbA-infected mice 
(5.7%). Taken together our data suggest that the percentage and type of Hz-containing 
phagocytes may be associated with disease severity. 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Hz containing leukocytes in two different mouse models of malaria. Groups of five 
C57BL/6 mice were infected with P. berghei ANKA (PbA) or with P. berghei NK65 (PbNK65). Blood 
was drawn on days 3, 5 12 and 18 and analysed after labelling with anti-CD11b and anti-Gr1. Mean 
percentages per group of Hz-containing monocytes and granulocytes, as well as parasitaemia (red line), 
are shown. Light grey bars: Hz-containing resident monocytes; dark grey bars: inflammatory monocytes 
and black bars: granulocytes. Uninfected controls had no Hz-containing leukocytes (data not shown). 
Mice infected with PbA were sacrificed on day 5. 
 Concluding remarks 
The findings in this chapter showed that following the adaptation of the Cyflow® 
Blue laser cytometer for the detection of SSC-2 it was possible to detect Hz-containing 
cells in human whole blood and isolated PBMC. Using this detection method, it was 
shown that monocytes are the main population to phagocytose Hz in a dose- and time-
dependant manner. It was also observed that cHz can induce different immunological 
effects, as shown by higher gMFI of CD16 on monocytes. This may be attributed to the 
presence of biomolecules on cHz, that are absent on sHz. Finally, our results using two 
different murine models of malaria infection suggest that detection of Hz in circulating 
granulocytes/monocites correlates with disease severity in mice. 
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2. Characterization of cellular functions 
impaired by ingestion of Hz 
Introduction 
Several studies suggest that monocytes and macrophages fed with Hz may have 
impaired cellular functions such as phagocytosis and generation of oxidative 
burst
[208,237]
. Impairment of these functions may be associated with reduced antibacterial 
and anti-tumour activities of monocytes in malaria patients
[238]
. Following the 
optimization of Hz detection using flow-cytometry, functional studies were carried out 
to characterize the immuno-modulatory properties of Hz at single-cell level. The aim 
was to investigate if Hz contributed to impairment of cellular functions (phagocytosis, 
oxidative burst and induction of TNF-α) only on Hz-containing cells or if the effects 
were propagated to non-Hz containing cells. Thus, Hz effects were assessed in the 
context of a mixed population of Hz-containing and non-Hz containing cells, which is 
most likely to reflect the in vivo scenario, where the median percentage of Hz-
containing circulating monocytes has been reported to be 2-5%
[312]
. All functional 
studies performed in this section used synthetic Hz kindly supplied by Dr Cevayir 
Coban (referred to in Chapter I). As mentioned in Chapter I, sHz was favoured over cHz 
to avoid possible confounding factors from the presence of other biomoleucales (protein, 
DNA and possibly lipids) on cHz. The reason to use Coban’s sHz instead of our own 
was due to the ease of access to larger batches of sHz, produced in a quality controlled 
manner, which allowed us to perform functional studies without inter -batch variability.  
Results 
Monocytes incubated with Hz have reduced phagocytic function  
The effect of Hz ingestion on phagocytic function was investigated in PBMC 
isolated from buffy coats of healthy donors. Phagocytosis was quantified by flow 
cytometry using E. coli bioparticles conjugated with a pH sensitive dye (pHrodo™ dye), 
that only fluoresces inside the acidic phagosome. PBMC were fed with 10 and 50 µM 
sHz, for 6 hours and then assayed for phagocytic capacity. As shown in Figure 13, 
where the phagocytic capacity of unfed monocytes was compared to that of monocytes 
fed with either latex beads or sHz, there was a reduction in the phagocytic capacity of 
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sHz-fed monocytes, of approximately 90-95%. This occurred both in the Hz-containing 
and Hz-negative population in sHz-fed monocytes. Contrastingly, bead-fed monocytes 
showed no reduction in phagocytic capacity. Thus, our results suggest that while 
ingestion of latex beads does not impair a second round of phagocytosis, ingestion of 
sHz leads to impairment of further phagocytosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Phagocytic capacity of human PBMC fed with Hz. Peripheral blood mononuclear cells 
(PBMC) isolated from buffy coats of healthy donors were incubated for 6 hours in the presence of 10 or 
50 µM sHz. Unfed PBMC and PBMC fed with latex beads were used as positive control (black bars). The 
phagocytic function was quantified by flow cytometry using E. coli bioparticles conjugated with a pH 
sensitive dye (pHrodo™ dye), which only fluoresces inside the acidic phagosome. The phagocytic 
capacity represents the percentage of monocytes with fluorescent bioparticles, normalized against the 
non-fed control. 
 
Hz-containing monocytes have an impaired oxidative burst response 
The oxidative burst response was evaluated in Hz-fed monocytes upon stimulation 
with phorbol myristate acetate (PMA) or following M. bovis BCG (BCG) infection. 
Thus, monocytes were fed with 10 or 50 µM sHz for 4 hours, and then either stimulated 
for 1 hour by the addition of PMA or by BCG infection. The 4 hour incubation period 
was sufficient to obtain similar amounts of Hz-containing cells to those obtained in the 
phagocytosis assay, where a 6-hour incubation period was used (not shown). Following 
stimulation/infection, the magnitude of oxidative burst was quantified by determining 
the gMFI of cleaved dihydrorhodamine 123 (DHR 123), a fluorogenic substrate which 
is converted to rhodamine 123 upon reaction with reactive oxygen species (ROS). 
Figures 14 and 15 show the reduced capacity of monocytes fed with sHz to produce 
ROS when stimulated with PMA or on BCG infection, respectively. This reduction in 
oxidative burst capacity was specific to monocytes that ingested Hz, since non-Hz 
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containing monocytes in the Hz-fed population had levels of ROS production identical 
to the non-fed positive control. The percentage of non-Hz containing monocytes in the 
Hz fed population was on average 30% for the lowest Hz concentration and 12% for the 
highest Hz concentration in the PMA experiments. Monocytes infected with BCG had 
percentages of non-Hz containing monocytes in the mixed population of 58% and 30% 
for the lowest and highest Hz concentrations, respectively.           
  
 
 
 
              
 
 
                                    
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Oxidative capacity of Hz-fed PBMC post-PMA stimulation. Peripheral blood mononuclear 
cells (PBMC) isolated from buffy coats of healthy donors were incubated for 4 hours in the presence of 
10 or 50 µM sHz. Following Hz ingestion, monocytes were stimulated with phorbol myristate acetate 
(PMA). Unfed, unstimulated PBMC and unfed PBMC stimulated with PMA were used as negative and 
positive controls, respectively. The magnitude of the oxidative burst was quantified by flow cytometry, 
via measurement of dihydrorhodamine 123 (DHR 123) oxidation. The gMFI of cleaved substrate of Hz-
fed monocytes normalized against the unfed positive control, of five independent experiments is shown. 
Black bars: oxidative stress response in non-Hz containing monocytes; red bars: oxidative stress response 
in Hz-containing monocytes. Differences between Hz-containing and non-Hz containing monocytes were 
signinficant (***p=0.0002; ****p<0.0001).   
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Figure 15. Oxidative capacity of Hz-fed PBMC following BCG infection. Peripheral blood 
mononuclear cells (PBMCs) isolated from buffy coats of healthy donors were incubated for 4 hours in the 
presence of 10 or 50 µM sHz. Following Hz ingestion, monocytes were infected with BCG for 1 hour. 
Unfed, uninfected PBMC and unfed PBMC infected with BCG were used as negative and positive 
controls, respectively. The oxidative stress response was quantified as described in Figure 14. Differences 
between Hz-containing and non-Hz containing monocytes were significant at the highest sHz 
concentration (p=0.0392) and between the Hz-containing population of the lower sHz concentration and 
the positive control (p=0.0026).  
 
Production of TNF-α is decreased in Hz-fed PBMC 
We were also interested in investigating whether Hz had a stimulatory effect on 
monocytes by inducing TNF-α production, as reported by others[257,313], or if its 
ingestion by monocytes could impair subsequent responses to other stimuli such as 
BCG infection. To assess whether Hz had stimulatory capacity, PBMC isolated from 
buffy coats of healthy donors were incubated with 10 µM sHz alone or in the presence 
of 2 µg/ml LPS. As shown in Figure 16, sHz by itself did not stimulate TNF-α 
production by PBMC, thus showing that Hz is not stimulatory. However, in the 
presence of LPS, Hz-fed PBMC produced TNF-α. There was a tendency for Hz-
containing cells to produce lower amounts of TNF-α than non-Hz containing cells 
although this difference did not reach statistical significance (Figure 16).  
Next, we investigated if levels of TNF-α induced by BCG infection of human 
PBMC were affected by sHz. For this, we used a M. bovis BCG strain that expresses 
GFP (green fluorescent protein) to identify infected cells. Thus, human PBMC were fed 
with 10 µM sHz and infected with BCG. The levels of TNF-α induced by BCG in the 
presence of sHz were compared to unfed PBMC infected with BCG. The results in 
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Figure 17 suggest that Hz exposure per se impaired TNF-α production in response to 
BCG infection, as both Hz-negative and Hz-containing PBMC had reduced levels of 
TNF-α production in response to BCG infection as compared to controls.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Ingestion of sHz by human PBMC does not induce TNF-α production. Peripheral blood 
mononuclear cells (PBMCs) isolated from buffy coats of healthy donors were fed with 10 µM sHz for 4 h. 
As a positive control for TNF-α production, PBMC were fed with 10 µM sHz in the presence of 2 µg/ml 
LPS. Unstimulated, unfed PBMC were included as a negative control. TNF- α production was determined 
by flow-cytometry, after intracellular staining. The gMFI, normalized against the non-Hz containing cells 
of the positive control, of four independent experiments, is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. TNF-α production in BCG infected human PBMC, fed with sHz. Peripheral blood 
mononuclear cells (PBMCs) isolated from buffy coats of healthy donors were fed with 10 µM sHz for 4 h. 
PBMC were then infected with BCG (GFP-expressing strain) and TNF-α production determined by 
intracellular staining after 18 hours of infection. In parallel, unfed PBMC were infected with BCG as a 
positive control for TNF-α production. The gMFI, normalized against the positive control, of four 
independent experiments is shown. Production of TNF-α between positive control and non-Hz containing 
cells was significantly different (p=0.0092).  
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M. bovis BCG infection of Hz and non-Hz containing monocytes. 
Given our results showing functional impairment of Hz-containing monocytes we 
went on to investigate the kinetics of BCG growth in Hz-fed and non Hz-fed monocytes. 
Bacterial growth was first determined by infecting PBMC, fed with either 10 µM sHz or 
latex beads, with BCG. Five days later, PBMC were lysed and serial dilutions of cell 
lysates were plated in solid media for determination of colony forming units (CFUs). 
Figure 18 compares the percentage of infection in unfed PBMC with PBMC fed with 
latex beads or sHz, prior to infection. Results showed that PBMC pre-fed with sHz had 
higher bacterial load than PBMC pre-fed with latex beads or unfed controls. 
BCG growth was also investigated by cytometry and fluorescence microscopy as 
we wanted to investigate bacterial growth in the mixed population of Hz-containing and 
non-Hz containing cells. For this, the M. bovis BCG strain expressing GFP was used. 
Unfed/fed PBMC were infected with BCG-GFP strain for five days, and then analysed 
either by flow-cytometry (Figure 19) or by fluorescence microscopy (Figure 20). Flow-
cytometry results showed no significant differences in bacterial growth between 
bead/sHz-fed PBMC and unfed controls. However, fluorescence microscopy results 
again suggested that Hz-fed PBMC have higher bacterial load than non-fed controls.  
Overall these results suggest that ingestion of Hz by PBMC leads to functional 
impairment of these cells. This in turn results in a lower bactericidal capacity that 
contributes to higher BCG loads. This might mean that in vivo, accumulation of Hz 
might contribute to a lower capacity to control TB infection.  
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Figure 18. BCG infection of Hz-fed PBMC. Peripheral blood mononuclear cells (PBMCs) isolated from 
buffy coats of healthy donors were incubated for 4 hours with 10 µM sHz or with 0.001% latex beads. 
Following Hz/bead ingestion, monocytes were infected with BCG for 3 hours. Unfed PBMC were also 
infected with BCG in parallel, as a positive control. After five days, cells were lysed and serial dilutions 
plated to allow the determination of CFUs. Results shown are the mean percentage of infection 
(normalized to the positive control) of five independent experiments. Differences between positive 
control and Hz-fed PBMC were significant (p=0.0072).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Assessment of BCG-GFP infection in Hz-containing monocytes. Peripheral blood 
mononuclear cells (PBMCs) isolated from buffy coats of healthy donors were incubated for 4 hours with 
10 µM sHz or with 0.001% latex beads. Following Hz/bead ingestion, monocytes were infected with 
BCG-GFP strain for 3 hours. Unfed PBMC were also infected with BCG-GFP in parallel, as a positive 
control. After 5 days, cells were analysed using flow-cytometry to assess bacterial growth in Hz-
containing monocytes. Results shown are the mean percentage of infection (gMFI of GFP positive cells, 
normalized to the positive control) of five independent experiments.  
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Figure 20. Assessment of BCG-GFP infection in Hz-containing monocytes by fluorescence 
microscopy. Peripheral blood mononuclear cells (PBMCs) isolated from buffy coats of healthy donors 
were incubated for 4 hours with 10 µM sHz. Following Hz ingestion, monocytes were infected with 
BCG-GFP strain for 3 hours. Unfed PBMC were also infected with BCG-GFP in parallel, as a positive 
control. After 5 days, cells were analysed by microscopy using a Zeiss Axiovert 200M microscope. An 
automatic programme was used to scan the cover slip and acquire 25 sequential photos. Images were then 
analysed using ImageJ 1.47v to measure the GFP integrated density (fluorescence). The geometric mean 
of the corrected total cell fluorescence (CTCF), of three independent experiments is shown (CTCF= 
fluorescence of the measured signal x area measured, corrected for the mean fluorescence of the 
background reading). Differences between unfed PBMC and Hz-fed PBMC were significant (p=0.0016).   
 
Concluding Remarks 
In this chapter the effects of Hz ingestion by human PBMC on cellular functions 
were investigated. Mainly, we investigated whether ingestion of Hz impaired 
phagocytosis, oxidative burst or the production of TNF-α. In contrast to previous studies, 
we aimed at finding possible Hz effects specifically on those cells that had ingested Hz, 
while investigating if these effects were propagated to non-Hz containing cells. To this 
end, we employed flow cytometry and the detection strategy described in the first part 
of this chapter. The results obtained suggested that cellular functions such as 
phagocytosis, oxidative burst and production of TNF-α following Hz ingestion were 
decreased when compared to non-fed control cells. Hz effects seemed to propagate to 
non-Hz containing cells in the case of phagocytosis and TNF-α production. However, in 
the case of the oxidative burst, significant differences were found between the responses 
of Hz-containing cells and non-Hz containing cells. While Hz-containing cells had 
decreased oxidative burst capacity, the non-Hz containing cells overall showed similar 
capacity to non-fed controls.     
Next, we investigated whether the impairment of the aforementioned cellular 
functions would promote a poorer control of mycobacterial growth. Therefore, the 
growth of BCG was assessed in human PBMC following Hz ingestion. Growth was 
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monitored by first determining CFUs levels. Then, to investigate if bacterial growth was 
different in Hz-containing cells and non-Hz containing cells, a GFP-expressing strain of 
M. bovis BCG was used, to determine mycobacterial growth using flow-cytometry and 
fluorescence microscopy. CFUs determination and fluorescence microscopy showed 
that Hz-fed PBMC contained higher mycobacterial loads than non-fed controls, thus 
suggesting that Hz ingestion through impairment of cellular functions may contribute to 
loss of bactericidal function.  
  
Materials and Methods 
M. bovis BCG strains used  
When indicated PBMC were infected with M. bovis BCG-lux (BCG transformed 
with the plasmid pMV306G13-Lux (Addgene; Cambridge, MA, USA) kindly provided 
by Dr Brian Robertson (Imperial College, London, UK). Alternatively, PBMC were 
infected with M. bovis BCG-GFP (BCG transformed with a GFP expressing plasmid) 
which was a kind donation from Dr Bianca Schneider (Borstel Leibniz-Center for 
Medicine and Biosciences, Germany). Unless otherwise stated, all infections were 
performed with the BCG-lux strain.    
 Cultures of M. bovis BCG-lux and M. bovis BCG-GFP were grown in 7H9 broth 
(supplemented with 0.05% Tween-80 and 10% oleic-albumin-dextrose-catalase 
(OADC); BD Diagnostics, Franklin Lakes, NJ, USA). Cultures of BCG-GFP were 
additionally grown in the presence of kanamycin (20 µg/ml). Strains were grown for 7-
10 days at 37°C, 5% CO2 and used to prepare frozen vials in the presence of 25% 
glycerol.  
 
Flow cytometer modification (depolarized Side Scatter detection) 
The CyFlow
®
 Blue laser (Partec, Münster, Germany) is a small, five parameter 
flow cytometer with blue laser (488 nm) excitation, and detectors for Forward Scatter 
(FSC), Side Scatter (SSC), green fluorescence (FL1), orange fluorescence (FL2) and red 
fluorescence (FL3). To allow for depolarized Side Scatter detection this set-up was 
changed, mainly by creating two SSC detectors, using a 50%/50% beam splitter. Then, 
a polarization filter was placed orthogonally (90º angle) to the polarization plane of the 
laser light, in front of one of these SSC detectors. Thus, allowing the detection of 
depolarized Side-Scatter. This and other necessary changes are indicated in Figure M1.  
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Figure M1. Alterations to the CyFLow
®
 Blue laser flow cytometer to allow detection of depolarized 
side-scatter. A) The lid of the flow cytometer was removed to allow access to the optical bench of the 
cytometer. B) Light path in conventional filter set-up for detection of Forward Scatter (FSC), Side-Scatter 
(SSC), green (FL-1), orange (FL-2) and red (FL-3) fluorescence. C) Filter set-up that allows detection of 
depolarized Side-Scatter instead of FL-2 detection. Squares with broken line indicate dichroic mirrors that 
needed to be changed. Red arrow shows 50%/50% beam splitter. Other beam splitters which divert more 
light to the depolarized SSC are possible, such as 90%/10% or even 95%/5%. DM = Dichroic Mirror; BP 
= Bandpass filter, LP = Longpass filter; numbers indicate wavelength in nm. 
 
In vitro incubation of human whole blood with sHz 
Heparin-anticoagulated blood from healthy human donors was diluted 1:1 in 
RPMI 1640 (Gibco™) and distributed into a 24 well plate. Then, sHz was added at 10; 
60 and 120 μM heme equivalent. The plate was incubated at 37°C in 5% CO2. 
Leucocytes were analyzed in triplicates at the time points indicated.  
 
 
 
 
 64 
 
In vitro incubation of human PBMCs with sHz and cHz 
Human PBMC were isolated from 40 ml heparin-anticoagulated blood collected 
from healthy volunteers and after dilution 1:1 in RPMI 1640 was placed in a Ficoll 
gradient (Ficoll-Paque Plus, GE Healthcare; Uppsala, Sweden). Cells were centrifuged 
at 700 g for 20 min and the interface containing the PBMCs was collected. The PBMCs 
were washed, counted and resuspended at a concentration of 1×10
6
 PBMC/ml in RPMI 
1640 (supplemented with 2 mM L-glutamine, 10 mM Hepes, 0.05 mg/ml gentamicin 
and 10% fetal calf serum) and distributed into a 24 well plate. Then, sHz was added at 
10 and 20 μM heme equivalent and cHz was added at 10 μM heme equivalent in 
triplicates. Polystyrene latex beads (0.1 μm) were diluted from stock at 10% (vol/vol) to 
a final concentration of 0.001% and used as control when indicated. The plate was 
incubated at 37°C in 5% CO2 for the indicated times.  
 
Flow cytometry analysis of human leucocytes  
For the in vitro whole blood assay, 50 μl of blood suspension were incubated with 
anti-CD14 (fluorescein isothiocyanate, FITC) and anti-CD16 (phycoerythrin, PE) 
antibodies (Ebioscience, San Diego, CA, USA), following Hz incubation. RBC were 
lysed with BD FACS lysing solution (BD Biosciences; San Jose, CA, USA) for 5 
minutes and washed before analysis. PBMCs were labelled as described for the whole 
blood assay, without RBC lysis. All in vitro samples were performed in triplicate.  
 
Flow cytometric analysis of murine leukocytes 
Groups of five C57BL/6 mice (7 weeks old from Charles River, Spain) were 
infected intraperitoneally (IP) with Plasmodium berghei ANKA (PbA) as model for 
experimental cerebral malaria or P. berghei NK65 (PbNK65) as model for 
hyperparasitaemia. Uninfected and PbNK65-infected mice were followed for 18 days. 
PbA-infected mice were sacrificed on day 5 when showing obvious signs of morbidity. 
Parasitaemia and flow cytometric analysis of blood was performed on days 3, 5, 12 and 
18 post-infection. At each time point, approximately 25 μl of blood was collected from 
a tail vein, incubated with Fc-block and then labelled with anti-CD11b (FITC) and anti-
Gr1 (PE) antibodies. After washing the cells, RBC were lysed with 125 μl of BD FACS 
lysing solution (BD Biosciences) for 5 min. The cells were washed again, resuspended 
in FACS buffer (1x PBS with 2% fetal calf serum) and analyzed by flow cytometry. 
Antibodies and Fc-block purchased from Ebioscience.  
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Isolation of human PBMC for functional assays 
Human PBMC were isolated from buffy coats discarded from blood donations of 
healthy volunteers and kindly provided by Instituto Português do Sangue. Buffy coats 
were diluted 1:1 in RPMI 1640 and placed in a Histopaque gradient (Histopaque
®
 1077, 
Sigma-Aldrich). Cells were centrifuged at 600 g for 20 min (without centrifuge brake) 
and the interface containing the PBMC was collected. Then, PBMC were washed once 
in RPMI 1640, counted and resuspended at a concentration of 5×10
5
 PBMC/ml in 
RPMI 1640. The PBMC suspension was distributed in 24-well plates and incubated for 
1-2 h at 37ºC, in 5% CO2 incubator, to promote cell adherence. At the end of the 
incubation time non-adherent cells were removed by aspirating the medium from the 
24-well plates, and washing two times with warm 1x PBS. Warm RPMI 1640 
(supplemented with 2 mM L-glutamine, 10 mM Hepes and 10% fetal calf serum) with 
or without Hz was added to the wells following the removal of adherent cells and 
incubated further at 37ºC, 5% CO2.  
 
Phagocytosis assay 
The phagocytic capacity of human PBMC following Hz ingestion was evaluated 
using the pHrodo™ E. coli BioParticles® Phagocytosis Kit for flow cytometry 
(Molecular Probes, Invitrogen). E. coli bioparticles were opsonized with autologous 
serum before the phagocytic assay. Human PBMC from healthy donors were isolated as 
described above. Unfed-PBMC and PBMC fed with 10 and 50 μM Hz were incubated 
at 37C, 5% CO2, for 6 hours. Then, the phagocytic assay was performed following 
manufacturer’s instructions with the following modifications. Hz-fed PBMC and 
control PBMC were transferred to cytometry tubes and E. coli bioparticles added at a 
20:1 (bioparticles:PBMC) ratio and incubated in a water bath at 37ºC for 180 min. At 
the end of the incubation time, tubes were kept on ice to terminate phagocytosis activity.  
Finally PBMC were stained with anti-CD14 (FITC) antibody for 20 min before 
acquisition on the cytometer.   
 
Oxidative burst assay 
The Phagoburst™ (Glycotope Biotechnology; Berlin, Germany) kit allows the 
detection of reactive oxygen species (ROS) by the addition and oxidation of the 
fluorogenic substrate dihydrorhodamine-123 (DHR-123). The gMFI of cells producing 
ROS can then be determined by flow cytometry using the green fluorescence channel 
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(FL1).  Human PBMC from healthy donors were isolated as before. Hz at 10 and 50 μM 
was added to PBMC and incubated at 37ºC, 5% CO2 for 4 h. Then, the oxidative burst 
assay was performed as per manufacturer’s instructions with the following 
modifications. Following Hz incubation, Hz-fed and control unfed-PBMC were 
transferred to cytometry tubes. Then, phorbol 12-myristate 13-acetate (PMA) was used 
to stimulate ROS production. For this, PMA was added to unfed-PBMC and Hz-fed 
PBMC and cells incubated at 37ºC in a water bath for 1 h. Unfed-PBMC with no added 
PMA were included as a negative control. After stimulation with PMA, DHR-123 was 
added to cells and further incubated for 10 min at 37ºC. Finally, cells were stained with 
CD14 (PE) and incubated for 20 min on ice before flow cytometry analysis. 
Alternatively, PMA stimulation was replaced by one hour M. bovis BCG (BCG) 
infection (at a ratio of 10:1) to evaluate the oxidative response of Hz-containing PBMC 
to BCG infection.  
     
TNF-α intracellular staining (with or without stimulation) 
For quantification of TNF-α, isolated PBMC were fed with 10 μM Hz and 
incubated for 4 h at 37ºC, 5% CO2. As a positive control for TNF-α production, Hz-fed 
PBMC were incubated in the presence of 2 µg/ml LPS. Brefeldin A (10 µg/ml; Sigma-
Aldrich) was added to cells at the same time as Hz. Alternatively, isolated PBMC were 
fed with 10 μM Hz for 4 h and then infected with BCG-GFP strain for 18 h in the 
presence of 10 µg/ml Brefeldin A. Intracelular staining was performed by fixing cells 
by adding paraformaldehyde (PFA) to a final concentration of 2% and incubating for 20 
min at room temperature (RT). Then, permeabilization buffer (0.5% saponin in 1x Facs 
buffer) was added to cells and further incubated for 10 min at RT. Finally, cells were 
washed 1x in permeabilization buffer and stained with TNF-α antibody (PE) for 20 min 
on ice before flow cytometry analysis.  
 
Mycobacterial load determination of BCG-infected PBMC  
Following PBMC isolation, 10 μM Hz was fed to PBMC for 4 h at 37ºC with 5% 
CO2. Then Hz-fed and unfed-PBMC were infected with BCG-lux (at a multiplicity of 
infection (MOI) of 2), for 3 h at the end of which extracellular bacteria were removed 
by two washes in warm 1x PBS. RPMI 1640 (supplemented with 2 mM L-glutamine, 
10 mM Hepes and 20% fetal calf serum) was added to cells and before incubation for 5 
days at 37ºC, 5% CO2. Mycobacterial burden determination by colony forming units 
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(CFUs) was performed as follows. After infection, PBMC were lysed by the addition of 
1% saponin (0.1% final concentration) and serial dilutions of lysed PBMC were plated 
on 7H11 Agar (supplemented with OADC; BD Diagnostics). Plates were incubated at 
37ºC, 5% CO2, for 21 days before counting CFUs. 
For quantification of mycobacterial growth by flow cytometry, isolated PBMC 
were fed with Hz (unfed PBMC were included as control). Then, Hz-fed and unfed 
PBMC were infected with BCG-GFP strain (MOI:10), as described above. Five days 
post-infection, cells were transferred to cytometry tubes, stained with CD14 (PE) and 
analysed by flow cytometry.  
Quantification of mycobacterial growth by microscopy was performed by 
distributing isolated PBMC onto 10 mm microwell glass bottom dishes (MatTek 
Corporation; Homer Avenue, Ashland, MA, USA) pre-treated with poly-L-lysine 
(Sigma-Aldrich). Hz-fed and unfed PBMC were infected with BCG-GFP strain (MOI: 
10), as before. Then, five days post-infection, cells were analysed by microscopy using 
a Zeiss Axiovert 200M microscope (Carl Zeiss, Göttingen, Germany) equipped with a 
cooled CCD camera (Roper Scientific Coolsnap HQ CCD).  
Discussion 
Hemozoin detection is normally restricted to microscopy. However, increasing 
interest in alternative methods of hemozoin detection and their applicability to new 
malaria diagnostic tests has driven research in recent years. Several methods have been 
proposed based on the paramagnetic and birefringent properties of hemozoin
[314–316]
. 
Although these methods seem promising, they present inherent limitations such as low 
sensitivity in the detection of P. falciparum malaria
[317]
. This is due to the fact that in P. 
falciparum malaria only immature forms are seen in peripheral blood circulation and 
these have lower hemozoin content. However, hemozoin based diagnostic tests might be 
useful in the diagnostic of other forms of malaria where mature forms with abundant 
hemozoin are also present in circulation.  
 Hemozoin detection by flow cytometry seems valuable as a rapid drug sensitivity 
assay or as a method to analyze Hz-containing and non-Hz containing leukocytes in the 
same sample, and to perform functional assays
[305]
. The first part of this chapter 
demonstrated how a conventional flow-cytometer could be modified, so that instead of 
the conventional layout, an additional SSC detector was included for the detection of 
depolarized side scatter. Following sHz incubation in whole blood, a gating strategy 
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was established to distinguish the cells that ingested hemozoin. This was achieved by 
comparing the conventional side scatter (SSC-1) with depolarized side scatter (SSC-2), 
and identifying cells with increased SSC-2. Monocytes could be distinguished from 
granulocytes by using a classical distinction in terms of their CD14 (monocytes) and 
CD16 (granulocytes) expression. However, it was observed that monocytes that 
ingested sHz also had increased SSC-1 and that their distribution overlapped with the 
granulocyte population. This is particularly important as some studies use a ‘classical’ 
monocyte gate strategy and may be excluding the Hz-containing monocytes from the 
analysis
[318,319]
. 
Ingestion of sHz both in whole blood or PBMC from healthy donors was time and 
dose dependant, and monocytes were the main cell population to phagocytose hemozoin. 
Classically, monocytes are considered to express CD14 while expressing low levels of 
CD16 (CD14
+
CD16
-
). However, it has been shown that during infection, other 
subclasses of monocytes emerge in circulation that express variable amounts of 
CD16
[320]
. During optimization studies, it was observed that whilst sHz did not seem to 
have an overall effect on the expression of CD16 on monocytes, cHz led to an increased 
expression of CD16. It is likely that cHz had increased stimulatory capacity than sHz, 
due to the presence of DNA and proteins. This highlights the importance of what was 
already discussed in the previous chapter, as to the necessity of careful hemozoin 
characterization.   
Hemozoin detection was further investigated in leucocytes of two models of 
murine malaria. Infection of C57BL/6 mice with P. berghei ANKA is considered to be 
a model of experimental cerebral malaria (ECM) with shared characteristics with human 
cerebral malaria (HCM)
[321]
, although this has been disputed by some
[322]
. Another 
model of murine malaria consists of P. berghei NK65 infection in C57BL/6 mice. This 
is a non-cerebral model, where mice usually die with hyperparasitaemia and is often 
used as a model for malaria-associated acute respiratory distress syndrome (MA-
ARDS)
[323]
. The presence of hemozoin in circulating leucocytes has been suggested to 
correlate with disease severity
[324,325]
, although a large scale study has challenged this by 
reporting no correlation
[312]
. However, these studies used microscopy and a leukocyte 
count based on a very low number of cells (100-200 monocytes/granulocytes). Also the 
reported number of patients with detectable Hz-containing monocytes and granulocytes 
was quite variable between study sites, which may account for the discrepant results 
between studies. Thus, using the two murine models described above it was investigated 
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if disease severity could be correlated with Hz-containing leukocytes in circulating 
blood. Results comparing the two models suggest that at similar parasitaemias, the 
percentage of Hz-containing inflammatory monocytes were a better predictor of disease 
severity. Similar findings were made in human malaria where inflammatory monocytes 
(CD14
+ 
monocytes which also express CD16
+
) were positively correlated with severe 
malaria anaemia (SMA)
[326]
. However, in this study pigment content in circulating 
leukocytes was not evaluated. 
  
It was also the aim of this chapter to establish a protocol for the analysis of Hz-
containing and non-Hz containing cells, in the same sample. While most studies use Hz 
doses or times of incubation that result in the uptake of hemozoin by virtually every 
phagocyte, in vivo, only a proportion of phagocytes will contain hemozoin
[327]
. 
Moreover, analysis of Hz-containing and non-Hz containing cells in the same sample, 
allowed to access if impairment of cell functions was restricted to cells that ingested 
hemozoin, or if effects were propagated to non-Hz containing cells as well.  
Phagocytosis, oxidative-stress response and TNF-α production were evaluated in 
isolated PBMC following sHz ingestion. Results obtained suggest that ingestion of sHz 
led to the impairment of all these important cell functions. The PBMC response to LPS 
stimulation in sHz-containing PBMC was also investigated. This was important to 
demonstrate that whilst sHz-containing PBMC produced TNF-α in response to LPS, 
sHz by itself had no stimulatory effect on PBMC. This suggests that the sHz used in our 
functional assays was free of LPS. Examination of Hz-containing PBMC and non-Hz 
containing PBMC populations showed that, while phagocytosis impairment seemed to 
be propagated to all cells exposed to sHz, impairment of ROS production seemed 
restricted to those cells that ingested sHz.  
The mechanism by which hemozoin ingestion leads to impairment of 
phagocytosis is not known. However, inhibition of ROS production by hemozoin 
ingestion seems to be associated to production of lipid peroxidation derivatives, which 
promote oxidation and damage of essential components of the oxidative response, such 
as cytosolic subunits of NADPH oxidase (NOX) and protein kinase C (PKC)
[237]
. 
During in vitro experiments, sHz was often observed outside cells following the 
incubation period. Removal of this undigested hemozoin was resistant to PBS washes 
thus, it is possible that continued exposure to sHz promoted damage to cell membranes 
and possibly led to an impairment of phagocytosis, even in those cells that did not 
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ingest sHz. Furthermore, in our study the oxidative response impairment seemed to be 
limited to Hz-containing cells. This supports Schwarzer’s investigation in which the 
inhibition mechanism of the oxidative response involves damage to cytosolic 
subunits
[237]
. Thus, it is reasonable to expect that only cells that have ingested hemozoin 
might become impaired in their oxidative response.  
 
As important cellular functions were impaired by hemozoin we set out to 
investigate how these cells would be able to control intracellular growth of 
mycobacteria.  Bacterial loads were investigated in sHz-containing PBMC, five days 
following infection with M. bovis BCG.  Loads were first determined by CFUs, in 
which it was found that Hz-containing cells had higher levels of BCG than control 
unfed-PBMC. This correlated with previous data showing that hemozoin ingestion 
promoted lower microbicidal and anti-tumour activity
[238]
. A BCG strain expressing 
GFP was used to determine bacterial load by flow-cytometry and to assess differences 
in Hz-containing and non-Hz containing cells, on the same hemozoin exposed 
population. However, it was observed that after five days post infection virtually every 
cell contained hemozoin. Thus, the mycobacterial load was compared between infected-
control and infected, sHz-fed PBMC. In this case, results obtained found no significant 
differences in bacterial loads. Use of flow-cytometry to detect small differences in 
mycobacterial loads might not be the best method to use, due to low sensitivity in 
detecting the GFP signal. Thus, microscopy was further employed to investigate 
bacterial burdens between unfed- and sHz-fed PBMC. Results obtained by microscopy 
corroborated results obtained by CFUs determination, in which higher bacterial burdens 
were observed in sHz-fed PBMC.   
Thus, results in this chapter suggest that hemozoin impairs important cellular 
functions and more importantly, our assays suggest that hemozoin may not only impair 
functions of Hz-containing cells but also effects may be propagated to adjacent cells. It 
is tempting to speculate that, in vivo, functionally impaired cells will not only be 
restricted to pigment-containing leukocytes, but also to neighbouring cells with which 
they will interact.     
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CHAPTER III 
Long term kinetics of hemozoin in mice organs 
Introduction 
The prolonged presence of Hz in tissues of individuals that had suffered from 
Plasmodium infections has been reported since the 18th century (reviewed in
[222]
) and, 
as already mentioned in the introduction to this thesis, it was, in fact, the presence of the 
pigment in host tissues that eventually aided in the discovery of the Plasmodium 
parasite and its mode of transmission
[6]
. However, little is known about the long-term 
kinetics of Hz in vivo. 
Despite Hz being ingested by circulating granulocytes and monocytes, their 
median half-life in blood – 72 and 216 hours for Hz-containing granulocytes and Hz-
containing monocytes, respectively – is relatively short[328]. Thus, the question remains 
as to what ultimately happens to Hz. Given the relatively short half-life of phagocytic 
cells in circulating blood it is likely that hemozoin is liberated and re-ingested by 
several generations of phagocytes, even when they are already located in host organs 
(tissue-resident phagocytes)
[288]
. Until now, only one study used a fluorometric method 
to try and address the issue of Hz elimination following an infection by the malaria 
parasite. This report showed that 70% of Hz disappeared from the liver over a period of 
270 days after parasite clearance, whilst the amount of Hz in the spleen increased 8-fold 
during that period
[329]
. However, no other organs were investigated and no detailed 
investigation of what happens to Hz inside the aforementioned organs was performed. 
This chapter describes our investigation of Hz persistence and kinetics in the 
mammalian host. 
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Results 
Hz quantification in murine tissues  
As a first approach we decided to measure Hz in murine organs by a method 
similar to the one used by Levesque et al
[329]
. Two models of infection were used in 
these experiments: P. berghei NK65 (PbNK65), because of the substantial amount of 
Hz it produces during infection and P. chabaudi AS (PcAS), due to its similarities to the 
human malaria parasite, P. falciparum. These similarities include preferential infection 
of normocytes, although both can also infect reticulocytes; both can adhere to 
uninfected RBC (rosetting) and the fact P. chabaudi like P. falciparum sequester to 
endothelial cells, and as such, mature forms are almost never seen in peripheral blood 
circulation
[330]
.    
All mice infected with PbNK65 for 14 days developed infection achieving 
parasitaemias ranging from 9 to 40% (mean 26%). Starting at day 14 post-infection, 
mice were treated daily with chloroquine (CQ) until complete parasite clearance from 
peripheral blood (less than 1 parasite in 2000 red-blood cells), eight days later. Mice 
infected with PcAS developed parasitaemias of 20 to 43% (mean 30%). PcAS infection 
is a self-limiting infection with infected mice able to self-cure. Clearance of peripheral 
blood parasitaemia was confirmed 20 days post-infection. Then, at the indicated time 
points, mice were sacrificed and Hz in homogenized liver and spleen quantified as heme 
equivalents, as described. Results are shown in Figure 21 for mice infected with 
PbNK65 and Figure 22 for mice infected with PcAS. Overall Hz levels in both models 
seemed constant over time, with a slight tendency to increase in the liver.  
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Figure 21. Colorimetric Hz quantification in liver and spleen of PbNK65-infected mice post-
malaria clearance. Hz in livers and spleens of P. berghei NK65-infected mice was quantified after 
parasite clearance by a colorimetric assay (QuantiChrom Heme Assay Kit) and expressed in heme 
equivalents (normalized to protein content). Overall Hz content remained quite stable over time. Liver 
and spleen of uninfected control mice had negligible amounts of detectable heme (468 and 890 μM 
heme/protein (mg/ml), respectively) most likely due to the presence of erythrocytes in these tissues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Colorimetric Hz quantification in liver and spleen of PcAS-infected mice post-malaria 
infection. Hz quantification in livers and spleens of PcAS infected mice was quantified at the indicated 
time points, as in Figure 21. Overall Hz content remained quite stable over time. Liver and spleen of 
uninfected control mice had negligible amounts of detectable heme (640 and 523.2 μM heme/protein 
(mg/ml), respectively), most likely due to the presence of erythrocytes in these tissues. 
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Hz kinetics in host tissues 
Since a simple quantification of Hz inside the host tissues provides no information 
about the location of Hz inside the different organs studied, we next investigated what 
happens to Hz after parasite clearance, using histological cuts of liver, spleen and bone 
marrow. Analyses of these sections revealed that Hz deposition in liver, spleen, and 
bone marrow of PbNK65-infected mice showed an initially sparse distribution of 
smaller-sized extracellular particles, as shown by the white arrows in Figure 23. 
Immediately after parasite clearance, Hz seemed to present a higher density in the liver 
than in the other organs analyzed. With time, Hz tended to accumulate in larger-sized 
intracellular particles (black arrows). This was accompanied by a redistribution of Hz 
from the liver to the hematopoietic organs (spleen and bone marrow). In the spleen, Hz 
deposition seemed to localize preferentially to the red pulp, as reported by others
[331]
.  
Organs of PcAS-infected mice were observed 20 days post-infection, at a time 
when parasites were no longer observed in circulation. The second time point was 
analyzed 140 days post-infection. Figure 24 illustrates the kinetics of Hz for liver, 
spleen and bone marrow. It was similar to that which we had already observed for 
PbNK65-infected mice, with Hz distribution initially sparse and consisting of smaller-
sized extracellular particles. Observation of organ sections at day 140 indicated that, 
over time, Hz was also redistributed from the liver to the hematopoietic organs. Hz 
deposition in the spleen also seemed to localize preferentially to the red pulp. 
Interestingly, PcAS-infected mice had smaller Hz aggregates when compared to the 
larger aggregates observed in the organs of their PbNK65-infected counterparts. This 
might reflect different rates of Hz production/tissue accumulation.  
Table 2 summarises the histopathological findings of Hz distribution for PbNK65-
and PcAS-infected mice.   
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Figure 23. Kinetics of Hz distribution in liver, spleen, and bone marrow of PbNK65 infected mice. 
Mice were infected with P. berghei NK65, and at the indicated time points, organs were extracted for 
histology. Hz kinetics for liver, spleen, and bone marrow showed an initially sparse distribution of small-
sized extracellular particles (white arrows) with increased density in the liver (A, B). This progressed to 
medium- and large-sized intracellular particles (C–H) (black arrows) with a decrease in density in the 
liver (E–H) and increase in spleen (M–P) and bone marrow (U–X). This redistribution was accompanied 
by a distinct organ-specific topographic localization of Hz, which appeared to encompass migration, first 
to liver (B) and then to the hematopoietic organs (spleen and bone marrow). See Table 1 for a detailed 
characterization of size, location, organ specific topography, and distribution pattern of Hz in these 
organs. 
 
days 
post-clearance 
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Figure 24. Kinetics of Hz distribution in liver, spleen, and bone marrow of PcAS-infected mice. 
Mice were infected with P. chabaudi, and at the indicated time points organs were extracted for histology. 
Hz kinetics for liver, spleen, and bone marrow were similar to PbNK65-infected mice: an initially sparse 
distribution of small-sized extracellular particles with increased density in the liver. This progressed to 
similar-sized intracellular particles (black arrows) with a decrease in density in the liver and increase in 
spleen and bone marrow. This redistribution was also accompanied by a distinct organ-specific 
topographic localization of Hz, which appeared to encompass migration, first to liver and then to the 
hematopoietic organs (spleen and bone marrow). See Table 1 for a detailed characterization of size, 
location, organ specific topography, and distribution pattern of Hz in these organs. 
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organ Days  
PC 
or 
PI 
Modifiers 
particle 
sizea 
location topography  
(organ-specific) 
distributionb severityc 
L
IV
E
R
 
7 S extracellular - sinusoidal Diffuse moderate 
20* S-M extra and intracellular endothelial/kupff
er cells 
sinusoidal Difffuse moderate 
90 M-L intracellular kupffer cells sinusoidal Multifocal moderate 
140* L intracellular kupffer cells sinusoidal and 
perivascular  
(periportal/perivenular) 
Multifocal moderate 
196 L intracellular kupffer cells perivascular  
(periportal/perivenular) 
Multifocal mild 
284 L extra and intracellular kupffer cells periportal, acinar Multifocal mild 
S
P
L
E
E
N
 
7 S extracellular - red pulp Diffuse minimal 
20* S-M extra and intracellular phagocytic 
mononuclear 
cells 
red pulp Diffuse moderate 
90 M-L intracellular phagocytic 
mononuclear 
cells 
red pulp; marginal zone Multifocal moderate 
140* M-L intracellular phagocytic 
mononuclear 
cells 
red pulp; marginal zone Multifocal moderate 
196 L intracellular phagocytic 
mononuclear 
cells 
red pulp; white pulp Multifocal moderate 
284 L extra and intracellular phagocytic 
mononuclear 
cells 
red pulp (subcapsular; 
fibrous trabeculae) 
Multifocal moderate 
B
O
N
E
 M
A
R
R
O
W
 
7 S extracellular - sinusoidal Multifocal minimal 
20* S-M extracellular - stromal Multifocal mild 
90 M extracellular - stromal Multifocal mild 
140* M extra and intracellular phagocytic 
mononuclear 
cells 
stromal Multifocal moderate 
196 L extra and intracellular stromal/phagocyt
ic mononuclear 
cells 
stromal Multifocal moderate 
284 L extra and intracellular stromal/phagocyt
ic mononuclear 
cells 
stromal multifocal to 
diffuse 
moderate 
*P. chabaudi AS (all other time-points refer to P. berghei NK65) 
        
Table 2. Histopathological characterization of hemozoin: size, distribution, and organ-specific 
topography. Mice were infected with PbNK65 or PcAS, and at the indicated time points (PC – post-
malaria clearance and PI – post-malaria infection, for PbNK65 and PcAS, respectively), organs were 
extracted for histology. aParticle size: S, small; M, medium; L, large. bDistribution: diffuse, affects the 
majority of the section examined; multifocal, more than one focus. cSeverity: minimal, amount of change 
barely exceeds normal limits; mild, easily identified but of limited severity; moderate, the change is 
prominent but with potential to increase. 
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Hz resides inside phagocytic cells  
As an alternative approach to Hz quantification by a colorimetric assay, we further 
investigated its kinetics by flow cytometry. Hz detection was investigated in CD11b
+
 
phagocytic cells present in whole blood and single cell suspensions of liver, spleen, and 
bone marrow. As mentioned in the previous chapter, CD11b is expressed in monocytes, 
mature macrophages, neutrophils, and NK cells. In all infected mice Hz accumulation 
could be detected irrespective of the strain used and is shown in Figure 25 (PbNK65) 
and Figure 26 (PcAS). Uninfected mice were negative for depolarizing cells. Overall, in 
both infection models, high numbers of Hz-containing phagocytic cells could be 
detected (7 days after the end of CQ treatment for PbNK65 model and 20 days post-
infection for PcAS model), when single-cell suspensions were investigated just 
immediately after parasite clearance. In whole-blood, Hz-containing cells were below 
background levels after the first time point, which is consistent with the clearance 
kinetics of pigmented cells from peripheral blood reported by White et al
[328]
. 
Interestingly, in PbNK65-infected mice, pigmented cells were again observable 280 
days after parasite clearance. In livers and spleens of these mice a marked decrease in 
Hz-containing phagocytes occurred after the first time point. However, levels of Hz-
containing phagocytes remained stable over the remaining time points investigated 
(medians of 18.9 and 18.2% for liver and spleen, respectively). In the bone marrow, Hz-
containing phagocytes were low overall, and remained at median levels of 2%.  
In PcAS-infected mice, only two time points were investigated, but a larger 
number of mice were included per group. Levels of Hz-containing phagocytes from 
liver and spleen 20 days post-infection were quiet variable (with medians of 26.2 and 
13.5, respectively). This was probably a reflection of individual mouse parasitaemia (ie 
higher parasitaemia leading to increased Hz accumulation) as this ranged between 
20.3%-43.2%. However, when Hz-containing phagocytes were investigated 140 days 
post-infection, inter-individual levels were identical. Contrary to what was seen in the 
PbNK65 model, where levels of Hz-containing phagocytes were stable with time, levels 
of Hz-containing phagocytes in PcAS-infected mice tended to decrease in the liver and 
increase in the spleen (19% and 21.8%, respectively). 
Although the latest time point investigated was 280 days after parasite clearance 
(for mice infected with PbNK65), the findings presented suggest that Hz may persist for 
even longer periods of time. Considering that the mean lifespan of C57BL/6 mice is 
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approximately 850 days
[332]
 this represents a substantial amount of time during which 
Hz may contribute to the modulation of the immune system.  
Results in this chapter suggest that, rather than being eliminated from the host, Hz 
is redistributed in host organs. Initially, Hz deposition in organs occurred in the form of 
small-sized extracellular particles. Later, Hz tended to accumulate in larger-sized 
intracellular particles. Accumulation of Hz occurred mainly in the liver at earlier time 
points but seemed to shift to the hematopoietic organs (spleen and bone marrow) at later 
time points. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Detection of Hz by flow-cytometry in the cells of PbNK65-infected mice. Hz was detected 
in phagocytic cells obtained from P. berghei NK65-infected mice, post-parasite clearance, at different 
times, based on SSC-2. Hz could be detected in CD11b
+
 phagocytic cells in all infected mice, whilst 
uninfected mice were negative for depolarizing cells. High numbers of Hz-containing phagocytic cells 
could be detected at the first time point (7 days after the end of CQ treatment) in livers and spleens with 
median levels of 56.5% and 24.4%, respectively. However, there was a marked decrease at later time 
points which seemed to stabilize between 90, and 196 days after CQ treatment finished. In bone marrow, 
the frequency of Hz-containing phagocytes was low overall (remaining at median levels of 2%)., levels of 
Hz-containing phagocytes in blood decreased to levels considered to be negative, with the exception of 
the last time point, where Hz-containing phagocytes were again detected. 
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Figure 26. Detection of Hz by flow cytometry in the cells of PcAS-infected mice. Hz was detected in 
phagocytic cells obtained from PcAS-infected mice, at 20 and 140 days post-infection, based on SSC-2. 
As for the PbNK65 model, presence of Hz was investigated in CD11b
+
 phagocytic cells of whole-blood 
and single cell suspensions of liver, spleen, and bone marrow. Hz was detected in phagocytic cells of all 
infected mice whilst uninfected mice had no detectable depolarizing cells. At the first time point median 
levels of Hz-containing phagocytic cells in livers and spleens were 26.2 and 13.5%, respectively. At the 
second time point measured, the median level of Hz-containing phagocytes decreased in the liver (19%) 
but increased in the spleen (21.8%). Hz-containing phagocytes in bone marrow were low overall (3%) 
and blood levels decreased over time to background levels.  
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Concluding Remarks 
Evidence for Hz accumulation in host tissues following malaria was previously 
demonstrated. However, further investigation about what eventually happens to Hz 
inside those tissues was lacking. Therefore, the aim of this chapter was to investigate 
the kinetics of Hz inside tissue organs using two models of murine malaria. Following 
malaria parasite clearance Hz deposition was investigated in liver, spleen and bone 
marrow. At all the time points investigated Hz could be detected in the aforementioned 
organs. Overall, histological observations suggest that initial Hz deposition in organs 
was in the form of small-sized extracellular particles. At later time points, Hz tended to 
accumulate in the form of larger-sized intracellular particles. This seemed to be 
accompanied by a shift in distribution from the liver to the hematopoietic organs (spleen 
and bone marrow). It was also observed that in the spleen Hz deposition seemed to 
occur preferentially in the red pulp.   
Single-cell suspensions of the organs were also analysed by flow-cytometry to 
investigate Hz deposition inside phagocytic cells. In whole blood, Hz was only detected 
in the earliest time point following parasite clearance. However, for the other tissues 
investigated Hz could be detected in all time points investigated. Hz deposition was 
overall low in the bone marrow and was more pronounced in liver and spleen. While in 
PbNK65 levels of Hz seemed quite stable in liver and spleen at the later time points 
evaluated, in PcAS the levels of Hz tended to decrease over time in liver and increase in 
the spleen.         
 
 Materials and Methods 
 
Mice and Parasites 
C57BL/6 mice (7 weeks old) were purchased from Charles River (Spain). Infected 
red blood cells (iRBC) from P. berghei NK65 (PbNK65) and P. chabaudi AS (PcAS) 
for infections were obtained from donor mice previously infected from frozen vials for 
each of the strains. Blood was collected by cardiac puncture and the parasitaemia was 
determined by counting the number of iRBC per 2000 RBC on Giemsa-stained blood 
smears. 
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Mice infection  
C57BL/6 mice were infected IP with 1×10
6
 PbNK65- or PcAS-iRBC. The 
PbNK65 infection was allowed to progress for 14 days during which mice reached high 
parasitaemias (ranging from 9–49%, average of 26%). Then, starting at day 14 after 
infection, mice were treated daily for 8 days with 100 μl IP injections of 7 mg/ml 
Chloroquine (CQ). Mice infected with PcAS reached peak parasitaemias by day 8 post-
infection (ranging from 20-43%, mean of 30%) and cleared the infection by day 20 
post-infection. Absence of parasites in circulating peripheral blood was confirmed on 
Giemsa stained blood smears at the end treatment/clearance period. Then, at the 
indicated time points mice were sacrificed with CO2 narcosis and whole-blood and 
selected organs (liver, spleen, and bone marrow) were extracted and aliquoted for 
subsequent Hz determinations.  
 
Quantification of Hz in murine tissues 
A portion of liver, spleen, or bone marrow were mashed and resuspended in 1x 
PBS. After filtering through a 40 μm cell strainer, lysis buffer (50 mM tris-HCL in 1% 
Triton
®
 X-100) was added to this extract. After lysis, 2 μl were used to measure protein 
content by the Bradford method following the manufacturer’s instructions (Bio-Rad); 
50 μl were converted to heme by dissolution in 2 mM NaOH and used to determine the 
amount of Hz, using the QuantiChrom assay kit as described previously.  
 
Histopathology 
Harvested organs (liver, spleen and bone marrow) were fixed in 4% vol/vol PFA 
and embedded in paraffin. Serial sections (3 μm) were stained with hematoxylin and 
eosin (H&E) and analyzed in a Leica DM2500 microscope, coupled with a Leica 
MC170 HD microscope camera. Tissue sections were examined by a pathologist 
blinded to experimental groups.  
  
Hz analysis by flow cytometry  
Liver portions were treated with DNase and then mashed through a 100 μm cell 
strainer. The resulting cell suspension was diluted in RPMI medium with 2% fetal calf 
serum to a final volume of 30 ml, washed and the pellet put on a 35% Percoll gradient 
(in RPMI). The obtained cells were washed again and then labeled for analysis. The 
spleen was mashed through a 100 μm cell strainer and resuspended in PBS. The bone 
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marrow was flushed from a femur bone into PBS using an insulin hypodermic needle 
and resuspended several times with the help of the needle to generate a single cell 
suspension. Whole blood was obtained by cardiac puncture in the presence of heparin, 
and washed with PBS. Whole blood and single cell suspensions from liver, spleen, and 
bone marrow were incubated with Fc-block and labelled with anti-CD11b (FITC) 
antibody. Erythrocytes were then lysed with 125 μl of BD FACS lysing solution (BD 
Biosciences) prior to analysis. The cells were washed again and resuspended in Facs 
buffer before flow cytometry analysis.  
Discussion 
The hemozoin accumulation in liver and spleen in a model of murine malaria was 
previously investigated by Levesque et al
[329]
. This study measured hemozoin 
concentration over a period of 9 months using a fluoromeric method, which was 
previously established by Sullivan et al
[333]
. Findings by Levesque propose that over 
time hemozoin concentration in the liver seemed to decrease, while it increased in the 
spleen, which suggested that overall hemozoin concentration in the murine host 
remained unchanged. In humans, evidence for hemozoin accumulation in host organs 
exists from autopsies of individuals that died of malaria since a time before the malaria 
parasite was discovered, as already mentioned (reviewed in
[222]
). Further evidence is 
provided by studies showing that hemozoin accumulates preferentially in brain, liver, 
spleen and lungs (reviewed in
[334]
). However, information on hemozoin dynamics 
following malaria clearance is limited. First, in many African countries autopsies are 
not routinely performed, either because of lack of certified personnel but mainly 
because of cultural reasons, especially in children
[335]
. Second, autopsies made to 
individuals dying of malaria would not be useful, since it would be impossible to 
distinguish hemozoin deposition from recent malaria episodes (including the one 
leading to death), from older malaria infections. The most useful information would 
possibly be obtained from autopsies of individuals dying from malaria un-related causes 
but with a recorded history of malaria. These individuals might either be immigrants of 
malaria endemic areas that moved to malaria free regions, those living in malaria 
regions that have meanwhile become malaria free or cases of imported malaria where 
individuals survived infection. It is very likely that autopsies of individuals with these 
characteristics have been performed. However, the importance of such findings are 
probably disregarded by the pathologist performing the autopsy, and in developed 
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countries it might even be the case that the “black pigment deposits” might not be 
recognized for what they are.  
 
Therefore, although evidence suggests that hemozoin may concentrate in tissue 
organs for very long periods of time after the last malaria episode, not much is really 
known as to what really happens to hemozoin over time in humans. We set out to 
further the knowledge on hemozoin dynamics in two models of murine malaria, P. 
berghei NK65 (PbNK65) and P. chabaudi AS (PcAS). As mentioned, the choice of 
strain was based on the high amount of hemozoin produced by PbNK65 and due to the 
similarities of a PcAS infection to P. falciparum. Also, as infection by PcAS is self 
resolving and the peak parasitaemia occurs around day 8 post infection, it is likely that 
the amount of hemozoin produced during infection is lower than during an infection 
with PbNK65. The first approach was to investigate hemozoin accumulation using a 
similar method than Levesque et al. Both are based on harvesting organs of 
Plasmodium infected mice, and determining hemozoin concentration in those organs at 
several time points, following infection clearance. We determined hemozoin 
concentration in liver, spleen and bone marrow using a colorimetric method 
(QuantiChrom Heme Assay kit).  
Overall our results correlate to those obtained by Levesque, in which hemozoin 
was detected in all organs investigated, up to 9 months after infection clearance. 
However, in our study hemozoin concentration either remained fairly stable throughout 
the time points analysed, or tended to increase in the case of the liver for both infection 
models. These differences might be explained by individual mice developing different 
parasitaemias, which may contribute to variable levels of hemozoin deposition. 
Moreover, in our study C57BL/6 mice were used, while Levesque used ICR mice, 
where different parasite loads or different hemozoin dynamics may occur. The 
limitation of this study was that in only provided information as to the overall content of 
hemozoin, without giving any information as to the localization of hemozoin within 
organs and to its dynamics over time.  
 
Thus, we also investigated hemozoin distribution in histological sections of liver, 
spleen and bone marrow. Observation of histological preparations of the 
aforementioned organs, suggested that hemozoin distribution following malaria 
clearance was initially sparse and that over time, hemozoin accumulated in larger sized 
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intracellular (Kupffer cells) aggregates. Hemozoin also seemed to have an early 
preferential accumulation in the liver that tended to shift to the spleen. This suggests 
that hemozoin deposition in the organs is not static, which can have several implications. 
Hemozoin accumulation inside Kupffer cells and the increase in size of aggregates 
suggests that hemozoin is likely re-ingested several times, as macrophages reach the end 
of their life time. Re-ingestion of hemozoin by several generations of phagocytes is 
likely to change the biomolecules attached to hemozoin, which may contribute to the 
production of different biological effects, caused by hemozoin
[288]
. Finally, Hz-ladden 
macrophages might participate in the response to other infections in the organs in which 
they reside, and contribute to an impaired/dysregulated immune response. 
 
Flow cytometry might also be a useful method for the quantification of hemozoin 
inside several organs. Our results suggested that shortly after malaria clearance while 
parasites are no longer seen in circulation (not shown), hemozoin is still detected inside 
phagocytes in circulating blood. This is consistent with evidence showing that following 
malaria clearance, Hz-containing leukocytes persist for median times of 72 and 216 
hours (up to 9 days) in granulocytes and monocytes, respectively
[328]
. At later time 
points this was no longer observed with one exception (last time point in the PbNK65 
model).  The appearance of Hz-containing phagocytes in the last time point probably 
consists of recent immigrants from the bone marrow. Hemozoin was detected in the 
bone marrow of both models studied throughout all the time points analysed. This is in 
line with findings by Casals-Pascual et al, in which post-mortem analysis of bone 
marrow of children dying of malaria, were found to contain Hz-containing myeloid cells, 
with associated abnormal erythropoiesis
[336]
.           
Considering that the average life span of a mouse is around 850 days
[332]
, it is 
impressive that hemozoin could still be detected in mouse organs 280 and 140 days, 
following parasite clearance for PbNK65 and PcAS, respectively. This represents 
approximately a quarter of the life span of a mouse. Assuming that the same happens in 
humans and considering that in malaria endemic regions, such as sub-Saharan Africa, 
the same individual is likely to get infected several times throughout life
[189]
, then it is 
likely that the amount of hemozoin accumulated in organs is enormous. If intracellular 
hemozoin in these organs consistently contributes to impairment of functions of these 
cells, then affected individuals will potentially have a proportion of immune cells that 
respond to other pathogens at suboptimal levels.      
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CHAPTER IV 
In vivo Malaria and Tuberculosis co-infection in a 
murine model. 
Introduction 
The next question we wanted to address regarded the interplay between malaria 
and tuberculosis in vivo. Our in vitro data suggested that Hz ingestion by phagocytic 
cells leads to their functional impairment and thus may have contributed to the 
increased mycobacterial burden observed. Therefore, we wanted to investigate whether 
Hz deposition inside phagocytic cells during an infection by the malaria parasite could 
aggravate a subsequent tuberculosis infection in vivo. We first assessed the outcome of 
tuberculosis co-infection during acute malaria. Then we investigated tuberculosis 
disease during chronic malaria, to compare how the tuberculosis disease will progress 
when malaria parasites were no longer detected in circulation. We hypothesized that this 
would be a good model to test how the long term deposition of Hz in host organs would 
affect the ability of the host to control tuberculosis infection.    
The murine model chosen was the P. chabaudi AS (PcAS) strain for the malaria 
infection and the M. bovis BCG (BCG) strain for the tuberculosis infection. Our choice 
was based on the fact that PcAS infection in mice resembles the human infection with P. 
falciparum. As mentioned in the previous chapter, this includes preferential infection of 
normocytes, adherence to uninfected RBC and sequestration to endothelial cells, so that 
mature forms are almost never seen in peripheral blood circulation
[330]
. The choice of 
BCG and the use of intraperitoneal route of infection were due to the fact that this 
model of infection more closely resembles the course of infection in humans. Although 
it might not be a good model to investigate pulmonary tuberculosis, it is a well 
established model for the study of cellular immunity and granuloma formation
[337]
.  
Following infection, mycobacteria are disseminated mainly to the liver and spleen and 
granulomas are usually visible two weeks post-infection. Eventually, replication of 
mycobacteria is controlled by the adaptive immune response, a process normally 
occurring three weeks post-infection. However, viable bacilli continue to persist at low 
numbers in infected organs
[337]
. Thus, using the model of BCG infection/intraperitoneal 
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route allows for the investigation of both active tuberculosis as well as latent 
tuberculosis infection.  
1. Tuberculosis co-infection during acute 
malaria. 
Results 
M. bovis co-infection in malaria infected mice leads to decreased survival. 
C57BL/6 mice were first infected with PcAS, and four days later, with BCG. 
Single-infections with PcAS and BCG were used as controls. Co-infected mice 
exhibited reduced survival compared to the single-infected control mice. Figure 27 
shows the Kaplan Meier survival of mice from 4 independent experiments. Out of a 
total of 19 mice per group, 7 (37%) died in the co-infected group between days 6-7 
post-BCG infection. Co-infected mice still alive at day 7, were extremely sick and thus 
we decided to terminate the experiment at this time. All mice in control groups survived.  
Clinically relevant manifestations of PcAS single-infected mice were 
characteristic of malaria disease such as ruffled fur, moderate weight loss and lethargy. 
However, these symptoms were aggravated in the co-infected group, where all mice 
developed progressive cachexia, until death or sacrifice. BCG single-infected mice did 
not show any clinical manifestations of disease. Figure 28 shows the degree of weight 
change in infected mice (three independent experiments); PcAS single-infected animals 
featured moderate weight loss, whereas in co-infected animals, weight loss was more 
severe. The clinical manifestations, summarized in Table 3 established a clinical scale 
of disease severity. Using this scale we set the humane endpoint at stage IV, which 
usually occurred between days 6-7 post BCG infection (10 to 11 days post PcAS 
infection). 
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Figure 27. Co-infection with BCG decreases survival of PcAS infected mice. C57BL/6 mice were 
infected with PcAS and after 4 days co-infected with BCG. Mice single-infected with PcAS or BCG were 
included as controls. The survival of mice from 4 independent experiments is shown. All mice in the 
single-infected groups survived, featuring either mild symptoms (PCAS) or no signs of disease (BCG). In 
the co-infected group 7 out of 19 mice died (37%), with surviving mice exhibiting severe signs of disease.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Co-infected mice had more pronounced weight loss than PcAS mice. Weight change of 
infected animals was monitored from the time they were infected with PcAS. The percentage of weight 
change of the mice by the end of the experiment, in the different groups, is shown.  Results are from 3 
independent experiments. Mild weight loss was observable in the PcAS single-infected group whereas in 
the co-infected group weight loss was more severe. Contrastingly, BCG single-infected mice actually 
gained weight.  
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Clinical Manifestations 
 
I. no signs 
II. ruffled fur and/or abnormal posture and/or minor weight loss (<15%) 
III. lethargy, mild hypothermia and/or moderate weight loss (≥ 20%) 
IV.* reduced response to stimulation, severe hypothermia (shivers) and/or respiratory distress/hyperventilation 
V. prostration and/or severe weight loss (>25%) 
VI. Death 
                                
*The humane endpoint was defined as mice reaching stage 4 
 
Table 3. Clinical scale of disease severity. The table describes symptoms developed during the course of 
infection in co-infected and PcAS single-infected mice. The more prominent manifestations of disease 
were weight loss, hypothermia and reduced response to stimulation, that ultimately resulted in death. The 
more severe manifestations (stages IV-VI) were only observed in co-infected mice, whereas PcAS single-
infected mice did not progress beyond stage III. BCG single-infected mice showed none of the clinical 
manifestations described above. Table was adapted from Cunnington et al
[338]
.    
 
 
Malaria parasitaemia and mycobacterial burden was not exacerbated in co-
infected animals.  
To determine if the decreased survival of co-infected animals was due to an 
exacerbation of the malaria disease or from increased tuberculosis disease, we 
investigated parasitaemia levels and mycobacterial burden. Parasitaemia levels, 
determined by counting parasitized RBC in peripheral blood smears, were similar in co-
infected and PcAS single-infected animals, as show in Figure 29. Both co-infected and 
PcAS single-infected mice reached peak parasitaemia at day 7 post-PcAS infection 
(average levels for one representative experiment were 30 and 25%, respectively).  
The mycobacterial load was first determined by luminescence. The BCG strain we 
used expresses the full luciferase operon which renders the mycobacteria auto-
luminescent. This allowed us to investigate the total mycobacterial burden of infected 
mice at the beginning of infection, as well as at the end of the experiment. As illustrated 
in Figure 30, the mycobacterial burden 7 days post BCG infection was similar between 
co-infected and BCG single-infected mice. Interestingly, at day 3 post BCG infection, 
co-infected mice appeared to have a lower infection level than the BCG single-infected 
mice. We next quantified colony forming units (CFUs) in livers and spleens of infected 
mice. Mice were sacrificed at day seven post-BCG infection, or earlier (day 6) if they 
had already reached stage IV of the clinical scale. Dilutions of homogenized organs 
were plated on 7H11 agar and CFUs counted 3 weeks later. As shown in Figure 31, 
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higher mycobacterial counts could be found in the spleens of infected mice than in the 
livers. However, no differences were found in mycobacterial counts of livers and 
spleens between co-infected and BCG single-infected mice.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Parasitaemia levels of co-infected and PcAS single-infected mice. Parasitaemia was 
monitored starting three days post-PcAS infection. Blood was collected daily and the percentage of 
infected RBC determined in Giemsa stained blood smears. Both co-infected and PcAS single-infected 
mice reached peak parasitaemia at 7 days post-infection, with an average parasitaemia of 30 and 25%, 
respectively. The result of a single representative experiment is shown.  
 
                     
 
 
 
 
 
 
 
 
 
           
 
 
Figure 30. Mycobacterial burden of co-infected and BCG single-infected mice. Mycobacterial burden 
following BCG infection was determined at 3 and 7 days post infection. A – The upper panel is an 
example of acquired images using the IVIS
®
 Imaging system. Variations in colour represent the relative 
levels of bioluminescence ranging from low (blue), to medium (green) and high (yellow/red). B – The 
graph represents the log10 of the quantified luminescence (photons/sec) as measured using the region of 
interest tool (ROI) in the Living Image software program, after background normalization. At day 7 post-
infection no differences could be found between the co-infected and BCG single-infected group. However, 
at day 3 post-infection the mycobacterial load in the co-infected group was significantly lower than in the 
BCG single-infected group (p= 0.0025). The results for two independent experiments are shown. 
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Figure 31. Mycobacterial burden in liver and spleens of co-infected and BCG single-infected mice. 
Infected mice were sacrificed at day seven post-BCG infection, or earlier (day 6) if they had already 
reached stage IV of the clinical scale of disease severity (Table 3). Liver and spleens were homogenized 
and dilutions plated on 7H11 agar. CFUs were counted 3 weeks later. The log10 of the CFUs count for 
mice from 3 independent experiments is shown. Whilst the spleen had higher bacterial loads than the liver, 
the mycobacterial load in co-infected mice as compared to BCG single-infected control mice was similar.  
 
Malaria-induced anaemia is more severe in co-infected animals 
Mice infected with PcAS develop anaemia due to destruction of infected 
erythrocytes (RBC) and removal of uninfected RBC, together with suppression of 
erythropoiesis and occurrence of dyserythropoiesis. Anaemia is negatively correlated 
with parasitaemia and normal levels are recovered after the peak of parasitaemia. We 
investigated the levels of anaemia in co-infected and single-infected mice using a 
hematology analyzer to determine the number of erythrocytes (RBC) and hemoglobin 
(HGB) levels. As shown in Figure 32, co-infected animals had significantly lower levels 
of RBC and HGB than single-infected animals, indicating an aggravated anaemia of 
PcAS-infected animals in the presence of BCG. Other parameters measured, such as 
hematocrit (HCT) were also lower in co-infected animals whilst mean corpuscular 
volume (MCV), mean corpuscular hemoglobin (MCH) and mean corpuscular 
hemoglobin concentration (MCHC) were not significantly different between the co-
infected and PcAS single-infected groups, although they were consistent with anaemia 
(not shown). 
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Figure 32. Hematology measurements of co-infected and single-infected mice. When mice were 
sacrificed (6-7 days after BCG infection) blood was collected from the orbital sinus and a full blood count 
was determined in a hematology analyzer. The erythrocyte count (RBC, A) and hemoglobin concentration 
(HGB, B) are shown. PcAS single-infected mice were anaemic, as indicated by the lower values of RBC 
and HGB. Co-infected mice had significantly lower levels of RBC (p=0.0014) and HGB (p=0.0017). 
BCG single-infected mice had normal levels of RBC and HGB when compared to reference values 
(reference values provided by Charles River for male C57BL/6 mice, 8-10 weeks of age).   
 
Co-infection increased inflammatory tissue responses in liver                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
To further characterize pathology in infected animals, serial sections of liver, lung, 
spleen, bone marrow and kidney were stained with hematoxylin and eosin. The liver 
was the organ that displayed the most important pathological changes (Figure 33). 
Livers of co-infected mice showed features of both PcAS and BCG single-infections, 
with the presence of lymphocyte-rich inflammatory foci (seen in PcAS single-infection) 
interspersed with macrophage-rich foci (seen in BCG single-infection). Inflammatory-
cell infiltration in co-infected mice was multifocal to diffuse, and of mild to moderate 
severity. In the single-infection controls these changes were mostly mild. Mild, 
multifocal hepatocellular necrosis was spatially associated with macrophage-rich foci 
and only present in co-infected mice and BCG single-infected mice. The severity of 
pathological findings are summarized in Figure 33B) and tended to be more severe in 
PcAS-BCG co-infected mice. 
For the other organs, severe red pulp hyperplasia, characteristic of Plasmodium 
blood stage infection, was seen for co-infected and PcAS single-infected mice, while 
BCG single-infected mice showed no changes. The same was observed for bone 
marrow, with mild to moderate myeloid hyperplasia (not shown). No significant 
changes were seen in kidney and lung in any of the experimental groups. 
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Figure 33. Liver lesions in co-infected mice during acute malaria. A – PcAS single-infected mice 
displayed inflammatory cell infiltration, mainly lymphocytic (black arrows), multifocal to diffuse and of 
mild to moderate severity; scattered hemozoin-laden Kupffer cells/macrophages were also seen. BCG 
single-infected mice also showed inflammatory cell infiltration, multifocal to diffuse, of mild to moderate 
severity, but inflammatory cells were mainly myeloid (macrophages, white arrows). The liver of co-
infected mice showed both myeloid cell-rich and lymphocyte-rich inflammatory foci, multifocal to 
diffuse in distribution and of mild to moderate severity. Hepatocellular necrosis (black thin arrows) was 
only seen in BCG single-infected and co-infected mice, being associated with inflammatory foci and of 
mild severity. B – Severity in the form of inflammatory cell infiltration and/or necrosis is represented for 
the different experimental groups to summarize pathological findings in the liver. 
Hemozoin (black arrowheads); lymphocyte-rich inflammatory foci (black block arrows); myeloid cell-
rich inflammatory foci (white block arrows); hepatocellular necrosis (black thin arrows).     
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2. Tuberculosis co-infection during chronic 
malaria. 
Results 
BCG co-infection during chronic malaria leads to mild decrease in survival. 
To assess the long term effects of Hz deposition in host organs on subsequent 
control of tuberculosis disease, mice were infected with PcAS and the infection allowed 
to progress for 20 days, before BCG co-infection. PcAS is a self-limited infection and, 
as such, by day 20 post-infection, no parasites could be detected in peripheral blood 
smears. However, mice remain chronically infected, as parasites can persist at subpatent 
levels, with occasional detectable recrudescence for up to 2-3 months
[330,339]
. 
Figure 34 shows the survival of mice in 2 independent experiments. Of a total of 
10 mice, 3 (30%) died in the chronic PcAS-BCG infected group. All mice in the control 
groups survived (n=9 for BCG single-infected group, and n=4 for PcAS single-infected 
group). Clinically relevant manifestations, as described in Table 3, were only observed 
during PcAS-infection, and corresponded to moderate manifestations of weight loss, 
ruffled fur and lethargy. None of the mice in the two experiments reached stage IV of 
the clinical scale of disease severity.  By the time malaria parasites were cleared from 
circulation, mice had recovered their initial weight. Following BCG infection, mice 
weights across all groups either remained unchanged or tended to increase (Figure 35).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34.  BCG co-infection in chronic PcAS-infected mice leads to moderate survival impairment. 
C57BL/6 mice were infected with PcAS for 20 days until parasite clearance and establishment of chronic 
infection. Mice were then co-infected with BCG.  Control groups included BCG single-infected mice and 
PcAS chronic mice. The survival of mice in 2 independent experiments is shown. All mice in the single-
infected groups survived, whilst in the co-infected group 3 out of 10 mice died (30%). 
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Figure 35.  BCG co-infection in chronic PcAS-infected mice does not lead to weight loss. Weight 
change of infected animals was monitored from the time mice were infected with PcAS. The percentage 
of weight change of mice at the end of the experiment, relative to their weight at the time of BCG 
infection is shown. Results are shown for 2 independent experiments. Whilst mice infected with PcAS 
lost weight during malaria infection (not shown), from the time chronic infection was established mice in 
the different groups either maintained or increased their weight.  
 
Mycobacterial burden is similar in chronic PcAS-BCG and BCG single-infected 
animals. 
Next, the mycobacterial burdens in chronic PcAS-BCG and BCG single-infected 
mice were investigated. Compared to mice in the acute co-infection, survival of chronic 
PcAS-BCG infected mice seemed to be increased since they survived longer, while only 
displaying moderate manifestations of disease and without reaching stage IV of the 
clinical scale of disease severity. Thus, CFUs levels were determined later (14 days 
post-BCG infection) than during acute co-infection. This allowed us to investigate 
mycobacterial burdens at a later time, which could help determine whether there are any 
differences in the ability of mice to control BCG growth, and to investigate granuloma 
formation. In the first experiment, mycobacterial load was also determined by 
luminescence. As shown in Figure 36, the mycobacterial burden in both groups 
appeared to decrease from day 3 to day 14 post-BCG infection. Although not significant, 
the decrease in mycobacterial load seemed faster in the BCG single-infected group than 
in the PcAS-BCG group.    
Determination of CFUs levels revealed that mycobacterial burden in spleens and 
livers of chronic PcAS-BCG as compared to BCG single-infected mice was not 
significantly different. However, there were less BCG single-infected mice with 
detectable CFUs in the spleen than chronic PcAS-BCG infected mice (Figure 37).     
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Figure 36. Mycobacterial burden of chronic PcAS-BCG and BCG single-infected mice. 
Mycobacterial burden following BCG infection was determined at 3, 7 and 14 days post-infection. A - 
The upper panel is an example of acquired images using the IVIS
®
 Imaging system. B – The graph 
depicts the log10 quantified luminescence (photons/sec) as measured using the region of interest tool 
(ROI) in the Living Image software program, after background normalization. No differences could be 
found between the chronic PcAS-BCG and BCG single-infected groups at any time-point. However, 
mycobacterial levels decreased from day 7 to day 14 post-BCG infection. The result for a single 
experiment is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37. Mycobacterial burden in liver and spleens of chronic PcAS-BCG and BCG single-
infected mice. Infected mice were sacrificed at day 14 post-BCG infection. CFUs were also performed 
for mice that died at day 11, but not at day 8, post-BCG infection. Liver and spleens were homogenized 
and dilutions plated on 7H11 agar. CFUs were counted 3 weeks later. The log10 of the CFUs count for 
mice from 2 independent experiments is shown. Whilst the mycobacterial load was similar in chronic 
PcAS-BCG and BCG single-infected controls, fewer BCG single-infected mice had detectable CFUs in 
the spleen than chronic PcAS-BCG infected mice (3/9 mice vs. 6/10 mice, respectively).  
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Malaria-induced anaemia is still present in chronic PcAS-BCG infected mice 
Hematological analysis was performed at the time of sacrifice in chronic PcAS-
BCG and single-infected controls. As shown in Figure 38, chronic PcAS single-infected 
mice had levels of RBC and HGB identical to BCG single-infected mice, suggesting 
that these mice had recovered from anaemia. However, chronic PcAS-BCG infected 
mice still had significantly lower levels of RBC and HGB than single-infected animals, 
suggesting that BCG infection may impair the recovery of PcAS-infected mice from 
anaemia.  Likewise, HCT was also lower in chronic PcAS-BCG infected animals whilst 
MCV, MCH and MCHC did not significantly differ from chronic PcAS single-infection 
(not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. Hematology measurements of chronic PcAS-BCG and single-infected mice. Blood was 
collected from the orbital sinus, on the day mice were sacrificed and a full blood count was determined. 
The erythrocyte count (RBC, A) and the hemoglobin concentration (HGB, B) are shown. PcAS and BCG 
single-infected mice had RBC and HGB values similar to reference values. However, chronic PcAS-BCG 
infected mice still presented significantly lower values of RBC (p=0.0033) and HGB (p=0.005) than 
PcAS single-infected mice. Reference values as provided by Charles River for male C57BL/6 mice, 8-10 
weeks of age.  
Inflammatory tissue responses in chronic PcAS-BCG infection.      
The inflammatory tissue response in chronic PcAS-BCG co-infection was also 
investigated in serial sections of liver, lung, spleen, bone marrow and kidney, stained 
with hematoxylin and eosin. As already seen for co-infection during acute malaria the 
liver was the organ that displayed the most important pathological changes (Figure 39). 
Significant hepatic lesions were only observed in BCG single-infected and in chronic 
PcAS-BCG co-infected mice, corresponding to inflammatory cells, mainly 
A B 
R
B
C
 (
1
0
^
6
/u
l)
B
C
G
P
cA
S
-B
C
G
P
cA
S
R
e f
e r
en
c e
0
2
4
6
8
1 0
1 2
1 4
**
H
G
B
 (
g
/d
l)
B
C
G
P
cA
S
-B
C
G
P
cA
S
R
e f
e r
en
c e
0
2
4
6
8
1 0
1 2
1 4
1 6
1 8
2 0
**
Malaria and Tuberculosis co-infection: a role for Hemozoin immunosuppression? 
99 
 
macrophages and neutrophils, multifocal and of moderate severity, which were similar 
in both groups. However, the livers of PcAS single-infected mice revealed the presence 
of Hz-laden Kupffer cells, diffuse and of mild severity, with minimal inflammatory cell 
infiltration; whilst in PcAS-BCG co-infected mice, Hz was mainly found inside 
macrophages, associated with granulomas, with multifocal distribution (Figure 39C). 
Findings for the other organs were similar to the ones already described during acute 
malaria infection.  
Overall these results show that malaria-tuberculosis co-infection results in severe 
disease. In the acute model, only 37% of mice died however, remaining co-infected 
animals developed progressive cachexia and had to be sacrificed. Although we did not 
observe increased parasitaemia nor increased bacterial loads in these mice, we did 
observe that malaria-induced anaemia was aggravated. Severe disease was not observed 
when mice were infected with tuberculosis during chronic malaria. However, at the end 
of the experiment co-infected mice still showed evidence of malaria-induced anaemia, 
whilst the PcAS-single infected mice had already recovered. Histological findings 
revealed that in the acute model, co-infected animals had increased inflammation and 
necrosis, which was no longer observed in co-infected animals in the chronic model. On 
the other hand, the chronic model revealed granuloma-like structures, which in the case 
of co-infected animals had an increased accumulation of Hz-containing Kupffer cells.  
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Figure 39. Liver lesions in co-infected mice during chronic malaria infection. A – Livers of PcAS 
single-infected mice displayed only minimal inflammatory cell infiltration and scattered hemozoin-laden 
Kupffer cells. BCG single-infected mice showed inflammatory cell infiltration, multifocal and of 
moderate severity, composed of foci (granulomas) of macrophages and neutrophils (white arrows), 
surrounding cell debris. The liver lesions of chronic PcAS-BCG infected mice were very similar to those 
seen for BCG single-infected mice (white block arrows), with further accumulation of hemozoin-laden 
phagocytic cells in the granulomas (arrowheads). B – Shown is the summary of the pathology severity 
(inflammatory cell infiltration and/or necrosis) found in the liver. C – Hz deposition in granulomas and 
surrounding parenchyma of co-infected animals was quantified and compared to Hz deposition in the 
parenchyma of PcAS single-infected animals. As shown, in co-infected animals Hz deposition occurs 
preferencially in granulomas. Quantification was performed using image analysis and expressed as the 
proportion of pixels occupied by Hz to the total pixel area.  
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Concluding Remarks 
This chapter concerned the investigation of in vivo interactions of malaria-
tuberculosis co-infection. PcAS infection resembles the human P. falciparum infection 
and was used to model acute malaria as wells as chronic infection. BCG infection was 
used to investigate the control of mycobacterial growth in the context of a malaria co-
infection. The findings presented suggest that tuberculosis co-infection during acute 
malaria severely impairs the disease outcome of co-infected mice. Although 
parasitaemia and bacterial loads in C57BL/6 mice were not significantly different from 
those of control animals, 37% of co-infected animals died quickly after BCG co-
infection, and all surviving mice showed signs of severe disease. The course of infection 
was characterized by increased weight loss and severe anaemia. Histological 
examination revealed increased leukocyte infiltration and necrosis in livers of co-
infected animals. 
Chronic malaria-infected animals had a mortality of 30%. However, they survived 
longer than acute malaria-infected animals and surviving animals only exhibited mild 
symptoms of disease. At the time mice were sacrificed, PcAS single-infected mice had 
recovered from anaemia, whilst PcAS-BCG co-infected mice still exhibited lower levels 
of RBC and HGB. Histology examination showed that liver lesions of chronic PcAS-
BCG infected mice and BCG single-infected mice were very similar. However, in 
PcAS-BCG co-infected mice there was a preferential accumulation of Hz in association 
with granulomas when compared to PcAS single-infected mice, in which Hz 
accumulated in Kupffer cells and presented a scattered distribution throughout the 
parenchyma.  
Materials and Methods 
Mice infection 
C57BL/6 mice (6 weeks from Charles River, Spain) were infected IP with 1×10
6
 
PcAS-iRBC. Then, for the acute infection mice were infected with 1×10
7
 BCG CFUs 
(from frozen vials) by IP injection four days post-malaria infection. For the chronic 
malaria infection, mice were infected with 1×10
7
 BCG CFUs 20 days post-malaria 
infection. Absence of parasites in circulating peripheral blood of mice 20 days post-
infection was confirmed on Giemsa stained blood smears. At the indicated time points 
or when mice reached stage IV of the clinical scale of disease severity, mice were 
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sacrificed with CO2 narcosis. When under anesthesia mice were sacrificed by cervical 
dislocation. 
 
Assessment of mycobacterial load by bioluminescence  
Assessment of bioluminescence was performed using a Xenogen IVIS
®
 Lumina 
imaging system (PerkinElmer, Massachusetts, USA). At the indicated time points, mice 
were anesthetized IP with a mixture of ketamine (Imalgene 1000, 75 mg/Kg body 
weight; Merial, Duluth, GA, USA) and medetomidine (Domitor, 1 mg/Kg body weight; 
Pfizer, New York, NY, USA) in 1x PBS. Mice were contained in a large airtight box for 
safety reasons, and placed inside the imaging chamber of the IVIS
®
 imaging system, 
with the stage heated to 37°C. Quantification of emitted photons was performed over 5 
min using the Living Image software version 3.0. Bioluminescence within specific 
regions of individual mice was quantified using the ROI tool in the Living Image 
software program (given as photons/s). 
 
Mycobacterial burden in murine organs  
Mice were sacrificed by cervical dislocation, while still under anesthesia and liver 
and spleen harvested for CFUs determination. Harvested organs were weighted before 
removing a portion for histology analysis (see below). Organs were then placed in 1 ml 
1x PBS and homogenized. Homogenized organs were serial diluted before plating on 
7H11 agar plates. Plates were incubated at 37ºC, 5% CO2 for 21 days before counting 
CFUs.    
 
Histopathology 
A portion of selected organs (liver, lung, spleen, bone marrow and kidney) was 
harvested, fixed in formalin and embedded in paraffin. Serial sections (3 μm) were 
stained with hematoxylin and eosin (H&E) and analyzed in a Leica DM2500 
microscope, coupled with Leica MC170 HD microscope camera.  
Analysis was performed by a pathologist blinded to experimental groups and the 
scoring system for liver lesions was as follows: for severity of hepatocellular damage or 
inflammatory cell infiltration the lesion was classified as absent (0), minimal (< 5%; 1), 
mild (5-25%; 2), moderate (25-50%; 3), severe (> 50%; 4). Additional modifiers, like 
the distribution (focal, multifocal, multifocal to diffuse, diffuse), the predominant 
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inflammatory cell type (neutrophils, macrophages and kupffer cells, lymphocytes) and 
the hemozoin distribution pattern were also assessed. 
 
Hematological analysis 
Blood was collected from the orbital sinus while animals were under anesthesia 
into micro collection tubes (containing 0.78 mg K2-EDTA; CAPIJECT
®
, Terumo; 
Somerset, NJ, USA). Blood was analyzed using an impedance hematology analyzer 
(PocH-100iV, Sysmex; Kobe, Japan).  
 
Granuloma association with Hz 
Images acquired for histopathology analysis were used to quantify Hz deposition 
in granulomas and surrounding parenchyma in liver sections. ImageJ software 1.47v 
was used to determine the proportion of pixels occupied by Hz in granulomas or in the 
parenchyma and expressed as the proportion occupied by Hz to the total pixel area 
measured.   
Discussion 
Malaria, especially in sub-Saharan Africa, is endemic with many other diseases 
and co-infections between different agents are likely to occur. Malaria co-infection with 
HIV
[126]
 is well documented, as well as co-infections with helminths
[129]
, and the 
common occurrence of malaria with bacteremia
[106]
. However, not much is known about 
malaria-tuberculosis co-infections and how the two diseases may interact, as well as the 
likely outcome of such co-infections. Reasons for this lack of knowledge might be 
because malaria is mainly a disease occurring in young children, whilst tuberculosis 
normally occurs in adults
[296]
. Another probable cause might be that while malaria and 
tuberculosis endemic regions overlap, spatial variations may occur as malaria is more 
frequent in rural areas, whilst tuberculosis is more frequent in overpopulated urban 
areas
[159,160]
. However, unplanned expansion of urban areas and rural practices in peri-
urban regions may lead to increased malaria transmission
[36]
, creating a setting which 
may also be prone for the transmission of tuberculosis. This may explain findings in 
ancient Lower Egypt, where evidence for malaria-tuberculosis co-infection was 
revealed by investigation of malaria and tuberculosis ancient DNA
[158]
. Modern studies 
are limited but suggest that malaria-tuberculosis co-infections might be 
overlooked
[161,163]
 and probably promote more severe disease and mortality
[164]
. 
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As our findings suggested that monocyte functions are impaired in vitro, and may 
promote increased mycobacterial burdens, as well as that hemozoin may persist in the 
host for a long time after malaria clearance, we wanted to investigate how malaria and 
tuberculosis may interact in vivo. Particularly, we were interested in investigating what 
would be the effect of hemozoin accumulation in tissue organs, on the susceptibility to 
tuberculosis infection. For this, the murine model was used, using two experimental 
approaches. The first model investigated acute infection, where mice were co-infected 
with BCG while malaria infection by PcAS was still ongoing. The second approach 
investigated BCG infection following clearance of PcAS infection (20 days post 
infection). In this model recrudescence might still occur for the following 10 days and at 
lower levels for up to 3 months
[339]
. This model of infection likely resembles individuals 
in malaria endemic countries, probably suffering from several malaria episodes until 
semi-immunity is developed. Such individuals may harbor asymptomatic parasitaemia 
(with low levels of circulating parasites), and likely have hemozoin accumulated in their 
organs. 
Results from both studies suggested that tuberculosis infection following malaria 
decreased the survival of co-infected mice. This was more striking in the acute model of 
infection where co-infected mice developed progressive cachexia and died or became 
extremely sick. These findings are similar to a study by Leisewitz et al where malaria-
tuberculosis co-infection also exhibited decreased survival, although in this study mice 
were infected first with tuberculosis and then with the malaria parasite
[173]
. Another 
study by Hawkes et al
[174]
 used a similar model of infection to Leisewitz et al, and 
although co-infection increased mycobacterial loads in organs, no decrease in mice 
survival was reported. In fact, most if not all murine studies on malaria-tuberculosis co-
infection are performed by first infecting mice with tuberculosis, and then with a 
malaria parasite strain. This follows the assumption that infection by a malaria parasite 
will disrupt latent tuberculosis infection, and promote active disease
[171,174]
. However, 
when an individual first comes in contact with tuberculosis, it is likely that that 
individual already had malaria during childhood. Therefore, infection of mice with a 
malaria parasite strain first, and then with tuberculosis, might mimic better what would 
happen in a human setting.   
The lower survival of mice due to co-infection is likely associated to an 
exacerbated Th1 inflammatory response. A review on co-infections has suggested that 
upon co-infection, the second infectious agent is likely to: exacerbate pathology 
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associated to the first infectious agent; have no effect or the first agent confers 
protection towards the second
[340]
. Studies have shown that tuberculosis infection can 
confer protection towards an otherwise lethal infection of malaria
[170,172,173]
. Lethality by 
P. yoelii or P. chabaudi in these studies is correlated to a weaker immune response, 
which also depends on the combination of parasite/mouse genotype used. Thus, mice 
that normally mount weaker immune responses to malaria become protected if they are 
previously infected with tuberculosis, since it will likely prime the immune response to 
a subsequent infection by the Plasmodium parasite. However, when co-infection occurs 
in a scenario where both infections induce strong immune responses, tuberculosis 
induced protection is no longer observed, and the co-infection likely becomes lethal. 
This is further supported by our results, where co-infected mice during acute disease 
quickly succumbed to disease and associated pathology (leukocyte infiltration, necrosis 
and malaria anaemia) was more severe in co-infected mice. Although we did not assess 
the production of inflammatory cytokines, it has been shown in other studies that 
increased inflammatory response is associated to increased pathology
[171,175]
. 
Interestingly, investigation of mycobacterial load by luminescence suggested that, at the 
beginning of infection, BCG load was lower in co-infected animals, which might be 
indicative of an ongoing immune response. Nonetheless, at the end of the experiment 
mycobacterial loads were similar between animals, suggesting that while in the BCG-
single infected group mycobacterial growth was controlled, in the co-infected group 
there was an increased mycobacterial survival, probably due to a lower bactericidal 
capacity. 
 
In the chronic model, although co-infected mice also succumbed to disease, mice 
did not become as ill as co-infected mice, in the acute model. Histopathological 
investigation of organs of co-infected mice revealed that, pathology observed was not 
significantly different from mice in the BCG-single infected group. Mycobacterial loads 
were also similar between the two groups. The data suggests that, impairment of 
phagocyte functions by ingestion of hemozoin seems to have little effect on the overall 
outcome of tuberculosis infection. However, histological findings of tuberculosis 
infection in mice with chronic malaria, suggest that Hz-containing macrophages have a 
preferential localization within granulomas. Hz-containing macrophages were also 
observed in PcAS-single infected mice however, distribution was dispersed throughout 
the liver parenchyma. The study by Hawkes et al did a similar observation
[174]
. However, 
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whilst increased mycobacterial loads were observed in livers and spleens of co-infected 
animals in this study, we did not observe significant differences between groups. This 
might be explained by slight differences in virulence between the strains of BCG used. 
Several reports suggest that the peak of BCG infection in mice occurs at 14 days post 
infection, and chronic infection is thought to be established three weeks post-
infection
[337]
. However, in our hands mycobacterial loads already seemed lower than 
initial levels following 14 days post infection, which might be indicative that our strain 
was more attenuated. On the other hand, reported differences in bacterial loads are 
usually small (usually less than 1 log difference)
[174]
. Only when virulent strains are 
used, such as M. tuberculosis H37Rv, more significant differences are observed 
(approximately 1 log)
[175]
. In fact, it has been shown that granuloma formation and 
mycobacterial dissemination by macrophages might differ between virulent strains, and 
strains lacking the Region of Difference-1 (RD1), such as BCG, which might contribute 
to different mycobacterial burdens
[85]
. Thus, it might be that in humans Hz-loaded 
macrophages, by participating in granuloma formation, will contribute to higher 
mycobacterial loads and increased dissemination, and may even promote progression to 
active tuberculosis disease, rather than establishing latency.  
In both acute and chronic models, co-infected animals seemed more anaemic than 
PcAS-single infected animals. In fact, following malaria clearance, PcAS-single 
infected animals recovered from malaria induced anaemia, which did not seem to occur 
in mice infected with BCG following PcAS infection. Similar findings have been 
observed in humans, in that co-occurrence of bacteremia with malaria, or following a 
recent episode of malaria, seem to contribute to more severe anaemia
[146]
. 
Thus, in vivo findings suggest that malaria-tuberculosis co-infection is detrimental 
and co-infected hosts will likely have a poor outcome, when compared to single 
infections. Although hemozoin contribution did not appear to have an important role in 
the overall immune response to tuberculosis, it was observed that hemozoin was 
significantly present in granulomas of co-infected animals. Therefore, as discussed 
above it might be that the relevance of hemozoin presence within granulomas might 
only become apparent in a model where virulent strains are used, such as the ones that 
would be found in human infections.   
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Conclusions and Future Perspectives 
 
The aims of this project were to investigate malaria-tuberculosis co-infection, with 
particular interest on the possible role of hemozoin phagocytosis by immune cells, and 
its deposition in host organs following infection. We wanted to first investigate the 
functional properties of hemozoin containing cells. Ideally, samples from malaria 
infected patients would have been analyzed. However, these samples were not readily 
available and more importantly, blood samples from human malaria patients usually 
have relatively low frequency of Hz-containing leukocytes. Thus, in vitro assays were 
performed in which hemozoin was added to PBMC, isolated from healthy donors.  
The methods available for the production of hemozoin are quiet diverse. This can 
range from synthetically produced hemozoin, to hemozoin isolated from cultures. The 
source of hemozoin, and/or the protocol employed to obtain it, is particularly important 
as some discrepant results have been attributed to differences in size of hemozoin 
crystals
[277]
, or the presence of certain molecules on the crystal surface
[282]
. Early studies 
on hemozoin in general did not characterized hemozoin at all, while more recent studies 
have performed some kind of characterization, and very few studies performed a 
thorough analysis of the hemozoin produced, with SEM and X-ray analysis. Thus, the 
beginning of this thesis’ project started with the development of standard methods for 
hemozoin production. Obtained hemozoin was then characterized to define crystal 
morphology and size, and also assessed for the presence of DNA, protein and heme 
contamination.  
  Following hemozoin production, the next step was to establish hemozoin 
detection using flow-cytometry. Most methods available for the detection of hemozoin 
are based on microscopy
[341,342]
. However, there is an increased interest in improving 
these methods of detection, for the rapid diagnostic of malaria. This includes 
automation of microscopy and the exploitation of the magnetic properties of 
hemozoin
[315]
. Yet, cases where mature forms of the parasite (the ones with higher 
hemozoin content) are absent from blood circulation, such as in P. falciparum infection, 
might be a limiting factor for such methods
[317]
. We established a method for hemozoin 
detection using flow cytometry, which is based on the detection of depolarized side 
scatter
[305]
. This method is promising both for the phenotypic and functional 
characterization of hemozoin containing cells, as well as a drug sensitivity test. Using 
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this method we were able for the first time to investigate the functional properties of 
phagocytes, following Hz ingestion, at the single cell level. Although impairment of cell 
functions by Hz was demonstrated previously, our investigation provided further 
information by suggesting that exposure to hemozoin can impair functions in cells that 
have not ingested hemozoin (such as phagocytosis). Whilst in other cases, such as the 
oxidative response, impairment was only observed in cells that had ingested hemozoin. 
We propose that this likely reflects hemozoin induced damage to different cell 
components, essential for these cellular functions that might only be located 
intracellularly, or might also be exposed to the extracellular environment. Because 
phagocytosis and the oxidative response were impaired upon hemozoin ingestion, we 
investigated how well these cells would control mycobacterial growth. Results obtained 
by us, suggest that PBMC infected with M. bovis BCG (BCG) following hemozoin 
ingestion, have higher mycobacterial loads than unfed controls, infected with BCG. The 
limitation of this study was that we were unable to compare Hz-containing and non-Hz 
containing cells, within the Hz-fed PBMC sample. This was because five days post-
infection virtually every PBMC contained hemozoin.  
 
We then investigated the kinetics of hemozoin using a murine model. Our 
hypothesis was that if hemozoin impairs important cell functions, and its presence in 
host tissues is long lasting and cumulative with each infection, then continuous malaria 
episodes and hemozoin deposition in host organs could have a major negative impact on 
host immunity. However, even though hemozoin presence in host organs has been 
recognized in several autopsies from individuals dying of malaria, it is not known what 
happens to hemozoin in these organs once an individual is no longer exposed to malaria. 
The challenge in answering such a question relies on the difficulty in accessing autopsy 
data from individuals dying from malaria un-related causes, but with a recorded history 
of malaria. Therefore, we decided to use the murine model to investigate hemozoin 
dynamics in host organs following malaria clearance. Using two models of murine 
malaria, it was observed that Hz accumulates in organs for long periods of time, and 
that there is a tendency for Hz to shift to larger agglomerates of intracellular localization, 
in livers and spleens. In the spleen, Hz showed a preferential localization within the red-
pulp
[343]
. Our results suggested that while hemozoin seems to be recycled by repeated 
phagocytosis, and may shift both within and between different organs (liver to spleen), 
evidence for hemozoin elimination was not clear. Hemozoin accumulation in the bone 
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marrow was also found, which might have important implications if the same occurs in 
humans. This accumulation in the bone marrow may contribute to inhibition of 
erythropoiesis, as already suggested by some, and contribute to severe malaria 
anaemia
[336]
. If Hz is not eliminated, or elimination only occurs at very slow rates, then 
inhibition of erythropoiesis and contribution of hemozoin to malaria associated anaemia 
might go far beyond malaria clearance/infection cure.  
 
The in vivo susceptibility of mice to a tuberculosis infection was also investigated. 
We first wanted to determined how these two diseases would interact, as published data 
using murine models suggested that tuberculosis infection could confer protection 
against malaria, whilst others suggested that tuberculosis infection would be 
exacerbated by malaria. Of note, all of the published studies on malaria co-infection 
found in the literature used tuberculosis infection first, followed by malaria. This was 
based on the hypothesis that BCG vaccination or a tuberculosis infection would protect 
against malaria. Alternatively, latency of tuberculosis infection would be disrupted by 
malaria and lead to tuberculosis reactivation, increased pathology and bacterial load. 
However, this might not be the more natural occurrence in the human setting. As 
malaria is typically a disease affecting very young children and tuberculosis normally 
affects adults, we assumed that tuberculosis would occur following a malaria episode, 
or the two might occur at the same time. We were also interested in investigating if 
hemozoin accumulation in host organs would increase tuberculosis disease, by 
increasing bacterial loads. Results obtained suggested that malaria co-occurrence with 
tuberculosis greatly decreased mice survival. This was likely due to an aggravated 
inflammatory response, because neither increased parasitaemia nor mycobacterial load 
was observed in co-infected animals, relative to control groups. Nonetheless, livers of 
co-infected mice tended to have more inflammatory leukocyte infiltrations and more 
necrosis. Mice chronically infected with malaria parasites did not succumb to disease 
upon BCG infection, as did mice during acute malaria. The model of chronic 
Plasmodium infection allowed the investigation of the contribution of hemozoin to 
tuberculosis infection. Results seem to suggest that hemozoin deposition in organs does 
not seem to increase tuberculosis related pathology. However, we did observe that 
hemozoin deposition occurred preferentially in granulomas. Thus, using a model of 
infection where virulent strains of tuberculosis are used, such as M. tuberculosis H37Rv, 
might reveal differences in terms of mycobacterial load, which was not observed here. 
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This is supported by studies showing that virulent strains of tuberculosis use 
granulomas to disseminate mycobacterial infection, and that virulence factors encoded 
within the RD1 region, which is absent in BCG, play an essential role in this granuloma 
manipulation
[85]
.  
 
Thus, although in vitro results suggest that hemozoin might have an important role 
in the modulation of phagocytic cell function, and may impair responses to other 
infections; in vivo hemozoin did not seem to play a very significant role. However, the 
contribution of hemozoin might be more apparent in vivo, in the context of an infection 
with a virulent strain, such as M. tuberculosis H37Rv. Hence, it would be interesting to 
investigate malaria-tuberculosis co-infection in C57Bl/6 mice using the P. chabaudi AS 
and M. tuberculosis H37Rv strains. It might also be important to use the natural route of 
infection, for each of the infectious agents (i.e mosquito bite for P. chabaudi and 
aerosol infection for M. tuberculosis), which might reveal further interactions, not 
addressed in our study. Another relevant approach would be to characterize Hz-
containing macrophages ex vivo. These macrophages could be obtained from livers or 
spleens of Plasmodium infected mice and then assessed for their functional capacity by 
flow-cytometry. This might provide further information as to the effects of hemozoin 
deposition in host organs. Moreover, as hemozoin would be acquired naturally as a 
result of the Plasmodium infection, doubts regarding the source of hemozoin, and 
confounding factors arising from the use of synthetic/isolated hemozoin, would not be 
in question here. Finally, our novel flow-cytometry method could also be used to study 
functional differences between hemozoin-containing and non-hemozoin containing 
leukocytes, from human malarious patients. Normally, these cells are present at low 
levels in malarious patients, which make functional analysis difficult. However, as our 
flow-cytometric method allows the detection of those cells which contain hemozoin, 
analysis of these cells might be possible, at significant levels, even when they are 
present at lower numbers.  
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